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Facial masking, the loss of expressive facial mobility in Parkinson’s disease, has the 
potential to impact communication, emotion perception, subjective wellbeing, and social 
relationship functioning. This unique symptom has been studied in the context of the 
healthcare and casual interactions, but little is known about how it affects people who have 
Parkinson’s in their family interactions. Since no cure for Parkinson’s disease presently 
exists, lessening the impact of the condition is an important aspect of Parkinson’s 
management.  However, research has been missing the voices of those who experience 
facial masking. This gap underscores the need to deepen our understanding of this symptom 
and the difficulties it may create. Thus, this research project sought to understand 
experiences and challenges related to facial masking in Parkinson’s, to transform those 
insights to targeted clinical tools, and to investigate the significance of masking in the 
psychosocial wellbeing of both people with Parkinson’s and their partners or family 
members.  
 In Study 1, in-depth personal accounts were collected of nine people who had 
Parkinson’s and their spouses or partners were separately interviewed about their 
experiences of facial masking. The study aimed to explore the common experiences and 
challenges related to facial masking, on an individual level and within close relationships.  
Facial masking was often falsely perceived by partners as a negative affect and wrongly 
interpreted to mean a lack of care or interest. The loss of expression and its 
misinterpretation was described as a barrier to emotional connection by some participants. 
Loss of the ability to physically embody one’s thoughts and feelings was unsettling and 
distressing for both people with Parkinson’s and their partners. The interviews revealed most 
participants had low awareness that this symptom was an aspect of Parkinson’s, with nearly 
all indicating a wish for greater education and support around this symptom.  
 Study 2 involved the development and validation of two separate questionnaires that 





Parkinson’s and the other for their partner, spouse, or other family member. Questionnaire 
items were derived from the findings of Study 1 and a review of relevant concepts in existing 
literature. Psychometric properties of the questionnaires were statistically evaluated among 
a community sample of 80 people who had Parkinson’s and 58 of their significant others. 
This included an item-level assessment, an exploratory investigation of the factor structure, 
an evaluation of the internal and test-retest reliability, and evaluation of the construct validity 
of the questionnaires. Results indicated the questionnaires had good reliability and initial 
evidence of validity. Modified (revised) versions of the questionnaires were produced based 
on the psychometric findings of Study 2.   
 Study 3 described the functioning of the participants in the psychometric study 
above. This study investigated the relationship between perceptions of facial masking and 
various psychosocial outcomes, and a study-specific measure of the impact of facial 
masking in Parkinson’s (developed in Study 2). Ratings of facial masking were made by self-
report and significant other reports, along with healthcare professional and researcher 
ratings based on a videotaped conversation. Healthcare professional ratings of FM were not 
found to be significantly related to self/significant other ratings of facial masking severity. 
Overall, having more negative consequences of FM was linked to poorer psychosocial 
outcomes, but suggested people with Parkinson’s and their significant others may be 
affected in different ways.  
 Findings of this programme of research add to what is known about the 
consequences of facial masking in casual and healthcare provider social interactions, by 
examining this symptom from the perspective of those living with facial masking in 
Parkinson’s. The results build upon and are generally consistent with the small amount of 
existing evidence showing that facial masking can have a detrimental impact on subjective 
wellbeing. The main implication of this research is that facial masking is a topic that warrants 
greater clinical attention and communication. The findings also call attention to the fact that 





condition and their families seem to lack knowledge about this symptom and desire greater 
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1. General Introduction 
 Facial masking (FM) is a symptom of Parkinson’s disease (PD) which causes an 
appearance of impassiveness and unusual stillness in the face. Investigation of this unique 
symptom has centred on the social perceptions of unfamiliar perceivers, overlooking the 
perspectives of people with Parkinson’s themselves and their families. Deepening our 
understanding of the impact of having FM could help to inform clinical practice and promote 
quality of life. This thesis helps to address that gap in two ways: firstly, by increasing 
understanding of the experiences and consequences of FM in the lives of people with 
Parkinson’s disease; secondly, by utilising those insights to inform the development of a 
questionnaire to detect the socioemotional consequences of facial masking. Existing 
assessments of facial masking do not address related aspects of wellbeing. This thesis 
presents and tests an alternative approach, drawing attention to the social and emotional 
difficulties related to facial masking, to better inform the management of wellbeing in 
Parkinson’s disease and lessen the impact of this condition on quality of life.  
 The thesis format follows the University of Waikato guidelines for the "with 
publication" thesis variant. This comprises traditional thesis chapters interspersed with 
research articles. The first two chapters introduce the topic of the thesis. Chapter 1 
describes Parkinson’s disease and provides background information about the disease 
context. Chapter 2 explains the symptom of facial masking, provides an overview of the 
literature mapping changes to facial expression in PD, reviews literature on the influence of 
facial masking for social perception, outlines the potential mechanisms involved in others’ 
responses to people who have facial masking, and summarises the two studies which 
previously investigated the psychosocial consequences of masking in people with 
Parkinson’s and their partners.  A summary and identification of gaps in the current literature 
is also provided. Chapter 3 outlines the present doctoral project with a description of the 
research aims, design, and assumptions, and briefly introduces each of the studies 





Study 1 presents a qualitative investigation of the experience of having facial masking. Study 
2 (Chapter 5) presents the development and validation of two novel questionnaires 
assessing FM impact. Study 3 (Chapter 6) presents an exploration of the link between facial 
masking and subjective wellbeing in Parkinson’s disease and compares how different 
perceiver ratings of masking severity are associated with psychosocial outcomes. A mixed 
methods summary of the integrated findings is presented in Chapter 7. Lastly, general 
discussion of the research findings, clinical implications, and conclusions are provided in 
Chapter 8.  
Parkinson’s disease: An Increasing Burden 
 PD has recently been identified as the fastest growing neurological disorder, 
exceeding the growth of conditions like Alzheimer’s disease (Dorsey et al., 2018). Across the 
lifespan, PD is the most common movement disorder and, together with essential tremor, is 
the second most common neurodegenerative disorder (Tanner & Aston, 2000). Rates of PD 
tend to rise sharply from middle age in studies of western populations, with estimates sitting 
at approximately 1% in the population aged 60 years (Nussbaum & Ellis, 2003; de Lau & 
Breteler, 2006) and 3–5% of the population aged 85 years or older (Fahn, 2003). PD does 
occur in younger age groups with approximately 4% of all PD patients showing clinically 
overt signs between the ages of 21–50 years (Alves et al., 2008). Incidence rates vary 
between studies and across countries, but a systematic review found international rates of 
220 to 670 per 100,000 per year for individuals 65–84 years of age, with the risk of PD 
peaking at about 75 years of age (Twelves et al., 2003). In Aotearoa New Zealand (NZ), the 
standardised incidence and prevalence rates of PD were most recently calculated from a 
community database of anti-parkinsonian medication users (Pitcher et al., 2014; Pitcher et 
al., 2018). Based on the total NZ population in 2013, values of 31 per 100,000 per year and 
220 per 100,000 per year were calculated for PD incidence and prevalence respectively 
(Pitcher et al., 2014; Pitcher et al., 2018). Using these rates, this would equate to just over 





estimates are likely to underrepresent the true rate, and therefore burden, of Parkinson’s 
disease. This is because many individuals may remain undiagnosed and because of 
diagnostic uncertainty during early stages of the condition. Early symptoms may be wrongly 
attributed to old age or other neurological conditions, and it is not unusual for a delay of 
months to years between the appearance of symptoms and clinical diagnosis (Breen et al., 
2013). 
 Several factors contribute to the increasing social and economic burden of 
Parkinson’s disease. In New Zealand, the growth of Parkinson’s disease is partly explained 
by an aging population structure (Wang et al., 2012), and because PD is mostly a condition 
of middle to later life (Alves et al., 2008), the number of people with aging related disorders 
such as Parkinson’s conditions is rising. Second, present therapies for Parkinson’s disease 
have limited efficacy. Even optimal pharmacological treatment only partially alleviates 
symptoms, and long-term use is constrained by dosage limits and the development of 
medication-related complications, such as uncontrolled movements (van der Marck et al., 
2009). Surgical and infusion treatment is usually only considered in a small number of cases; 
the benefits, and drawbacks of which are briefly discussed below. Third, the disease course 
is characterised by increasing disability paired with declining quality of life, yet there is 
limited impact on life expectancy. Factors which predict mortality in Parkinson’s populations 
are not well understood; survival seems dependent on the individual’s disease profile. For 
example, the survival rates for individuals diagnosed with Parkinson’s before the age of 60 
(Chaudhuri, et al., 2011) and for individuals with Parkinson’s who have largely intact 
cognitive function (Bäckström et al., 2018) are often reported to be similar to the general 
population. Older age at diagnosis and the presence of dementia or other Parkinsonism 
conditions are generally associated with a reduced rate of survival relative to the general 
population (Macleod et al., 2014). The most common cause of death in all people with PD is 
typically a comorbid disorder such as pneumonia (Beyer et al., 2001; Fall et al., 2003). While 
Parkinson’s disease itself is not fatal, it is a condition characterised by chronic and pervasive 





significant reduction across all areas of quality of life (van der Marck et al., 2009; Williams & 
Litvan, 2013). The wide-ranging symptoms of PD require integrative, patient-centred 
approaches to routine PD care (Eggers et al., 2018). However, the provision of day-to-day 
support often relies on familial caregivers until the individual has high care needs. Given 
these unique disease factors and with the expected number of people with PD on the rise, it 
is important to document the broader implications of PD in the context of an individual’s life.   
Clinical Characteristics, Pathology, and Aetiology 
 Parkinson’s disease (PD) is a progressive neurodegenerative disorder. Historically 
considered a disorder of movement, current understanding of PD also incorporates a wide 
range of motor and non-motor symptoms.  PD falls under the umbrella of Parkinsonism, a 
general term for a cluster of neurological disorders characterised by movement-based 
dysfunction. The essential feature of this syndrome is bradykinesia, a slowness and reduced 
amplitude of muscular movement with a weakening of repetitive movements, along with 
additional features of rigidity and/or resting tremor (Bartels & Leenders, 2009; Williams & 
Litvan, 2013; Postuma et al., 2015).  Aside from PD, Parkinsonism also encompasses 
corticobasal disease, multiple system atrophy, progressive supranuclear palsy, Parkinson’s 
with Lewy bodies, and Parkinson’s dementia (with the latter two conditions collectively 
known as Lewy body disease). Clear definition among these disorders is yet to be 
established, in part because there is overlap of clinical presentation and treatment options. 
However, when compared to other Parkinsonism disorders, PD is the most prevalent and is 
characterised by relatively better outcomes in treatment and prognosis. Current diagnostic 
criteria for PD includes the presence of at least two of the following motor symptoms: resting 
tremor, bradykinesia, rigidity or postural imbalance, and the absence of atypical features 
which may indicate another condition (Fahn, 2003; Alves et al., 2008; Jankovic, 2008). Other 
key features of PD include secondary motor symptoms, such as gait changes and speech 
difficulties, and non-motor symptoms such as autonomic dysfunction, cognitive and 





 Onset of PD is often subtle, and the course of the disease is characterised by great 
individual variation in symptomology and progression. Preclinical and dominant symptoms 
vary widely across people with the condition. There is no widely available definitive test for 
PD, so diagnosis typically relies upon the presence and progression of clinically overt 
features (Litvan et al., 2003; Bartels & Leenders, 2009). Discriminating between conditions 
of Parkinsonism may be not immediately possible, and it is not uncommon for initial 
diagnoses to be updated over the disease course.  Some individuals may be diagnosed 
under the general term "parkinsonism" and only receive a definitive diagnosis at autopsy or 
through longitudinal observation of the disease course (Clough & Sethi, 2003; Alves et al., 
2008). In New Zealand, a clinical diagnosis of Parkinson’s involves a medical history, an 
interview, and a neurological examination (Neurological Foundation of New Zealand, 2013). 
Several additional criteria are supportive of establishing a PD diagnosis and are considered 
important features in discriminating among types of Parkinsonism, such as asymmetric 
symptom onset and a positive response to anti-Parkinsonian medications (Williams & Litvan, 
2013).    
 The stages of PD progression may be classified using a rating system (Hoehn & 
Yahr, 1967). Recent revisions of the system classify five stages and two substages of the 
disease (Goetz et al., 2004). Progression is seen from a unilateral presentation with very 
minimal functional impact to bilateral presentation with increasing impairment of functionality 
(see Table 1). The median time between PD stages has recently been evaluated in a 
relatively large group of people with PD (N = 695, mean age in years = 65.2, male gender = 
57.3%). The transition between stages 2 to 2.5 was identified as generally the longest, at a 
median time of 62 months, with all other stage transitions between 20–26 months. The total 
(median) transition time from the first to final stage was found to be 157 months or 








 The symptoms of Parkinson’s disease are thought to be caused by 
neurodegeneration (cell death), which disrupts nigro-striatal circuits of the brain through the 
depletion of the neurotransmitter dopamine (Hornykiewicz, 2008). The hallmark of this 
condition is the selective death of cells in a region called the substantia nigra pars compacta, 
a component of the basal ganglia system located within the mid-brain (Less et al., 2009). 
The basal ganglia are involved in several brain functions but are essential to the facilitation 
and coordination of motor movement. In simple terms, when the decision to make a 
movement occurs, the inhibition of the basal ganglia on the motor system is released. This 
leads to excitation of the motor cortex, which then signals the muscles and allows movement 
(Bonnet & Houeto, 1999; Takakusaki et al., 2004). The neurotransmitter dopamine is 
essential to enhancing the actions of basal ganglia pathways underlying motor movement. 
Table 1  
Simplified description of clinical classification of PD staging and median time to transit 
between stages.  
Stage: Characteristics: Time to 
transit 
stages  
0 No signs of disease - 
1 Unilateral involvement only; minimal or no functional impairment - 
1.5 Unilateral disease - 
2 Bilateral disease, without impairment of balance 20 
2.5 Mild bilateral disease  62 
3 Mild to moderate bilateral disease; some postural instability;  
independent but needs help with activities of daily living. 
25 
4 Severe disability; still able to walk or stand with help of equipment 24 
5 Wheelchair bound or bedridden unless aided 26 
 
Note. PD staging descriptions simplified from Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force 
report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on 
rating scales for Parkinson's disease. Movement disorders 2004;19(9):1020-28. 
Median transit time in months as reported by Zhao YJ, Wee HL, Chan YH, et al. Progression of Parkinson's disease as 





When dopamine is depleted in PD, the inhibition of the basal ganglia on the motor cortices is 
harder to release, and the net result is difficulty in initiating and coordinating movement. Put 
simply, declining levels of dopamine in PD reduce the ability of the brain to effectively 
communicate with the muscles of the body. This makes movement slower and less 
coordinated and sometimes causes abnormal movements like shaking (tremor) or freezing. 
The depletion of dopamine also has implications for non-motor functions such as cognition, 
emotion, behaviour, sensory perception, and autonomic processes (Chaudhuri & Quinn, 
2014). 
 While the neurodegenerative process of Parkinson’s disease is well understood, the 
aetiology of this degeneration has been less well-established. Researchers have generally 
proposed that an interaction of environmental, occupational, lifestyle factors, and a genetic 
susceptibility contribute to the pathogenesis of the disease. Risk factors consistently 
mentioned in the literature include the following: exposure to pesticides (Brown et al., 2006); 
head injury in early life (Taylor et al., 2016); and male gender (Picillo et al., 2017). Other 
variables which have limited, or conflicting evidence include exposure to environmental 
pollutants (heavy metals, organic solvents, magnetic fields); high levels of inflammation; 
comorbidity (diabetes, cancer, and other neurological conditions); high alcohol consumption; 
low physical fitness; and various dietary patterns or food groups (de Lau & Breteler, 2006; 
Wirdefeldt et al., 2011). Although a genetic contribution to the disease has been long 
proposed, genetic mutations are thought to account for only small proportion (<10%) of the 
aetiology of this condition, outside of the small minority of hereditary Parkinson’s disease 
(Alves et al., 2008). 
The Status of Therapeutic Options 
 No current treatment effectively prevents or halts the progression of PD. Since its 
introduction in the 1960s, the mainstay has been dopamine replacement therapy, which 
aims to increase levels of the neurotransmitter dopamine in the brain (Hornykiewicz, 2010). 





remaining substania nigra cells, rather than replacing it. Unfortunately, within a few years of 
treatment and due to the progression of the disease, the benefits of dopamine replacement 
therapy fade, and likelihood of unpleasant complications increases (Marsden & Parkes, 
1977; Marsden, 1994). The limitations of dopamine replacement therapy led to the 
introduction of other treatments including catechol-O-methyltransferase (COMT) and 
monoamine oxidase type B (MAO-B) inhibitors, which act by extending levodopa/dopamine 
half-life. To minimise symptom fluctuations in response to oral pharmacotherapy, the 
delivery of levodopa and dopamine agonists can be improved by using an infusion pump, 
which continuously delivers the agents to the bloodstream. Surgical procedures also exist, 
such as deep brain stimulation, a form of electrical stimulation via a pacemaker-like device 
which can restore function of the motor system, possibly through minimising abnormal 
activity in mid-brain structures (Lozano et al., 2002). Although generally considered to be 
safe and effective, surgical procedures are typically recommended to only those patients 
who have responded poorly to pharmacological intervention, such as having severe side 
effects or fluctuations in response to medications (Lozano et al., 2002). While surgical 
treatment offers clinical improvement of motor symptoms in PD it does not treat the root 
cause, providing limited benefit for the progression of dopamine depletion (Hilker et al., 
2005). Only a small number of people are approved each year for surgical treatment of 
Parkinson’s disease in New Zealand (Neurological Foundation of New Zealand, 2013). 
Given present limitations on medical treatment and the chronic decline of functioning that 
occurs in Parkinson’s, it is perhaps not surprising to find that a growing body of literature 
focuses on improving subjective wellbeing and quality of life in this condition. 
Expressive Loss in the Parkinson’s Context  
 To this point, Parkinson’s disease has been framed as neurodegenerative movement 
disorder primarily caused by a dopamine deficiency. However, difficulties carrying the 
movements required for walking or in activities like dressing are only part of the picture. The 





identity, and self-concept (Bramley & Eatough, 2005). Often, PD is described to imprison the 
individual within an increasingly unresponsive shell (Anonymous, 1999; Tickle-Degnen, 
Zebrowitz & Ma, 2011). Not only are people out of tune within their own bodies, but also 
diminished in their ability to communicate and express themselves to others due to the 
disease-related changes. The following sections briefly introduce the modalities of self-
expression that may become impaired in PD, such as speech and facial movement.  
 Speech and communication deficits are common symptoms of Parkinson’s, evident 
in up to 89% of individuals (Dashtipour et al., 2018). Verbal communication is impacted by 
wide ranging symptoms stemming from both the physical and cognitive production of speech 
(Forrest et al., 1989; Sapir et al., 1999; Dashtipour et al., 2018). Deficits in emotional 
expression also occur in verbal communication, namely in the impairment of emotional tone 
or prosody of the voice (Penner, 2001; Schröder et al., 2010). Changes to vocal prosody in 
PD (a loss of loudness, alternations to pitch, and a slowing of the tempo of speech) tend to 
be observed by others as sad or lacking emotion (Pell et al., 2006). It has been proposed 
that the social consequences of changes to vocal prosody are not only a difficulty in 
communicating intelligibly but also decreased social-linguistic competence and a tendency 
for listeners to perceive the communication of people with PD in misleading or detrimental 
ways (Pell et al., 2006). Further to this, one the most impactful aspects about having a 
speech disorder in PD was the effect on social participation and family connections, (Miller et 
al., 2006). Miller and colleagues (2006) also found the social impacts of changes to speech 
occurred before speech intelligibility was overtly compromised. This suggests it is clinically 
important to address disease related changes with respect to their impact for psychosocial 
wellbeing, and this might require earlier intervention than waiting until physical functioning is 
impaired (Miller et al., 2006).    
 Other abnormalities of bodily movement occur (including but not limited to tremor, 
freezing, dyskinesia, and dystonia) and may contribute to a visible physical difference, 
marking out individuals who have PD in ways that tend to be negatively interpreted by 





rigidity, slowness, and decreased coordination seen in the movement of the body similarly 
affects facial musculature, causing a reduction of movement and therefore emotional 
expression in the face.   
Facial Expressive loss in other clinical conditions 
 Research has highlighted that the expression of emotion is vital to effective 
communication, crucial to the ability to partake in social interactions, and a fundamental 
aspect in determining subjective wellbeing (Ishii et al., 2011; Ishii et al., 2018), and has 
explored the role of facial expressive loss in other clinical conditions. Deficits in facial 
movement and expression occur in number of medical and psychiatric conditions. This 
includes congenital or acquired facial paralysis where one side or all the facial muscles lose 
the ability to move (Valls-Solé & Montero, 2003); and traumatic brain injury, where there can 
be a reduction in the expression of emotions (Kupferberg et al., 2001; de Sousa et al., 2011; 
McDonald et al., 2011).  Facial expressive deficits may also occur in psychological disorders 
such as depression where the experience and expression of emotion may become flattened 
(Jaeger et al., 1986; Gaebel & Wölwer, 1992; Sloan et al., 1997); and in schizophrenia, 
where the experience of emotion may become dissociated from displays of expression or 
emotion on the face (Bleuler, 1911; Andreasen, 1982; Gelber et al., 2004; Gur et al., 2006; 
Kohler et al., 2008). Facial expressive loss in PD is set apart from these conditions because 
FM is gradually acquired, progressive, and because there is often simultaneous impairment 
of the other channels of communication such as speech and bodily gesture (as outlined in 
the section above). This uniqueness also means knowledge drawn from other clinical 
populations about the consequences and treatment of facial expressive loss may not be 
universally applicable to FM in PD.  
 Nevertheless, literature in other clinical populations recognises the significance of 
facial expressive loss and encourages awareness of the broader implications in social and 
emotional functioning. In brain injury, the reduction of expressivity is linked to deficits in 





In congenital facial paralysis, decreased self-perception of the ability to communicate 
emotion has been associated with reductions in quality of life (Coulson et al., 2004). There is 
evidence of the negative influence of facial paralysis on subjective emotional well-being and 
the ability to maintain relationships, emotion recognition abilities of perceivers; and with 
respect to issues and interventions for communication (May & Schaitkin, 2000; Bogart et al., 
2012; Bogart et al., 2014; Bogart & Tickle-Degnen, 2015; Michael et al., 2015). In acquired 
facial palsy, a positive association between the altered or diminished capacity for expression 
and greater psychological distress has been shown (Fu et al., 2011). In facial neuromotor 
disorders, a specific impairment in the ability to smile has been associated with greater 
levels of depressive symptoms (Van Swearingen et al., 1999).  
 The social and psychological dimensions of facial expressive dysfunction in PD have 
not received similar attention in scientific literature. This is perhaps because the traditional 
focus of PD treatment has been on the physical symptoms which lead to difficulties in 
performing activities of daily living. Indeed, the characteristics healthcare providers focus 
clinical attention on in PD often differ from patient reports of the most bothersome 
symptoms. In one study, dressing, ambulating, and cognitive difficulties associated with 
motor sequencing were considered by experts to be characteristic problems of Parkinson’s, 
but patients themselves reported that such issues concerned them less than cognitive and 
psychosocial symptoms of the condition (Abudi et al., 1997). The focus of clinical 
communication and treatment in PD may have changed in the last 20 years, yet symptoms 
like FM, which may be less physically debilitating but take a toll on subjective wellbeing, 







2. Facial Masking in Parkinson’s disease 
Clinical Features & Occurrence 
 Facial masking is variously called hypomimia, amimia, facial bradykinesia, masked 
facies, or more colloquially as "the Parkinson’s mask". This thesis uses the term facial 
masking or FM. From a medical perspective, FM is defined as the loss or reduction of facial 
expression. From patients’ perspective, FM is a reduced ability to express one’s emotions, 
thoughts, and characteristic behaviours on their faces (Lyons et al., 2004). The net result 
being the individual seems increasingly unresponsive, and therefore uninterested, in the 
environment around them (Bologna et al., 2013). Clinical staging instruments define FM as a 
loss of facial emotional expressivity which is manifested by a decreased blink frequency, 
less spontaneous smiling, and the parting of lips when the mouth is at rest (Goetz et al., 
2008). Neurophysiological studies of the face in Parkinson’s disease have also identified 
various facial folds which become flattened around the nose, mouth, and eyes (Bandini et 
al., 2017).   
 Disease-related changes to positive expressions, as well as an overall reduction of 
expressivity, seem to play a significant role in FM in PD. Video analysis of behavioural cues 
during naturalistic interaction in people with PD and matched cardiac disease controls 
revealed individuals with PD showed a majority of smiles without a cheek raise, known as  
phoney smiles, with very few genuine smiles (Pitcairn et al., 1990).The Parkinson’s group 
also showed very few other emotional expressions, while the cardiac group showed a range 
of different expressions (Pitcairn et al., 1990). Posed expressions of happiness have also 
been studied and are shown to be less recognisable and lack a cheek raise (Simons et al., 
2004), and spontaneous expressive reactions to humorous stimuli are also reduced in 
frequency in people who have PD compared to healthy controls (Katsikitis & Pilowsky, 
1991).  
 Despite being a distinctive feature of PD, just a few studies have formally measured 





were investigated from routine care visits (Fereshtehnejad et al., 2017). FM was measured 
by the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008), with 
FM recorded in approximately 37% of the participants at baseline, rising sharply to around 
92% of participants at follow-up, where the average follow-up duration was 4.2 years 
(Fereshtehnejad et al., 2017). Another recent study provided a description of 89 people who 
had PD who were also clinically evaluated using the MDS-UPDRS, finding some degree of 
FM present in 70% of the sample cohort at the point of testing (Ricciardi et al., 2020). For 
comparison, other characteristic symptoms of PD occur at similar rates. Resting tremor has 
been observed in 75% people with PD throughout the stages of the disease (Hughes et al., 
1993), and speech difficulties are found in 89% (Dashtipour et al., 2018). This suggests FM, 
while not as well-known or noticeable as other symptoms of PD, is just as ubiquitous.   
 Previous FM research in PD has focused on three main areas of investigation. First, 
early papers typically turned attention to defining facial movement deficits and their 
underlying neural mechanisms. Second, the implications of FM were examined for general 
social functioning, namely in the context of casual and healthcare interactions. Third, a small 
number of recent studies have examined the consequences of FM from patient-centred 
perspectives. The sections below summarise key findings from each area of existing 
research and highlight some of the gaps in present knowledge of FM. 
Mapping Facial Masking  
 Early investigations of FM concerned the differential impairment of spontaneous 
versus voluntary facial movements and the related discussion of the neural bases 
underpinning facial motor control. While there was a consensus that spontaneous 
expressions were impaired in Parkinson’s, some disagreement existed about the impact on 
voluntary expressions. This debate originates from theories about the neural bases of the 
motor system. A classic review of the neuropsychology of facial expression suggested the 
impairment of basal ganglia function underlies the reduced spontaneous expressivity 





were thought to originate from cortical regions, with voluntary facial movement believed to 
remain intact. Initially, evidence seem to give weight to the dissociation of movement 
systems. In one such study, the intensity and frequency of posed and spontaneous 
expressions of PD patients and healthy age-matched controls were compared while 
watching emotionally evocative stimuli. The people with Parkinson’s had fewer overall 
spontaneous facial reactions to the stimuli than controls (Smith et al., 1996). In contrast, the 
posed expressions of the participants seemed to remain intact (Smith et al., 1996). Later 
research put forward that volitional and spontaneous expressions might be differentially 
impaired. More specifically, the individuals with Parkinson’s were found to have greater 
difficulty concealing or intensifying their negative expressions and a slightly increased 
difficulty in intentionally mimicking facial movements than the control group (Simons et al., 
2003). 
 The type of relationship between the person with masking and the perceiver may 
also impact expressivity. When people with PD were recorded speaking with a researcher 
and then with their spouse, participants displayed greater expressivity when interacting with 
the researcher (an attentive but unfamiliar person) than when secretly observed in 
conversation with their spouse (Simons et al., 2004). There was some inconsistency in the 
findings, however, as the posed expressions of the same people with Parkinson’s (when 
explicitly instructed) were found to be markedly impaired. Although it is possible that 
voluntary expressive ability varies by social context, the researchers suggested this finding 
could be better explained by the heightening of emotion when an amicable but unknown 
individual is present, which prompted greater expressivity from the participants with PD 
(Simons et al., 2004). This suggests greater expressive loss occurs in primary social 
relationships, rather than with unfamiliar social partners. Thus, it could be proposed that any 
consequences of FM are amplified in private social contexts, such as with family and close 
friends.   
 At present, the scientific literature seems to have reached consensus that marked 





facial expression does take place, it is typically less severe than that of spontaneously 
arising facial movements. Several studies have contributed greater detail to the 
understanding of voluntary facial expressive impairment in Parkinson’s disease. Compared 
to healthy controls, the voluntarily induced (posed) facial expressions of Parkinson’s patients 
were reduced in speed and size (Bowers et al., 2006). Computer-based analyses of posed 
smiles found these expressions have a lower speed and intensity in individuals with 
Parkinson’s compared to healthy controls, and that posed expressions were not improved by 
dopamine replacement therapy (Marsili et al., 2014). Currently, it is proposed the loss of 
fluidity and spontaneity of all movement (controlled by the basal ganglia system) has a 
negative influence on voluntary movement, as well as an evident impairment of spontaneous 
movement (Rinn, 2007). Two major theories have been proposed to explain a basal ganglia-
controlled deficit in expressive movement. One theory proposes an impairment in the 
activation of motor program circuitry for movement such as facial expressions. Both selected 
and non-selected motor programs become suppressed, along with an impairment of the 
timing of activation of different programs (Nambu, 2005; Bowers et al., 2006).The second 
theory describes a corruption of motor programs responsible for movement of facial muscles 
and the resultant facial expressions (Bowers et al., 2006) 
 More recent trends in FM research explore techniques for recording the extent of 
facial expressive loss and identifying the presence of FM. Computer and video-based 
methods have utilised both objective assessments and subjectively coded rating systems to 
analyse facial behaviours (Wu et al., 2014; Gunnery et al., 2017). This is discussed further in 
Study 3, so will not be elaborated upon here. 
Impact of Facial Masking on Perceiver Impressions 
 The impressions formed by perceivers when interacting or viewing a person with FM 
show a consistent negative bias. Investigations of how people with FM are socially perceived 
suggest that inaccurate judgements are made of character, mood, or mental state (Lyons et 





clinicians were warned the person with PD may appear to have lost feeling or intelligence 
because they do not seem engaged in conversation, and that true character may be 
concealed by an outward impression of coldness and indifference (Monrad‐Krohn, 1957). 
Recent evidence shows perceivers evaluate individuals with FM in an unfavourable light, 
describing them as cold, moody, unfeeling, avoidant, or even intellectually impaired 
(Monrad‐Krohn, 1957; Pentland et al., 1987; Abudi et al., 1997; Chiong-Rivero et al., 2011; 
Hemmesch, 2014). For the most part, research exploring this impression bias has 
concentrated on the viewpoints of unfamiliar perceivers. For example, when strangers 
judged the social desirability of people with Parkinson’s and healthy age-matched controls 
from videotaped interview excerpts, people with Parkinson’s were rated as less involved, 
interested, intelligent, optimistic, attentive, and physically attractive (Schwartz & Pell, 2017).    
 Unfamiliar perceivers are not the only group susceptible to misinterpreting FM as 
feelings or attitude. Even healthcare professionals make more negative judgements of 
people with FM. When clinicians were shown silent videotapes of people with heart disease 
and people with Parkinson’s disease, judgements of the individuals with Parkinson’s were 
negatively biased (Pentland et al., 1987). Clinicians had unfavourable evaluations of the 
people with Parkinson’s’ intellect, affect and personality traits, despite there being no 
measured difference between the Parkinson’s and Cardiac groups. When 19 speech therapy 
students were shown videos of four people with Parkinson’s and four people with ischaemic 
heart disease, impressions were measured using visual analogue scales (Pentland et al., 
1988). Both groups demonstrated irregularities on standard psychological testing, but 
compared to the cardiac group, the PD group were rated as “more anxious, hostile, 
suspicious, depressed, bored and tense than the controls; they seemed less intelligent, more 
introverted and passive and looked as if they enjoyed and maintained their part of the 
conversation less well” (Pentland et al., 1988, pg. 31). Even for experienced healthcare 
practitioners with greater knowledge of PD, it may be difficult to override the usage of facial 
expressions to form impressions of personality. A more recent study compared personality 





Parkinson’s who had varying levels of expressive dysfunction (Lyons et al., 2004). 
Unsurprisingly, the students were reported to form particularly inaccurate judgements of 
personality as FM increased, but both students and experts rated individuals with higher 
masking less positively, especially in interpersonal and affective domains (Lyons et al., 
2004). The authors concluded that even experienced practitioners may be prone to using 
behavioural cues associated with Parkinson’s symptomology to make judgements of 
personality or other individual characteristics (Lyons et al., 2004).  
 The greater the degree of expressive dysfunction, the more negative impressions of 
an individual with FM tend to become. For example, healthcare professionals evaluated 
individuals with higher levels of FM as less socio-emotionally competent and less likeable 
than those with mild FM (Lyons et al., 2004; Tickle-Degnen et al., 2011). This finding has 
also been replicated with naive observers who were not familiar with the person they were 
watching. When strangers viewed video clips (with filtered verbal content) of people with FM, 
they were less interested in relationships with individuals who had a higher severity of FM 
(Hemmesch, 2014). Greater masking has also been associated with impressions of less 
social supportiveness (Hemmesch et al., 2009). 
Theoretical Explanations of Facial Masking 
 The following sections summarise the social and cognitive mechanisms currently 
thought to underlie the effects of FM. Two broad areas of research that may help to explain 
how FM is interpreted with reference to emotional perception and social interactions. 
Interaction with Social and Cultural Norms  
 The impact of FM in PD may be greater when it contradicts social or cultural 
expectations of behaviour. Researchers have suggested that FM could have greater 
influence on perceivers' impressions of women who have Parkinson’s compared to men who 
have Parkinson’s. In Western societies, women are expected to be more socially expressive 
than men (Fischer & Manstead, 2008; Hemmesch et al., 2009), so when expressivity is 





perceivers for the lack of expression (Hemmesch et al., 2009). Gender bias in healthcare 
practitioner’s impressions of people with PD has also been evidenced, with more negative 
impressions formed of women with FM than men with FM (Tickle-Degnen et al., 2011). 
There is limited evidence that the impression bias resulting from FM extends to different 
cultures. When experienced Taiwanese and American healthcare professionals were shown 
speech filtered video clips of people with PD, practitioners from both countries judged 
individuals with higher levels of masking in ways that were less favourable those with lower 
masking (Tickle-Degnen et al., 2011). As pointed out by Tickle-Degnen and Lyons (2004), 
more research is needed to understand how practitioners, or any social partner, can better 
attune to markers of personality and mental state in individuals with Parkinson’s. 
Neuropsychological Mechanisms 
 Few studies have explored the neuropsychological basis of disruptions to social 
functioning that result from facial masking in PD. Various theories of emotion may help to 
explain the possible influence of FM for human interaction. The following section summarise 
these theories in relation to FM for perceivers and then for people with PD, as originally 
outlined in the work of Argaud and colleagues (2018).  
 The apparent pervasiveness of the FM impression bias, even in groups such as 
doctors who are aware facial behaviours are invalid cues of mood or personality in PD, may 
occur because the brain processes emotional signals automatically and without intention or 
conscious awareness of doing so (Lakin & Chartrand, 2003; Lakin, 2006; Lakin et al., 2008). 
In laboratory conditions, inferences made about social characteristics can be performed as 
quickly as 100 milliseconds (Willis & Todorov, 2006).  
 One explanation for why FM leads others to come to the wrong conclusions about 
the thoughts, feelings, and attitudes of someone with FM might be the impact of the loss of 
mimicry for the perceiver. Humans rapidly and automatically synchronise facial activity with 
that of people around us, often without conscious awareness; this activation can be so subtle 





see in others aids empathy and enables understanding of other mental states, actions, and 
intentions (Carr et al., 2003). When a mechanical or chemical block of facial musculature 
(and therefore facial expressions) is performed experimentally in healthy individuals, emotion 
recognition in those individuals becomes temporarily compromised (Oberman et al., 2007; 
Neal & Chartrand, 2011; Ponari et al., 2012). It has previously been shown that when people 
with Parkinson’s are less able to display expressions, it can make them appear cold or 
uncaring to perceivers (Smith et al., 1996; Brozgold et al., 1998). This may be because 
signals that would be mimicked by and facilitate emotion understanding for the perceiver are 
blocked by the facial masking of the person with PD. It might also be that the face of 
someone with FM does not synchronise (mimic) emotion of the perceiver during social 
interactions, cutting off feedback of the perceiver's own emotion in the face of the person 
with FM.  
 Perceivers may judge the emotional or mental state of people with FM as negative 
because socially reinforcing expressions, like making a smile, seem to be selectively 
affected in PD. People with PD are demonstrated to be able to reproduce a frowning 
expression to some degree but are shown to have greater difficulty mimicking the smile of 
another person (Livingstone et al., 2016). The ability of people who have PD to mimic some 
expressions (e.g., frowning) but not others (e.g., smiling) may reflect that areas of the face 
are thought be somewhat neurologically independent but tend to be perceived as an overall 
signal by others (Gunnery et al., 2017).   
 When we see the emotional displays of other people, we respond with subjective 
internal experience as well as external expressive action (Dimberg & Thunberg, 2012). 
Emotion contagion is a process where emotional states of others are mirrored in our own felt 
experience (Hatfield et al., 1993). Although mimicry and contagion processes are inter-
twined, mimicry is defined by a matching of external facial displays, and contagion is defined 
as the internal mirroring of felt experience. Emotion contagion is thought to be an automatic 
process which facilitates the felt experience of emotion (Hess & Blairy, 2001). It is thought 





as the facial feedback hypothesis (Buck, 1980; Adelmann & Zajonc, 1989). When perceiver’s 
own internal mirroring of felt emotion or expressive actions are blocked by FM, they may 
have greater difficulty accurately recognising the emotion of the person with PD.   
 With respect to the experience of people with PD, it is much less clear how emotion 
simulation processes such as emotion mimicry, emotion contagion, and facial affective 
feedback are influenced in people who experience FM and what this could mean. There is 
evidence that people with Parkinson’s also have difficulty recognising the emotions of others, 
with some speculating deficits in emotion perception could be associated with reduced 
mimicry (Peron et al., 2012; Ricciardi et al., 2015). Whether a mimicry deficit in PD is 
selective for certain emotions, or more generalised, has been debated. One meta-analysis 
suggested the recognition of negative emotions is more greatly impaired, compared to 
positive emotions (Gray & Tickle-Degnen, 2010). However, another recent study found a 
decrease in facial mimicry for mainly positive expressions that was associated with poorer 
recognition of positive and neutral expressions (Argaud et al., 2016). A second review 
pointed out that the inconsistencies in these findings may be related to variations in 
methodology, stimuli, or analytic procedures, such as using a restricted range of emotions or 
the way emotions were classified (Argaud et al., 2018). On the other hand, there is evidence 
in non-clinical populations that mimicry of only minimal cues is necessary to predict the 
internal state or behaviour of others (Baron-Cohen et al., 1997), and emotion recognition is 
also found to be intact in conditions where expressive mimicry is absent from birth, such as 
Moebius syndrome (Rives Bogart & Matsumoto, 2010).  
 Another factor that may influence Parkinson's disease patients and their perceptions 
of emotions in others is the presence of affective disorders. Depression (Cummings, 1992), 
apathy (Pluck & Brown, 2002), alexithymia (Assogna et al., 2012), anxiety (Latoo et al., 
2013), and involuntary emotional expressive disorder (Latoo et al., 2013) can occur in 
Parkinson’s. Along with the blocking of emotion simulation processes by FM, all of these 
disorders have a potentially separate or overlapping influence on how people with PD see 





recognition deficits in PD were linked to greater levels of interpersonal distress (Clark et al., 
2008). Similar findings have been observed in non-PD populations where having depression 
delays the processing of sad emotion information and results in a bias towards interpreting 
neutral faces as negative (Gollan et al., 2008). However, as noted by Argaud et al., (2018) 
the nature and direction of the link between depression with emotion recognition in people 
who have PD is currently unclear.  
 In summary, FM may lead other people to draw the wrong conclusions about an 
individual with FM’s thoughts, feelings, or attitude because it hinders the usual signals which 
facilitate socioemotional perception in the perceiver. Two ways FM may do this are by 
blocking perceivers’ internal mirroring of emotional experience or action, and by cutting off 
perceivers from receiving feedback of their own emotion in the face of someone who has 
PD. In people who have FM, socioemotional functioning may become compromised through 
the PD-related dysfunction of cognitive systems underlying emotion perception, together with 
or in addition to FM dampening important mechanisms of emotion simulation (Argaud et al., 
2018). Where FM potentially lessens the ability to recognise and respond to the feelings of 
others, for people with PD and others who perceive them, it seems reasonable to assume 
the quality of social interactions and relationships could become compromised. 
Living with Facial Masking 
 Relatively few studies have explored the consequences of having FM, investigated 
the impact of FM on social perception in primary social relationships, or explored the link 
between FM and wellbeing for people who have PD and those who share closely in their 
lives. During the planning of this thesis no research focused on living with FM for people with 
PD and their family relationships had been published.  
 Research on broader themes of the PD experience offered the first glimpses of the 
social and psychological consequences of FM. In a study exploring personal accounts of the 
impact of PD, focus groups and one-on-one interviews were conducted with PD patients (n = 





cities. Transcripts were analysed to deduce themes, using a cutting-and-sorting approach to 
organise and code conceptually related segments of text. One participant was noted to 
speak about the deep effect of FM on their personal relationships:  
“It was really hard on her in the beginning because I had symptoms, you know, a few 
years before and I had the mask face and everything, and ... I’d throw water in my 
face because I would just be so stiff in that, and evidently, she thought that I was 
losing interest in her, and once I got the Sinemet and we found out what happened 
and all the dystonia went away, you know, she cried because she thought I didn’t 
love her anymore. She’d say something and I’d ... be smiling at her, but she couldn’t 
really see it”. (Chiong-Rivero et al., 2011, p. 61)  
Perceivers may mistake the lack of expression for emotional detachment of the person they 
knew and loved, leading to a state of increasing alienation for both (Chiong-Rivero et al., 
2011). The researchers further proposed that the loss of facial movement was emblematic of 
the greater PD experience as it came to signify the sense of imprisonment within an 
unresponsive body that characterises the disease and the reality of having an utterly life-
changing condition (Chiong-Rivero et al., 2011).  
 Two recently published studies have investigated the connection between FM and 
wellbeing. The relationship between FM with social life and relationship quality was 
examined in one study of 40 American PD patients and their care partners, recruited from a 
specialist clinic and a community sample across the Boston region (Gunnery et al., 2016). It 
was not clear how care partners were defined, for example, whether they were also in a 
romantic relationship. PD and care partner participants separately rated facial masking 
severity by estimating the general expressivity the face using the following question: ““In 
general, how much difficulty does your partner have showing expression (emotion) in their 
face” (Gunnery et al., 2016, pg. 3). Ratings of expressive difficulty were made on a five-point 
scale where 1= no difficulty and 5= very severe difficulty. They also completed measures to 
assess social rejection (as a composite of perceived social isolation and perceived stigma in 





using Pearson correlations to investigate the relationships among facial masking with social 
wellbeing variables, and multiple linear regression was used to test whether reports of 
expressive difficulty predicted social rejection and partner enjoyment, independent of 
depression, in people with PD and their care partners.  
 No mean difference was found between PD participants and care partner participants 
ratings of expressive difficulty (t (39) = 1.00, p = .32), however, no statistically significant 
correlation was found between PD and care partner ratings (Gunnery et al., 2016). In care 
partners, higher ratings of expressive difficulty were found to be significantly correlated with 
less enjoyment of the relationship (r = −.55, p < .001) and greater perceptions of social 
rejection (r = .35, p < .05), care partner enjoyment was predicted by care partner's 
perceptions of the degree of expressive difficulty, but no associations were found with PD 
enjoyment (Gunnery et al., 2016). The relationship between greater expressive difficulty and 
reduced enjoyment of relationship was also found to be independent of depression. With 
respect to the PD participants, a significant positive correlation was found between 
expressive difficulty and social rejection (r = .41, p < .05), but no association was found 
between expressive difficulty and relationship enjoyment in the participants with PD 
(Gunnery et al., 2016). Depression in the PD participants was also found to have significant 
large correlations with their own ratings of expressive difficulty (r = .56, p < .001) and with 
social rejection (r = .70, p < .001) (Gunnery et al., 2016). Findings of the regression analysis 
showed that depression, but not expressive difficulty, predicted social rejection in PD 
participants. The latter is an interesting finding because it could be expected that the more 
expressive difficulty someone has, the more difficult socioemotional interactions could 
become and the less they are able to understand and share in emotions of the other, leading 
to decreased enjoyment in their interactions. However, that is not what Gunnery and 
colleagues found (2016). They proposed one explanation for this finding may be disease-
related deficits known to occur in the emotion recognition abilities of people with Parkinson’s 





partner's response to the lack of expression, in turn sheltering their perceptions of the 
relationship.  
  Although self-reported ratings of FM by participants with PD and care partners were 
shown to be similar in the Gunnery and colleagues’ study (2016), the ratings did not have a 
statistically significant correlation and the accuracy of ratings of expressive difficulty were not 
assessed. While there is limited evidence that people with PD are aware of their expressivity 
deficits, further investigation of this topic might to help explain the differences seen in the 
outcomes of expressive impairment for people with PD compared to their partners. It seems 
pertinent to evaluate the accuracy of self/partner ratings of FM severity against expert 
clinical evaluation or other measures of expressive ability, and to assess the level of 
agreement (whether ratings were concordant and where there are differences) within PD 
and care partner dyads. The relative lack of negative outcomes for people with PD reported 
by Gunnery and colleagues (2016) is puzzling, when considering qualitative evidence that 
proposes FM can inhibit healthy engagement in social life and relationships for PwP 
(Chiong-Rivero et al., 2011) and may have negative outcomes for psychological health, such 
as emotional distress or embarrassment about facial appearance (Abudi et al., 1997). Even 
if relationship enjoyment and social rejection are not affected by FM for people who have 
PD, it remains unknown what impact FM might have on other aspects of mental wellbeing 
such as anxiety, stress, and coping, or the impact on other aspects of social relationship 
functioning such as communication, affection, closeness, or social supportiveness. Related 
to this, it would be interesting to further explore the separate and shared ways that FM 
potentially influences the wellbeing of people who have PD and those closest to them.  
 In another study of FM and wellbeing, stigma and gender were explored as potential 
mediators of the relationship between FM and decreased quality of life (QOL) in people who 
have Parkinson’s disease (Ma et al., 2019). Depression was also examined as a separate 
(parallel) mediator of the relationship between FM and QOL, because it is thought to be 
linked with the ability to show expression in the face (Girard et al., 2014) and linked with 





have been long associated with having PD (Nijhof, 1995; Bramley & Eatough, 2005; 
Simpson et al., 2013). A stigmatised person is one who feels different from what is normal or 
expected, and as such, may feel marked out, tainted, discounted, or reduced (Maffoni et al., 
2017). Ma and colleagues (2019) examined the relationship between FM, stigma, gender 
and quality of life in 90 Americans with Parkinson’s, drawing from data of an ongoing 
longitudinal investigation of social self-management in PD (Tickle-Degnen et al., 2014). 
Participants were asked to complete a series of self-report questionnaires. Facial masking 
severity was assessed by asking participants to make a global self-rating of the level of facial 
expressive difficulty using the single item earlier reported in Gunnery et al., (2016), where a 
rating of 1 = no difficulty and 5 = very severe difficulty. Self-ratings were compared with 
clinical evaluation of FM severity on the MDS-UPDRS and found to have a small statistically 
significant correlation (r = .22, p < .05). Stigma was measured using the Stigma Scale for 
Chronic Illness (SSCI), a self-report questionnaire that includes assessment of felt and 
enacted stigma. Symptoms of depression were measured using the Geriatric Depression 
Scale (GDS) and quality of life was measured using the Parkinson’s disease Questionnaire 
(PDQ-39); both are self-report measures. People with PD who reported greater expressive 
difficulty also tended to report more feelings of stigma. This association predicted lower 
levels of quality of life and was stronger when the gender of the person with PD was female. 
Depression was also found to mediate the impact of masking on quality of life, but this 
relationship was weaker than that of stigma, and the stigma pathway remained when 
controlling for depression. For people who have PD, this indicates that greater perceptions of 
stigma arise when the impassive appearance of FM breaks implicit expectations of 
behaviour during social interaction. Ma and colleagues (2019) proposed that when 
appropriate facial behaviours cannot be performed, it elicits unfavourable reactions from 
others by diverging from expected norms of facial behaviour or is seen as a defect. People 
with FM who perceive greater levels of stigma may internalise a sense of defectiveness and 
experience emotional distress (Ma et al., 2019). However, the role that greater perceptions 





family members and friends, remains unclear.   
 Ma and colleagues (2019) and Gunnery and colleagues (2016) findings give a 
preliminary indication of some of the impacts masking may have on emotional and social 
wellbeing for people who have PD and for their family members. As these two studies were 
published after this thesis began, the present research methods and materials were not 
selected to build upon their work. However, the findings of the present thesis do add to what 
is now known about FM by further exploring the consequences of FM in the context of the 
close social relationships in the home.    
Clinical Evaluation and Management of Facial Masking 
 At the time of planning this thesis around 2014, scientific literature and educational 
resources regarding the clinical management of FM were lacking. Patient health education 
was scarce and characterised by medical interpretations of FM, with information often limited 
to short physical descriptions and little discussion of the impact of this symptom for daily life. 
More recently, a growing appreciation of this symptom and broader implications is seen. A 
simple Google search presently reveals that several PD support organisations include 
educational resources about FM, how it may be misread by others, and the possible impacts 
for families.  
 Despite the progress in online information, very few clinical evaluation tools include 
FM. Clinical staging instruments include measurement of FM severity (such as the 
Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale; Goetz et al., 2008) 
but do not include any questions to assess FM-related psychosocial dysfunction. PD-specific 
quality of life (QOL) instruments exist, but also do not include questions to assess FM 
impact. For example, the PDQ-39, a commonly used measure of QOL in PD, includes three 
questions about social functioning, but none refer to the loss of facial expression (Marinus et 
al., 2002). It is noted, however, that QOL instruments may still indirectly capture FM impact 
in PD, as they include domains potentially relevant to FM-related difficulties, such as 





 A third area where FM is little addressed in the literature is rehabilitation. Parkinson’s 
rehabilitation programs are typically comprised of speech, physical and occupational 
therapy, delivered in a group or individual format. Standardised treatment systems include 
the Lee Silverman Voice Treatment Programs, which are intended to help improve 
communication and mobility in activities of daily living (Ramig et al., 1988; Ramig et al., 
1995; Farley & Koshland, 2005). Although physiotherapeutic programs are usually targeted 
at general mobility rather than FM per se, evidence demonstrates they may help protect and 
promote facial movement, at least in the short term (Dumer et al., 2014; Ricciardi et al., 
2020) .Whether treatment with medication alleviates FM is also unclear as some studies 
show medication has little benefit on the ability to pose expressions (Marsili et al., 2014), yet 
others suggest overall masking severity is improved with medication (Ricciardi et al., 2020). 
Psychological approaches to managing FM are not reported in the published literature.  
Summary & Gaps in Existing Literature 
 In summary, a small but growing body of literature has examined FM. Research has 
focused on mapping the facial motor deficits manifested in PD and has recognised the 
impact of FM for casual and healthcare interactions. Yet there is still much to be understood 
about FM. Little is known about the consequences of FM for people with Parkinson’s 
themselves. For example, how do people who have FM and their significant others perceive, 
interpret, and respond to the loss of facial expression? In the scientific literature, it remains 
unclear whether the negativity bias shown to impact the impressions of strangers and 
healthcare professionals also generalises to primary social relationships, such as those with 
close family and friends. If unfamiliar perceivers tend to form automatic and inaccurate 
impressions of people with masking, would spouses or family members also have difficulty 
correctly detecting what their loved one is thinking and feeling? Alternatively, could the 
heightened familiarity between individuals in close relationships override the impression bias 
and any detrimental effects of facial masking? Additionally, despite initial evidence of a link 





have been scarcely explored. For example, little is known about the possible factors 
associated with better or worse adjustment to this symptom, or whether facial masking 
affects people with PD and their significant others in distinct or overlapping ways. If FM has 
the potential to shrink vital social connections in the context of a chronic and debilitating 
illness, it seems pertinent to explore the social and psychological consequences of FM in 
PD.  It is these unanswered questions which guide the focus of the present thesis.   
 





3. Research Outline 
General Aims   
 The overall aims of this programme of research were twofold: to better understand 
lived experiences of FM from perspectives of people who have PD and their significant 
others, and to assess the link between FM and psychosocial wellbeing in PD. Enhancing 
understanding of FM was achieved through gathering personal accounts of having FM in 
daily life and by examining the association between FM and subjective wellbeing in PD.  
 Until a cure for Parkinson’s disease or an effective treatment for FM is found, it is 
imperative to find ways to help people and their families cope with the condition. Thus, the 
approach adopted in this research forms part of a growing trend that explores social 
participation and emotional wellbeing in PD (Winter et al., 2010). A focus on social and 
psychological wellbeing is particularly vital in PD because these domains have been found to 
play a larger role in patient's perceptions of health and wellbeing than physical symptoms 
(Abudi et al., 1997; Chrischilles et al., 2002).    
 The novel contribution of the present programme of research lies assessing the 
impact of FM for PD patients and their families, in building knowledge of the link between FM 
and wellbeing, and in developing targeted clinical tools that provides opportunities for 
dialogue about FM and the management of this symptom in day-to-day life. The broad intent 
of this thesis was shaped by pragmatic and applied approaches, with the research questions 
and methodology driven by a wish to have the findings be of value to people who experience 
FM and to inform professional practice. 
Research Design  
 This research comprises a series of three studies investigating FM in people who 
have Parkinson’s disease and individuals that are part of their primary social relationships 
(partner/spouse, adult family members or close friends). A summary of the research design 





(2017). Broadly speaking, the research design can be divided into four phases (Creswell, 
Plano Clark et al., 2003):  
o Qualitative data collection and analysis 
o Development of a quantitative instrument and identification of variables for analysis  
o Quantitative data collection and analysis 
o Joint interpretation of the findings  
 This sequence reflects an exploratory sequential mixed-methods design. The timing 
of the design is consecutive, meaning the quantitative phase was conducted after the 
qualitative data collection and analysis was completed. The research began with in-depth 
semi-structured interviews to explore individual accounts of facial masking and enrich 
understandings of expressive dysfunction in the context of daily life. It was important the 
initial step was exploratory since there was limited knowledge or theory to build upon at that 
time.  
 The subsequent quantitative phases of the research were then developed. The 
choice to construct a psychometrically valid clinical tool and the identification of relevant 
variables for further investigation, was driven, in part, by the qualitative findings. The 
quantitative phase can be further divided into psychometric and conceptually oriented 
studies. In the former, the qualitative findings were used to inform the development of two 
targeted self-report questionnaires (one for people with Parkinson’s and one for significant 
others), followed by an evaluation of their psychometric properties. The latter investigation 
examined the association of perceived FM with psychosocial outcomes in PD. A summary of 
the studies included in the qualitative and quantitative phases is provided in the following 
sections, with each study described in further detail in their respective chapters of this thesis 
(4–6). The juncture between the qualitative and quantitative components of this research is 
the first point of integration, as the qualitative findings (themes and codes) were used to 
build the quantitative instrument (generate items for the questionnaires). The second point of 





quantitative findings is presented together (Chapter 7).  Additional analyses which could not 
be incorporated into the separate papers for Studies 1-3 are also included in their respective 
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Psychological health, close 
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social support, caregiver 
strain, and quality of life. 
Data Collection   
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Note. Figure adapted from Berman, E. A. (2017). An exploratory sequential mixed method approach to understanding researchers’ data management practices at UVM: Integrated findings to 




Research Rationale & Positionality 
 A mixed-methods design was selected as it was considered best to accomplish the 
aims of the study, and because it aligns with the adoption of pragmatist and applied 
orientations. Pragmatism is an action-oriented process, which mixes research methods and 
presents a joint interpretation of research findings (Teddlie & Tashakkori, 2012). Taking up 
this orientation can be traced to my background in population health, clinical psychology, 
and more broadly to applied fields of social science, which emphasise practical application in 
the treatment of ill-health and the promotion of wellbeing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 To summarise, the basic assumptions of mixed methods are as follows: the nature of 
reality is both singular and multiple; a practical approach is taken to focus on addressing the 
research problem and the best methods to answer it effectively (Teddlie & Tashakkori, 
2012). The process of research mixes inductive data (using personal perspectives to build 
common patterns and interpretations) and deductive data (testing a priori theory) (Creswell & 
Plano Clark, 2017). Mixed methods is distinguished by a cyclical method involving an 
exploratory process, where theory or variables may be generated from the data, and a 
confirmatory process, where theories are tested (Johnson & Gray, 2010; Denzin & Lincoln, 
2011). By incorporating both types of findings, a fuller and more balanced account of a 
phenomenon can be provided (Morse & Niehaus, 1994; Onwuegbuzie & Leech, 2004; 
Onwuegbuzie et al., 2007; Creswell & Plano Clark, 2017). As recommended by 
Onwuegbuzie and Leech (2005), the framework of Greene, Caracelli, and Graham (1989) 
was used in defining the purpose of the core design: expansion (multiple standpoints or 
realities provide an enriched account of the under-researched phenomenon of FM than 
either method alone might provide), development (to use the results of the qualitative 
exploration of FM experiences to inform the construction of an instrument or intervention), 
and complementarity (to verify and elaborate on the results from the qualitative phase using 
the results from the quantitative phase). 




the design is considered apt when little is known about the phenomenon or the variables of 
interest are largely unknown (Creswell & Plano Clark,2017), as is the case with the present 
research topic.  Secondly, the selection of an exploratory sequential sequence was a 
response to the status of FM research at the time of planning this thesis. Beginning the 
research by gathering individual accounts of masking was important because the 
investigations of FM had been largely constrained to the social judgements of unfamiliar 
perceivers, rather than understanding the everyday significance of having this symptom or 
having a loved one with this symptom. In addition, giving voice to the perspectives and 
experiences of people who have FM was thought appropriate within the context of optimal 
PD management, which encompasses an equal consideration of medical treatment and the 
impact of living with the condition, both for people with PD and those they share their lives 
with (van der Eijk et al., 2011; Lim et al., 2017; Bloem & Brundin, 2020). 
 Thirdly, the decision to use an exploratory sequential design was also a response to 
the status of FM within PD care in New Zealand at the time of planning this thesis. Informal 
discussions with healthcare practitioners and PD support organisations at that time (around 
2014) suggested FM was a topic given little clinical attention compared to other aspects of 
the disease. While the practitioners commonly observed FM, most had rarely spoken with 
their patients/clients about this topic. Rating tools available at the time (Goetz et al., 2008; 
Tickle Degnen, 2010) also did not provide evaluation of the impact of FM in PD. It was these 
observations, along with a pragmatist orientation, which contributed to the selection of an 
emergent design that could explore personal experiences of FM and apply relevant insights 
to the construction of a clinical tool sensitive to the consequences of this aspect of PD in 
everyday life.  
Qualitative Phase Summary: Study 1 
 Study 1 aimed to explore personal accounts of people with PD and their partner's or 
spouse’s experiences of FM. In-depth, semi-structured interviews with people who reported 




symptom might influence psychological and social wellbeing of people with PD and their 
spouses and considered how wellbeing may be enhanced and managed. An approach of 
interpretive description was adopted to generate new knowledge that has clinical relevance 
and could make a difference to people who experience masking and their families (Thorne et 
al., 1997; Thorne et al., 2004). 
 Specific hypotheses were not identified prior to data collection, but assumptions 
about what types of topics might be important to people with FM and their families were 
derived from existing literature relating to facial masking in PD and other populations. 
Interview topics included the following: general/history information, personal impact of having 
FM, perceived impact of FM for their close relationships, reactions to FM in other social 
contexts, and ways of coping with FM.   
 Interview participants (n = 9 couples) came from a general community sample 
recruited through advertisements placed in national publications and a public hospital 
intranet in the North Island of New Zealand. Inclusion criteria included a diagnosis of 
idiopathic PD with masking status clarified when potential participants first made contact by 
checking whether reported descriptions of facial appearance were broadly consistent with 
markers of FM in PD. Face-to-face interviews were conducted separately with PD 
participants and their spouse or partner to allow for open discussion of potentially sensitive 
topics (n = 18 interviews). Telephone interviews were also conducted with subset of 
participants located outside of the central North Island of New Zealand (n = 12 face to face 
interviews, n = 6 telephone interviews). Analysis of the interview data followed the guidelines 
of thematic content analysis, with an inductive (or descriptive) approach employed (Braun & 
Clarke, 2006). A detailed description of the study is provided in Chapter 4. 
Quantitative Phase Summary: Study 2 and Study 3 
 The quantitative phase of the research involved two studies, which shared the data 
collection phase, but were analysed separately and had different aims. Study 2 was 




questionnaires to assess FM-related difficulty in people with PD and their significant others. 
Study 3 was conceptual, exploring the nature and strength of association between perceived 
FM with health and wellbeing outcomes in PD. In the (shared) data collection phase, a 
community sample of people who have Parkinson’s (PwP) and their significant other (SO) 
were recruited from multiple centres across the North Island of New Zealand, via 
advertisements to PD support group members (n = 80 PwP, n = 58 SO). SO could include a 
spouse or partner, close friends, or family members (aged over 18 years). Eligibility was not 
based on FM status so that participants had a range of FM severity from normal expression 
to severe FM. Participants were asked to complete self-report rating scales assessing 
various aspects of health and wellbeing. PwP were able to optionally consent to a 
videotaped conversation with the researcher to assess the level of facial expressivity.  
 A flowchart breaking down the basic steps of Study 2 is provided in Figure 2, with a 
detailed description of the study materials and methods provided in Chapter 5. The aim of 
developing two new questionnaires was to aid understanding of the consequences of FM for 
people who have PD and their loved ones, and to provide a structured way to identify people 
that need help or support with this symptom. Thus, the first objective of Study 2 was to 
generate items for the preliminary questionnaires and evaluate the content validity, general 
feasibility, and clinical applicability. Item content was primarily generated from the interview 
data obtained in Study 1. Existing assessment measures were also reviewed for 
conceptually relevant content which could be adapted to fit the experiences of interviewees. 
Two separate forms of the questionnaire were developed: one for people with PD, and one 
for significant others. The pre-test version of the two questionnaires were revised through 
expert consultation and feedback from people with PD and their partners from the original 
interview sample. The second objective of Study 2 was to statistically evaluate the 
psychometric properties of the two questionnaires. The revised preliminary questionnaires 
were then administered to a sample of people with PD and their significant others 
(participants who had PD n = 80, significant other participants n = 58) on two separate 




item-level evaluation, factor structure, reliability, and validity testing. A final version of the 
questionnaire was then developed based on the psychometric findings and suggestions for 
future revisions compiled. Supplemental data, which was submitted for publication but could 
not be included in the main manuscript for reasons of brevity, is presented in separate 
appendices for Study 2.    
 
Provisional items generated directly 
from prior thematic analysis 
Preliminary questionnaires completed by participants 
 
Revised by expert opinion  
 
Revised by consumer feedback  
 
Initial questionnaire content developed   
Figure 2 
Flowchart summarising the procedure of Study 2 
Item-level evaluation  
Existing literature reviewed & 
potential items adapted within  
thematic framework 
 
Factor structure investigated  
Internal consistency & test-retest reliability examined  
Construct validity examined 









 There were two broad aims of Study 3. First, to explore how FM is perceived by 
people with PD themselves and their family members. Four groups provided ratings of FM 
severity: PwP and SO who separately reported facial masking severity on a study specific 
self-report measure; Parkinson’s nurses who provided clinical assessment of FM staging 
from a videotaped conversation; and a researcher-rated evaluation of facial expressive 
behaviour using the videotaped conversation. The second aim was to examine the effects of 
FM on wellbeing, by examining the association between FM severity and various 
psychosocial outcomes for PwP and SO. Other factors which impact psychosocial outcomes 
in PD were also examined. Self-report questionnaires measuring psychological health, social 
functioning, and quality of life were completed by people who had Parkinson’s and their 
significant others. Supplementary data on the coding procedure for the video is presented 
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Objective:  Facial masking is a characteristic symptom of Parkinson’s disease, traditionally 
measured by determining symptom severity. Existing measures are based on clinicians’ 
observations and may not address experiences of living with facial masking day to day. We 
report the development and validation of two self-report questionnaires for use with people 
with facial masking and their significant others. 
Method: Questionnaire items were generated from in-depth interviews with people self-
reporting facial masking, their partners, and relevant literature. Expert opinion and feedback 
from members of the interview group were used to refine the provisional items. Preliminary 
questionnaires were administered to a separate sample (N = 138) for psychometric 
evaluation. 
 Results: The Parkinson’s version of the questionnaire (n items = 28) measures facial 
masking severity and impact, comprising individual and relationship difficulties subscales (n 
= 6 each). The Significant Other version is a unidimensional measure (n items = 30), with a 
single facial masking difficulty subscale (n = 18). Internal and test-retest reliability were good 
(Parkinson’s version subscales α = .830, r =.762, and α =.765, r = .729, Significant Other α 
=.936, r = .895). Convergent validity was supported by satisfactory correlations with scales 
measuring emotional health, relationship satisfaction, quality of life, and caregiver strain 
(Parkinson’s version all r’s > .25, Significant Other all r’s > .26, p < 0.05).  
Conclusion: The Facial Masking Questionnaire provides assessment of socioemotional 
consequences of FM. Psychometric evaluation showed the questionnaires are reliable and 








 Parkinson's disease (PD) is a chronic and progressive neurodegenerative condition 
characterized by difficulty with motor-movement.1 It has a negative impact on subjective 
wellbeing, and as PD is common in middle to older age, poses an increasing burden on 
aging societies2. Since research into PD treatment is ongoing, increasing attention has 
turned to improving the lives of people with PD and their families. This article describes the 
development of a tool to assess and monitor the social and psychological consequences of 
facial masking in PD.  
 Facial masking (FM), variously known as Hypomimia, facial bradykinesia, or the 
mask of Parkinson’s, is the reduction of facial emotional expressivity. It arises from motor 
deficits which occur in the muscles of the body in PD, including the muscles of the face. FM 
can result in an unusual stillness of the face and reduces the capacity to express emotions 
and convey thoughts and intentions3. FM may be in present in 70% 4 to 90% 5 of people with 
PD, but its impact on the experience of everyday life in PD is poorly understood.  
 The bulk of existing research focuses on the influence of FM on the social 
impressions of strangers6-8 and healthcare practitioners.9-11 These studies find that even 
experienced healthcare practitioners are not immune to the influence of FM and form a 
negative impression of those with FM. However, research has largely overlooked the impact 
of living with FM for people with PD and their families. The consequences of having FM, or 
having a loved one with FM, remain largely unexplored. 
 Two assessment tools offer evaluation of FM status in PD (MDS-UPDRS and ICRP-
PD)12 , 13 yet no self-report questionnaire to measure FM-related psychosocial difficulties has 
been developed. Quality of life instruments for PD14-18 also omit specific reference to FM. 
Existing measures typically assess FM severity focusing on blinking, active expressivity in 
the face, and active lip/mouth closure during speech.12, 13 These methods are useful for 
research or clinical staging, rather than evaluating the impact of having FM day to day.  
 There are several reasons that justify the development of an assessment tool 
measuring FM impact. Foremost, evidence shows the negative consequences of FM extend 




associated with having FM, and being female, are found to predict poorer quality of life in 
people with PD.19 FM also adversely impacts relationship enjoyment for PD care partners.20 
Secondly, because PD treatment aims to lessen the impact of the condition on people’s 
lives21, 22, addressing problems associated with FM is a worthwhile undertaking. The 
development of a measure will help to generate insights about the concerns and needs of 
individuals living with FM. Indeed, some individuals have poor FM awareness or may not 
bring up this topic with their healthcare providers, and many reported a desire for increased 
access to FM education and support.23 This is not surprising given the challenges of 
providing information in a complex condition like PD.24, 25 However, it is important that 
clinicians who work with PD increase their own and their patients’ awareness of the 
psychosocial consequences of FM. Thus, our intent in developing a new measure was to aid 
understanding of FM’s consequences in close relationships, and to provide a structured way 
for healthcare professionals to identify individuals that need help or support with this 
symptom.  
 This paper describes the process of questionnaire development and initial validation 
among a community sample of people who have Parkinson’s and their significant other 
(partner, close friend, or family member aged over 18 years). The first objective was to 
generate items for the preliminary questionnaire and evaluate its content validity, general 
feasibility, and clinical applicability. Secondly, we examined the reliability and construct 





MATERIALS AND METHODS 
Item Generation & Scale Construction 
This questionnaire aims to capture perceptions of the extent of expressive impairment and 
rate the amount of emotional and social difficulty associated with FM. As FM effects 
individuals who have PD and the people around them, separate versions of the 
questionnaire were developed for people with PD (PwP) and their significant others (SO, 
partner/spouse, adult family member, or close friend). Although item content varies, each 
version covers similar dimensions associated with FM: psychological characteristics or 
distress, and difficulties in close relationships (including relationship quality). 
 Figure 1 summarizes the development of The Facial Masking Questionnaire (FMQ). 
Scale construction followed the steps outlined by DeVellis26 and Creswell & Plano Clark.27 To 
incorporate experiences of FM in everyday life, items were primarily generated from semi 
structured interviews with people with PD who self-reported FM and their partners.23 Existing 
literature was reviewed for conceptually relevant variables that could be adapted to fit the 
experiences of individuals with FM and their partners. Expert opinion and healthcare 
consumer feedback was used to refine the preliminary items. This was followed by 
psychometric evaluation and item reduction of the questionnaires. A more detailed 
description of the development process and preliminary items is provided in the 
Supplemental Data Appendix I.  
 The preliminary FMQ-PwP and FMQ-SO each contained 37 items (Supplemental 
Data Appendix I).  The first two items asked individuals to rate the severity of FM on a 4-
point scale (#1), and to rate knowledge their knowledge of FM (#2). This was followed by 28 
items assessing emotional and social difficulties associated with FM in close relationships. 
Items (#3-30) were rated by selecting how often each statement occurred/applied to them on 





 Participants were then asked three questions to screen for psychological health  (I 
feel uncertain, worried, or concerned; I feel angry, irritated, or frustrated; In general, I feel 
happy or in good spirits) using the same Likert response scale. This was followed by two 
open ended questions asking about strategies they use for coping with FM, and to describe 
their experiences of living with FM. The last two questions asked participants to rate the 
overall FM-related difficulty on a 5-point scale (#36), followed by a yes/no item asking if they 







Provisional items generated directly from the prior 
thematic analysis 
Format and response style determined 
• Studies assessing expressive loss in other contexts 
(i.e., medical professionals, strangers, other clinical 
populations) 
• Scales measuring emotional expressivity, relationship 
quality/marital satisfaction, PD-specific wellbeing, 
quality of life, and caregiver strain  
 
• Review of semi-structured interview data  
of people self-reporting FM and their spouse or  
partner (N = 18) 
• Theme, subtheme, code, and extracts translated 
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- Perceived Impact  
Expert Opinion / Item Revision 
(experts n = 6) 
Healthcare Consumer Feedback / Item Revision 
(original interviewees n = 4) 
Preliminary version of the Facial Masking Questionnaire (FMQ) 
(PwP version n = 37 items, SO version n =37 items) 
Shared and separate item content developed for  
each questionnaire  
Figure 1 
Flowchart summarizing the development and validation of The Parkinson’s Facial Masking Questionnaire (FMQ-
PwP and FMQ-SO). 
Psychometric Evaluation & Item Reduction 
(N = 138, PwP n = 80, SO n = 58) 
Conceptually relevant literature reviewed, and 




Validation of the Facial Masking Questionnaire  
Design and Setting 
 The questionnaires were validated in a cross-sectional multiple center study that 
included 138 participants. This comprised people with PD (PwP, n = 80) and their significant 
other (SO, n = 58) who came from a general community sample across different regions of 
the North Island of New Zealand (NZ). Several waves of advertisements seeking participants 
were placed in PD support group newsletters and emailed directly to support group 
members. Data collection took place throughout March to November 2019.  
 After potential participants made contact, they were telephoned and screened for 
eligibility. Potential participants were provided with verbal/written information about the 
study, before being asked if they consented to taking part. Testing took place at participant’s 
home or workplace.  At the conclusion of testing, participants were asked if they were happy 
to take part in retesting in approximately one month’s time.  
Inclusion and Exclusion Criteria 
 Individuals with a diagnosis of idiopathic PD were eligible to participate. Those who 
self-reported diagnosed cognitive impairment or who had difficulty conversing in English, 
were excluded. Individuals with PD but who did not have a significant other were eligible to 
participate. Selection was not made on the basis of FM status, so that participants had a 
range of FM severity from none to severe. 
Assessment  
 Demographic and disease-related variables were collected first. The two Facial 
Masking Questionnaires (FMQ-PwP & FMQ-SO) were administered alongside other self-
report scales assessing health and wellbeing. Individual Expressive Disposition was 
assessed using The Berkeley Expressivity Questionnaire (BEQ).28 A modified BEQ was also 
created for SO participants to complete. Affection and enjoyment dimensions of social 




subscales of the Rand Medical Outcomes Study – Social Support Survey (MOSS-SSS)29, 
which has previously been used in people with PD and their partners.20 Participants whose 
SO was a marital or long-term partner rated relationship satisfaction using the Kansas 
Marital Satisfaction Scale (KMSS).30 To measure psychological health, PwP completed the 
Hospital Anxiety and Depression Scale (HADS)31, which has been found valid in PD 
populations.32 Quality of life for PwP was assessed with the Health-related Quality of Life 
Instrument: Fifteen dimensions (15D).33 SO quality of life was assessed using the World 
Health Organization Quality of Life Assessment -Short Version (WHOQOL BREF)34. Strain 
related to caregiving role in SO participants was measured using the Caregiver Strain Index 
(CSI).35  
Statistical analyses 
 All analyses were calculated using IBM SPSS (version 26 for windows). 
Demographic and disease-related variables are presented descriptively. PwP and SO 
versions of the Facial Masking Questionnaire were analyzed separately. Psychometric 
analyses focused on the main scale items (#3-30). Items with occasional (< 15%) missing 
values were replaced with item means for analysis, because losing further data in this 
relatively small sample could influence the generalizability of the analysis and bias factor 
loadings.36 
 Items were assessed for suitability in a number of different ways including, no more 
than 15% of missing data, the use of a range of response options (≥ 3),37 item mean within 
±1 of the mid score, item mean within ± 0.50 of the median, and item standard Deviation >  
0.75. Floor and ceiling affects were examined, with items scrutinized case by case basis to 
consider items that did not meet the above requirements but focused on conceptually or 
clinically important information for some individuals.38 Such items were excluded from the 
factor analyses as they are likely to produce uninterpretable factor390 but were retained in the 
final questionnaires (see Table 2).  
 The dimensionality of the main items was examined using Exploratory Factor 




scale where little is known a priori, screening addressed the overall factorability of the data, 
rather than data reduction. This involved checking conceptually related items were clustered 
together in the range of 0.2 to 0.9.38 Principal Axis Factoring was performed, and scree plot 
inspection and Kaiser’s Criterion (eigenvalues ≥1) were used to identify interpretable factors. 
Sampling adequacy (Keiser-Meyer-Olkin statistic), sphericity (Bartlett’s test), and anti-image 
matrix diagonal/off diagonal values were checked.  
 The internal consistency of items comprising each factor was tested by Cronbach’s 
alpha coefficient. An alpha of > .7 40 , 41, mean inter-item correlation range of .15 to .50 42, 
and item-subscale correlations of > .4 43 were taken as acceptable.  
 Test-retest reliability of the questionnaire subscales was evaluated using an 
Intraclass Correlation Coefficient (ICC, two-way random effect model with absolute 
agreement)44, and evaluated according to guidelines for psychological instruments.45 
 Convergent validity was examined by comparing correlation coefficients between the 
scores on the FMQ with scores on rating scales measuring related wellbeing constructs. 
Criterion validation could not be conducted for the main items, as no corresponding measure 
could be located for comparison. The extent to which FM-severity rating (a single index item) 
corresponded with the Berkeley Expressivity Questionnaire, an existing measure rating 
individual expressive disposition, was examined.   
Approval and consent  
 Ethical approval for this study was received from the University of Waikato Human 
Research Ethics Committee, prior to commencement (ref#2018:46). Respondents received 
verbal/written information about the study and gave their informed consent before 






Demographic and Disease-Related Data  
A cohort of 138 participants (PwP n = 80, SO n = 58) were included in the sample. The 
demographic and clinical characteristics for the participants are displayed in Table 1.            
Psychosocial Consequences of FM  
 The right-hand column of Table 1 shows the mean FMQ scores by self or SO-
reported level of FM; 66.25 % (n = 53) of PwP reported themselves to have FM, and 86.21% 
of SO (n = 50) reported FM. Most participants categorized FM severity as low or moderate 
(PwP 63% and SO 81%). For both PWP and the SO, those reporting higher levels of FM 
severity obtained higher total scores on the FMQ. A similar pattern was observed for the 
other health and wellbeing scales; those with more severe FM had more anxiety/depression 
symptoms (HADS: PWP), lower marital satisfaction (KMSS: PWP & SO), increased 
caregiver strain (CSI: SO), lower social support (MOS-SSS: SO) and poorer psychological 







Table 1  
Sociodemographic and clinical characteristics of study participants  
PwP Participants (n=80) 
Demographics                                                                                                         Health and wellbeing measures mean (SD) range 
Age in years mean (SD) range 69.64 (9.36) 44.00-86.00 MOS-SSS Total Score 7.94 (1.58) 4-10 
Male n (%) 57.00 (71.25%) KMSS Total Score 19.36 (2.34) 12-21 
Early Onset < 50 years n (%) 6.00 (7.50%) HADS Total Score 10.16 (6.04) 0-29 
Time since diagnosis mean (SD) range 6.40 (4.99) 0.50-22.00 15D Total Score .734 (.09) .47- .93 
FM self-reported at eligibility n (%) 60 (75.0%) FMQ -PwP Total Score  
Dopamine Replacement n (%) 74.00 (92.50%)           Self-rated FM None 4.93 (3.25) 0-11 
No medication n (%) 4.00 (5.00%)           Self-rated FM Low 7.88 (3.71) 2-17 
Deep Brain Stimulation n (%) 3.00 (3.75%)           Self-rated FM Moderate 12.22 (7.48) 3-27 
New Zealand or Other European n (%) 73.00 (91.25%)           Self-rated FM Marked 20.67 (5.51) 15-26 
Māori & Pasifika n (%) 5.00 (6.25%)   
Other ethnic background n (%) 3.00 (3.75%)   
Retired or unable to work n (%) 65.00 (81.25%)   
Married/Living together n (%) 68.00 (85.00%)   
Took apart alone n (%) 22.00 (27.50%)   
Lives in private home n (%) 73.00 (91.25%)   
SO Participants (n=58) 
Demographics                                                                                                         Health and wellbeing measures mean (SD) range 
Female n (%) 45.00 (77.59%) MOS-SSS Total Score 7.58 (2.02) 2-10 
Relationship length mean (SD) range 41.97 (12.52) 11.00-62.00 KMSS Total Score 1.24 (4.13) 3-21 
New Zealand/Other European n (%) 55.00 (94.83%) WHOQOL Psychological Health  14.37 (1.96) 9.33 -17.33 
Other ethnic background n (%) 2.00 (3.45%) WHOQOL Social Relationships  15.37 (3.09) 6.67–20.0 
Māori n (%) 1.00 (1.18%) CSI Total Score 3.55 (3.17) 0-10 
Retired n (%) 40.00 (68.97%) FMQ -SO Total Score  
Has current illness n (%) 9.00 (15.52%)           Self-rated FM None 3.75 (3.37) 1-10 
Tertiary Education n (%) 31.00 (53.45%)           Self-rated FM Low 12.03 (8.68) 0-38 
Took part with spouse/partner n (%) 55.00 (94.83%)           Self-rated FM Moderate 16.79 (10.03) 1-33 
Took part with parent (n, %) 3.00 (5.17%)           Self-rated FM Marked 39.33 (8.51) 33-49 
Note. Dopamine Replacement, Sinemet or Madopar use. MOS-SSS, Rand Medical Outcomes Study – Social Support Survey; Affectionate 
Support and Positive Social Interaction Items only; KMSS, Kansas Marital Satisfaction Scale; HADS, Hospital Anxiety and Depression Scale; 
SO Psychological and Social Relationships Subscales, WHOQOL BREF, World Health Organization Quality of Life Assessment -short version; 
CSI, Caregiver Strain Index; 15D, Health-related Quality of Life Instrument -Fifteen dimensions; FMQ, Facial Masking Questionnaire, self-





Psychometric Properties of the FMQ  
Item Level Descriptive Statistics and Acceptability  
 Four items were excluded from the FMQ-PwP. Two items each were excluded for 
frequent missing values and low response variability among respondents with FM. For the 
FMQ-SO six items were removed, two items for frequent missing values, three items for low 
response variability among FM-reporting respondents, and one item for insufficient inter-item 
correlations. Details of all excluded items are provided in the Supplemental Data Appendices 
II and III.  
Dimensionality 
 A principle axis factor (PAF) analysis was conducted with orthogonal (varimax) 
rotation for the FMQ-PwP, as initial analyses revealed factors were not correlated.37 Nine 
items were eliminated from the analysis as they did not contribute to the factor structure, with 
content of removed items mostly reflecting relationship quality. One item each was removed 
for low loading (<.4) and cross loading (absolute difference in factor loadings < .2). Seven 
items were removed for low communalities (<.2). 
 A scree plot and Eigenvalues of > 1 identified two major factors and several minor 
factors.  A two-factor solution was preferred to aid interpretability. The PAF was run a 
second time to check if the factor structure held following reliability analysis (where a further 
three items were removed for relatively high item total correlations > .7, or to improve 
reliability). 
  Table 2 shows the final factor matrix of the FMQ-PwP (n =12 items). Sampling 
adequacy (KMO = 0.717), Sphericity (p < 0.001), and anti-image diagonal/off-diagonal 
values met predetermined criterion. A two-factor solution was retained with eigenvalues of 
3.2 and 2.6, which combined accounted for 44.03% of the variance. 
 For the FMQ-SO, PAF analysis was conducted (n items = 22). All items contributed 
satisfactorily to the factor structure. Scree plot inspection and Eigenvalues of >1 identified 




single factor solution the most clinically interpretable. The PAF was run a second time to 
check if the factor structure held following reliability analysis (where four items were removed 
for relatively high inter-item correlations >.7, or corrected item totals > .8).  
 Table 2 shows the final factor matrix for the FMQ-SO (n =18 items). Sampling 
adequacy (KMO = 0.842) and Sphericity (p < 0.001) met predetermined criterion. A single 
factor solution was retained with an eigenvalue of 7.50, which accounted for 41.67% of the 
variance. Although no items correlated >.80, the determinant of the matrix (0.00005) and 
residual off diagonal values suggested further redundancy in the scale (possibly due to the 








Factor Loading Matrix of FMQ main scale items and clinically or conceptually relevant items retained outside main 
scales future testing. 
 






1 2    
8. It troubles me that way I feel inside is different from how I look on the outside .849 -.086 .722 26.70 .830 
7. It troubles me that my face does not look like me .778 -.057 .623   
11. I withdraw from people close to me because of my facial appearance .727 .126 .543   
14. I avoid interactions with others because of what they might think of my face .681 .147 .484   
5. When I make an expression like a smile, it takes a lot of effort, feels false, or “put on” .660 .099 .442   
4. People comment I appear to be in a bad mood much of the time .431 .189 .216   
15. (R) My partner listens to me .036 .748 .627 17.33 .765 
9. (R) My partner is supportive and understanding when I need to talk or confide in them -.070 .721 .419   
22. (R) I feel loved and wanted by my partner -.026 .576 .348   
21. My lack of expression creates a barrier with my partner .177 .513 .333   
18. My partner avoids or ignores me because my face does not respond .165 .505 .319   
20. Interaction with my partner can feel uncomfortable or stilted .109 .473 .208   




Q19. I feel disconnected from my partner because their face does not respond to me .794  .630 41.67 .936 
Q29. (R) My partner makes me feel loved and wanted .742  .551   
Q3.  My partner appears to be in bad mood a lot of the time .737  .543   
Q10. (R) I can count on my partner to be supportive and understanding .737  .543   
Q8. I find myself second-guessing what my partner is thinking and feeling .733  .538   
Q4.  It is hard for me when my partner’s face does not respond .729  .531   
Q27. I wish I were closer to my partner .683  .467   
Q16. It is upsetting my partner’s face/expression has changed so much from their former 
self 
.676  .457   
Q11. I feel rejected or criticized when my partner shows little expression .671  .450   
Q15. (R) I have a close and warm relationship with my partner .653  .427   
Q24. I think my partner might be better off without me .624  .389   
Q5. (R) My partner shares in my life’s ups and downs .570  .325   
Q22. (R) I feel a strong emotional connection with my partner .566  320   
Q12. (R) My partner is interested in interacting with me .546  .299   
Q6. (R) I can easily tell when my partner is feeling positive emotions .540  .291   
Q9. I think my partner’s unhappiness must be my fault .525  .275   





Q25. I worry my partner cares less for me than before .469  .220   
Items retained outside main scales for clinical or conceptual importance  
FMQ – PWP FMQ – SO 
3. When I am happy people close to me can easily tell what I am feeling.   7. My partner is more expressive with other people than with me 
10. My partner misreads my emotions, attitude, or communication 14. I avoid being near my partner or interacting with my partner 
12. People have been unkind to me because of my facial appearance 20. My partner’s emotional signals make me concerned they might want to 
end our relationship 
13. My partner can usually tell what I am feeling 21. My partner’s emotional signals make me concerned they are considering 
an affair or are having an affair 
16. I feel isolated from people important to me because they cannot see 
emotion on my face. 
23. My partner’s staring or lack of expression gets in the way of our sexual 
relationship 
17. I take extra medication to make my face more expressive in social 
situations. 
26. My romantic relationship with my partner is strong and rewarding 
26. My romantic relationship with my partner is strong and rewarding.  
Note.: EFA results presented here verified following item reduction with reliability analysis. Major loadings in bold. 
* PAF with varimax rotation, retaining a two-factor solution.     





Internal and Test-Retest Reliability  
Cronbach’s alpha was good for both questionnaires (Table 2). For the FMQ-PwP Individual 
Difficulty subscale (n = 6 items), internal consistency was acceptable (α = .830), however the 
mean inter-item correlation (r = .548) fell marginally outside the recommended range. For 
the FMQ-PwP Relationship Difficulty subscale, the internal consistency of the final items (n = 
6) was acceptable (α =.765). The average inter-item correlation (r = .364) was within 
recommended range and item-scale correlations were acceptable (> .4). 
 On the FMQ-SO FM Difficulty Scale, the internal consistency of the final items (n = 
18) was acceptable (α = .936). All item-scale correlations were high (> .4), and the average 
inter-item correlation was within recommended limits (r = .461).  
 A good to excellent degree of test-retest reliability was found between the subscale 
across two administrations, for both versions of the questionnaire (Table 3). 
Validity   
 Correlation of the FMQ-PwP total and subscales scores with other rating scales 
measuring related constructs of psychosocial wellbeing was weak to moderate (Table 4). 
The FMQ-SO total and scale scores had weak to strong correlations with other rating scales 
measuring psychosocial wellbeing. Construct validity was supported by the overall pattern of 
correlation, which was as expected for questionnaire measuring a related yet distinct 
phenomenon from mood difficulties, social support, caregiver strain, quality of life, and 
relationship satisfaction (see Table 4).  
 Criterion validity of the FM severity item on the FMQ-PwP with total expressive 
disposition on the BEQ was weak (r = -.233), and not significantly correlated with individual 
BEQ subscales. In comparison, criterion validity of FM severity on the FMQ-SO with BEQ 
(modified SO version) was moderate (Expressive Disposition Total r = -.555, Negative 
Expressivity Subscale r = -.434, Positive Expressivity Subscale r = -.517 and Impulse 




  Table 3 
Test-retest reliability coefficients, means, and standard deviations for main subscales of the FMQ 
 Test Retest 
                                        Test-Retest Reliability 
 (average measurement)                  (single measurement) 
Measure 
Subscale  
M ± SD 
(range) 
M ± SD 
(range) 
ICC Lower Upper 
 











.885 .784 .916 
 











.843 .747 .903 
 










.945 .890 .971  .895 .802 .943 20.681 .001 
Note. Includes data of participants who completed the retest outside of 4-weeks due to personal or medical circumstances.  





  Table 4 
Correlation of FMQ subscales and total scores with other measures of psychosocial wellbeing  



























.303** .281* .251* -.455** -.394** -.431** -.256* -0.190 
Total score a .406** .454** .282* -.337* -.279* -.263* -.188 -.349** 



















Interaction   
FM Difficulty 
Scale Score 
.530** -.262* -.505** -.328* -.301* -.269*   
Total score a .539** -.277* -.524** -.344** -.315* -.284*   
Note. Spearman rank correlation coefficients. a Includes subscale scores plus clinically or conceptually important items excluded from the main 
analysis due to inadequate psychometric properties. 
 *Correlation is significant at the 0.05 level (2-tailed). 







 This paper provides an alternative approach to existing assessment of FM, which 
focuses on clinician-based outcomes. The FMQ measures the consequences of FM for 
psychosocial functioning, turning attention to the impact of having FM for people who have 
Parkinson’s and their families.  The results suggest the FMQ is a well-accepted and reliable 
tool with initial support for validity, which can serve to support management of FM in PD.   
 An additional advantage of the FMQ is the inclusion of peer-report (SO) version. The 
wellbeing of partners is of special importance in the clinical management of PD, since 
practical day-to-day care is commonly provided by family members in the home46 and 
because of the close interconnection between caregiver strain and health outcomes for 
individuals with PD.47 
 Respondents who perceived greater FM severity tended to obtain higher FM 
Difficulty scores on the FMQ and poorer subjective wellbeing ratings on other measures. 
Whilst earlier studies showed the relationship between FM and quality of life to be mediated 
by stigma19, our interview and testing samples seemed less concerned about feelings of 
stigma in the context of their closest relationships. However, responses to the FMQ open 
answer items suggested some participants did feel self-conscious of FM in public places or 
at social gatherings, such as at work, church and on the marae (cultural sacred place). 
Future investigation of the influence of FM and the factors mediating its impact should focus 
equally on social interactions in groups or with casual acquaintances, and on more private 
relationships with immediate family and friends.  
 Individual and relationship difficulties were not significantly related for PwP in the 
FMQ, and many general relationship quality items were removed during the questionnaire 
development. For SO, the most interpretable solution unified individual and relationship 
dimensions as single theme. This suggests that there is a difference in perspectives of the 




FM severity was associated with decreased relationship enjoyment in partners, but not 
people with PD themselves.20  
 The low correlation of the FM severity item in FMQ-PwP with external measures of 
expressive disposition was not surprising. Whilst awareness of expressivity deficits has been 
shown in other PD populations48, about 13% of our PwP participants (n =10) reported they 
had never heard of FM, and 19% (n = 15) were not sure if they had FM before testing. Low 
awareness of FM in PD and a failure to attribute related relationship problems to FM, were 
also salient themes of our original qualitative interviews.23 This may mean some individuals 
who experience FM-related problems are not able to be identified by the FMQ, as the items 
assume respondents have a degree of symptom awareness. Despite this, supporting patient 
awareness and insight about FM is an important topic.   
 Psychometric properties of the FMQ were satisfactory, but a key limitation of this 
study is the sample size. This reflects, in part, the relatively small NZ population and the lack 
of a central register for PD. Further validation of the FMQ in a larger and separate sample is 
required.  
 As relatively little research on FM impact has been conducted, other aspects of 
experienced FM may not be captured by the FMQ.  Further research in this area might 
explore fears about the meaning of losing emotional expressivity, perceptions of how loved 
ones versus casual acquaintances react to FM, and feelings of stigma in public places or 
social gatherings (such as work or when meeting friends in public). Nonetheless, as no 
current measures assess the psychosocial consequences of FM, the FMQ is a promising 






 The FMQ extends existing assessment of FM by focusing on the everyday 
consequences of FM for individuals with PD and their families. Whilst further validation of 
this tool is recommended, it will be of interest to clinicians who wish to take better account of 
the social and emotional challenges of FM, by identifying key concerns and needs for help. 
We hope this study will foster a greater appreciation of this unique aspect of PD.   
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Supplementary Data  
Study 2 Appendix I. Development of the Facial Masking 
Questionnaire (FMQ) 
Review of Qualitative Data 
 Provisional item content was generated based on interviews with nine couples who 
self-reported FM (interviewees n = 18), from our previous qualitative work on experiences of 
FM (see Wootton, Starkey, and Barber, 2018). At that time (early 2016), we could not locate 
any other study which investigated FM from the standpoint of people with PD. Therefore, the 
themes, subthemes, codes, and quotes from our qualitative findings were closely examined 
to develop item content. This was not a strict translation of thematic content into items but 
considered the impact and importance of the various thematic elements. We focused on 
examining the thematic data for the most salient and important problems described by 
people with FM and their partners. Where possible, provisional items were phrased similarly 
to the interview data. Distinct and overlapping themes across the person with PD (PwP) and 
Significant Other (SO) groups led to the development of shared and differential items for 
inclusion in the two questionnaires. A small number of items were included about social 
difficulties in less familiar contexts, such as having colleagues or strangers be unkind about 
a visible facial difference.  
Review of Existing Literature 
 Existing assessment literature was reviewed for topics that were not covered by the 
interviews but could be conceptually relevant, with potential item content collated and 
adapted to fit the experiences of individuals with FM and their SO. We located conceptually 
related measures falling into two broad categories: the measurement of individual emotional 
expressivity and/or FM severity, and the measurement of social-emotional wellbeing. A 
literature search was conducted using the key words: facial masking, hypomimia, individual 
emotional expressivity/expressive disposition, affective communication, caregiver strain, 




literature were reviewed, where available. As we were focused on the contribution of facial 
movement to emotional expressivity, literature focusing on other modalities of emotional 
expression (e.g., speech) were excluded. Item statements were then reviewed as a whole, to 
check for similarity of content, remove or rework item statements. 
Expert Opinion 
 Experts with experience in working with people with Parkinson’s disease were invited 
to provide their opinions on the preliminary questionnaires. Experts were contacted directly 
by the first author who explained the goal of research, their rights in providing feedback, and 
the limits of confidentiality. Experts were sent the questionnaires one to two weeks in 
advance, before taking part in group or individual discussions about the questionnaire with 
the researcher. The six experts who took part were registered nurses who work with people 
who have Parkinson’s. Most were experienced in recognizing the signs of FM, but some 
reported they were less conversant with its functional impact. Familiarity in administering 
rating scales was highly varied across the expert panel. Experts were asked to provide 
general opinions of the questionnaires and review each statement providing any responses 
evoked by the item and suggestions for improvement. 
 Content. Experts generally thought FMQ content was relevant, appropriate, and 
comprehensive. Some experts were surprised that SO misread masking as a signal of 
reduced interest in the relationship or a sign of infidelity. Several items were reworked or 
refined to make sure statements were unambiguous. A small number of items were removed 
which experts viewed as too general, redundant, or irrelevant (PwP n = 2, SO n = 3).  
 Item order. Experts reported the question order was confusing because it jumped 
between topics, so statements were re-ordered to group similar topics and improve flow. 
Short statements to demarcate and introduce the topic of each group of statements were 
added. One expert expressed concern a few questions might be too personal in nature, so 
potentially sensitive topics were moved towards the end of the checklist, to lessen the 




question topics, as they thought it would deter respondents becoming indifferent or careless 
in answering.   
 Appearance/Format. Experts thought format of the questionnaire made it clear to 
understand and easy to respond. Tick boxes, rather than circling a response, were added to 
increase the ease of selecting a response.  
 Clinical Utility. One expert thought FM did not justify specific assessment, but most 
judged information obtained by the questionnaire to be useful and relevant. Perceived utility 
of the questionnaire included: greater confidence to manage FM and related issues, 
potential to facilitate client learning and motivate clients to assume a role in self-
management, normalizing discussion of topics that can be challenging to address (for 
instance, relationship issues). Because of few existing resources at that time, there was 
some concern about how to respond to needs for greater FM information/support.  
 Administration and General Feasibility. Experts cautioned the questionnaires might not 
be appropriate for clients with little FM knowledge who would require further education to 
understand and respond to the checklist’s questions. Due the personal nature of some 
question topics, it was also noted rapport would need to be established prior to 
administration. Another concern was that questionnaire follow-up might impinge on already 
limited resources. To clarify how to administer the questionnaire, recommendations were 
added to the FMQ administration and scoring instructions (see Appendix VI). Experts also 
suggested online/electronic administration, to extend the usability of the questionnaire to a 
wider range of individuals. 
Healthcare Consumer Feedback 
 Two people with self-reported FM and two partners from the original interviewees 
provided feedback on the preliminary questionnaires via face-to-face meetings (n = 4). 
Participants were asked to provide general opinion on the questionnaires, as well feedback 
on item relevance, comprehensibility, appropriateness, and whether aspects of the FM 




the consumer feedback. 
 Content. Minor changes to wording were made to increase the likelihood items were 
worded plainly and unambiguously. Content was generally viewed as relevant, appropriate, 
and resonating with personal experience. Rather than being intrusive, participants believed 
addressing sensitive topics was valuable. 
 Format. Participants offered positive feedback about format, which was easy to read. 
The inclusion of open-answer items was also thought to be beneficial because it provided 
opportunity to express personal views and experiences. However, it was noted some 
individuals might not be prepared to give an immediate response to open-style questions. 
Partners valued the opportunity to express their experiences and concerns as some felt no-
one had asked what Parkinson’s was really like for them.  
 Perceived benefits. Participants thought the FMQ made it comfortable for people to 
ask for information or help related to FM. Use of the questionnaires was perceived to be 
beneficial in three ways: it could help people learn the signs of masking; it helped explain 
and normalize confusing or strained interpersonal interactions; it may help people start 
conversations about unspoken or unacknowledged issues. Interviewees also stated the 
inclusion of direct questions about psychological wellbeing was essential because their 
mental health had rarely been discussed with healthcare providers in New Zealand.   
 Administration. It was suggested that some individuals might need to take a break to 
complete the questionnaire, due to difficulties with concentration and/or fatigue. Although 
people with Parkinson’s estimated the checklist would take them longer to complete than 
their partners, they did not perceive it to be overly burdensome. Another point of concern 
was that appropriate and timely follow up is received following administration. To address 
this issue, guidelines for administration and patient education were added to the FMQ 
instructions (see Study 2 Appendix VI).  Tables 1 and 2 summarize the item content, 





Table 1.  
Item provenance, content, and response format of the FMQ-PwP (preliminary version) 
Qualitative Findings Quantitative Assessment Instrument  
Themes, Subthemes, Codes & Interview Quotes Domain/ 
Dimension 







Theme 1. Disturbances of Facial Movement and Social-emotional 
Expressivity  
Subtheme 1a1a “Watered down”: Muted and Distorted 
Expressions  
Subtheme 1b The Absence of Expression 
 
“It’s shaped different, it’s shaped differently and, and it doesn’t 
incorporate the face, you know? The, the… the rest of the face. 
Yeah it hasn’t got all that other subtle stuff that comes with a 
smile” (P02 – PDparticipant)  
 
 “The majority of the time it's a blank expression…. [laughter]”. 
(P01 – PDparticipant) 
 
“ I noticed when I was talking to people it was almost like I was 
looking at something behind them. These people would turn to 
see what I was looking at. But I was looking straight through them” 




1 Please rate the 
overall expression or 
movement of your 
face, on everyday 
basis. 
 
Closed-ended response (select 
the best descriptor from four 
options):   
3 =Facial movement and/or 
expressions are almost always 
absent.  
2=Facial movement and/or 
expression are noticeably less 
intense or less frequent than 
before Parkinson’s developed.  
1=Facial movement and/or 
expressions appear somewhat 
less intense or less frequent 
than before Parkinson’s 
developed.  
0= Facial movement and/or 




(item 3.2), & 
ICRP-PD (items 





Theme 4. ‘It can affect you quite badly without you realising 
exactly what it is’: Poor Symptom Recognition and Understanding 
 
“ I spose in the first instance was when looking at a photograph of 
myself...That was the first indication that I don’t look the same as I 
used to. Um, I didn’t know why. Although I probably thought it had 
something to do with Parkinson’s, but I didn’t know whether it did 
or not. And facial masking I never heard of it, until I read the 
article in the paper” (P06 – PDparticipant) 
FM 
Knowledge  
2 Had you heard about 
the symptom of 
facial masking (the 




Three-point response scale: I 
have heard of it and feel 
informed about it, I have heard 
of it but do not know much about 








Theme 4. ‘It can affect you quite badly without you realising 
exactly what it is’: Poor Symptom Recognition and Understanding 
 
“Other people notice it, but you don’t… So it may affect the way 
they see things…you may be as happy as them and quite content 
and think that everything’s fine. But when they’re looking at it, it’s 




3 When I am happy 
people close to me 
can easily tell what I 
am feeling.                                                
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 






Subtheme 2a. Misattribution of Negative Affect 
Theme 4. ‘It can affect you quite badly without you realising 
exactly what it is’: Poor Symptom Recognition and Understanding 
 
“I feel that people,  it’s hard,  people would misinterpret what I was 
thinking or how I was reacting to something… and I’d be quite 
often surprised to find out that someone had said, “oh you know, 
we just thought you were really grumpy or disengaged or 
disinterested”. (P03 – PDparticipant) 
FM Impact 4 People comment I 
appear to be in a bad 
mood much of the 
time.  
For e.g., sad, 




likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Subtheme 1c. Inauthentic and Effortful: Voluntary Expressions 
 
“The smile doesn’t come naturally. It’s a matter of trying to 
coordinate a whole lot of muscles… So to smile, you’re having to 
go through a whole thought process as to how am I going to do it. 
Because it doesn’t come naturally”  
(P06 – PDparticipant) 
FM Impact 5 When I try to make 
an expression like a 
smile, it seems to 
take a lot of effort, 
feels false, or “put 
on”.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Code(s): loss of attunement within important relationships 
 
“When I feel very rigid and unable to move and sort of physically 
stuck, to have that stoicism thrown across your face as well and 
you’re blunted… People can think you have disengaged from your 
family or from your life and you know, that’s really not the case”. 




6 My partner shares in 
my ups and downs.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 





and from   
MOS- Social 
Support Survey 
Subtheme 1d. ‘I can see him, but I can’t’: Facelessness 
Code(s):  challenge to self-concept/self-identity 
 
“I don’t know who it is. It’s not me…. I used to be able to express 
myself in face and laugh and things like that, I don’t know. I look at 
photographs of me, and I don’t think they’re me at all…I don’t 
believe it’s me” (P09 - PDparticipant).   
FM Impact 7 It troubles me that 
my face does not 
look like me.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Subtheme 1d. ‘I can see him, but I can’t’: Facelessness 
Code(s): Dissonance between experienced and expressed 
FM Impact 8 It troubles me that 
way I feel inside is 
Four-point dichotomous-ordinal, 





emotion, bodily autonomy 
 
“It makes me a little bit sad in the fact that it doesn’t reflect me.  
Looking in the mirror doesn’t reflect what, how I’m feeling, or what 
I’m, I should be seeing in the mirror. I’m just seeing someone 
who’s looking at mirror with no expression at all” (P04 - 
PDparticipant).   
different from how I 
look on the outside. 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Subtheme 3a. (reversal) ‘You haven’t got someone who’s 
excited when you’re excited, or sad when you’re sad’: Reduced 
Emotional Reciprocity. 
Code(s): undermining of bond/interaction  
 
“A relationship is built on all those tiny little subtle cues …I know 
that you understood what I was just talking about by what 
happened in the corner of your mouth and what happened with 
your eyes, and so on. You take that away, and nobody thinks oh 
there’s something missing from this relationship but, it’s suddenly 
that trust starts to dissipate. And the communication diminishes 
and the preparedness to communicate diminishes.” (P02 - 
PDparticipant).   
FM Impact 
(reversed) 
9 My partner is 
supportive and 
understanding when 
I need to talk or 
confide in them. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Adapted from 
Mos-SSS 
Theme 2. ‘If that information’s not there, you fill it in’: 
Misinterpretations of Negative Affect   
 
“I mean [she] might look at me sometimes and, and say ‘are you 
grumpy or something or’, and, and when I say no I’m not, I can 
honestly say no I’m not.” (P07 - PDparticipant).   





likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection 
Code(s): withdrawal, avoidance 
 
“It puts…a couple apart. It can… put [Carol] in a, in a place where 
she doesn’t wanna be with me or doesn’t wanna to talk to me and 
I’m in a version of the same. I can’t talk to [her], or don’t want to 
talk to [her]” (P04 - PDparticipant).   
FM Impact  11 
 
I withdraw from 
people close to me 
because of my facial 
appearance. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 




Subtheme 1b. The Discomfort of Facial Difference: The Absence 
of Expression 
Code(s): unpleasant interaction (colleagues & strangers) 
 
“I can remember him saying several times in the middle of 
meetings you know, ‘I can’t read you, your face is blank. You 
never smile’ … He said, ‘your face would crack if you even tried to 
smile!’” (P07 – PDparticipant). 
FM Impact  12 
 
People have been 
unkind to me 
because of my facial 
appearance.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 








Theme 1. Unmoving and Unmoved: Disturbances of Facial 
Movement and Social-emotional Expressivity 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection 
 
“Like we’re in a dark room or whatever, cause she can’t see 
anything she’s got to listen to really what I’m saying… I find it very 
frustrating…there’s something happening that’s isn’t being passed 
through by your face or whatever” (P04 - PDparticipant).   
FM Impact 
(reversed) 
13 My partner can 
usually tell what I am 
feeling.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection 
Code(s): fear negative evaluation of facial appearance by others 
(public gatherings), social isolation/withdrawal 
 
“I’m inclined to ah, not be, as friendly with people I spose… you 
sometimes feel that they’re looking as though to say ‘god he’s a 
gormless wonder now!’ So (laughs). That’s what I think they’re 
thinking and that alters what I feel, which means I’ll drift to the 
back of whatever’s happening.” (P07 - PDparticipant).    
 
“It just got tiring. Yeah I got sick of having to explain the whole 
time, you know, ‘I know I’m not grumpy with you I’m not pissed off 
I’m just, I just have Parkinson’s’ yeah. And in the end it was just 
easier not to go…and that’s the trap that you can fall to very 
easily.” (P03- PDparticipant).   
FM Impact 14 I avoid interactions 
with others because 
of what they might 
think of my 
face/expression. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Code(s): communication difficulties, feeling unheard, FM & 
speech difficulty combined 
  
“I get frustrated because I think, you know, she’s not listening but 
the thing is, she never heard what I had to say in the first place, 
so. And the, when you know, I have a mask on, she can’t tell that 
either even actually said anything or you know” (P03- 
PDparticipant).   
FM Impact 
(reversed) 
15 My partner listens to 
me. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection 
 
“I think there would’ve been a distance growing between me and 
other people because (inaudible) I wasn’t showing those subtle 
signs of empathy….I think possibly I was seen as being unmoved 
by things”.  (P02- PDparticipant).   
FM Impact  16 I feel isolated from 
people important to 
me because they 
can’t see emotion on 
my face. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 







Code(s): Compensatory behaviours, extra medication  
 
“So many people came up to me that night and said to me, ‘oh my 
god, [he] looks amazing’… he was getting everyone tequila shots 
up at the bar, he was on the dance floor! He was just, he was 
fabulous, he was absolutely fabulous. What people didn’t know is 
he’d doubled his medication and couldn’t get out of bed for three 
days afterwards (voice breaking up)” (P12- Partner).   
FM Impact  17 I take extra 
medication to make 
my face more 
expressive in social 
situations. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 




[Theme from SO which was included here to test whether it was 
also true of PwP] 
 
FM Impact  18 My partner avoids or 
ignores me because 
my face does not 
respond. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 






[Theme from SO which was included here to test whether it was 






19 I find my partner’s 
company enjoyable 
& comfortable  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 




Index (CSI)      
 
 
Code(s): sense of discomfort or unease in close relationships 
 
“I think it’s changed the relationship in that, she’s tentative. She is 
tryin’ like hell to read me and can’t. Even the decision over what 
we are having for tea, she’s sometimes reluctant to make it in 
case masking shows up as, I don’t know if I want that or not. 
Whereas it probably in all honesty is quite the opposite... So it has 
affected us, yes” (P07- PDparticipant).   
FM Impact 20 Interactions with my 
partner can feel 
uncomfortable  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection 
 
“I think [she] …was getting pretty frustrated with my lack of 
expression… she read into that a distance between us that I 
wasn’t feeling. I think that stuff like becomes self-fulfilling…with 
that diminishment in subtle signs of caring, I think…self-protection 
kicks in ….And I think self-protection itself creates distance, and it 
elicits a response from me....So not trying as much, so distance 
develops.” (P02- PDparticipant).    
 
“The only thing I’ve got left is my family and my close friends…It’s 
the only thing left in my life and it’s what I’m trying to do... And to 
have that impacted by…an emotional sort of stonewall um, yeah 
it’s really depressing. It’s really hard” (P03- PDparticipant).   
FM Impact 21 My lack of 
expression creates a 
barrier with my 
partner  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 









22 I feel loved and 
wanted by my 
partner. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Adapted from 
MOSS-SSS 
NA  Relationship 
Quality 
23 I worry my partner 
cares less for me 
than before. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 









24 I think my partner 
might be better off 
without me. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 











25 My sexual 
relationship with my 
partner is satisfying. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Couples 
Satisfaction 





26 My romantic 
relationship with my 
partner is strong and 
rewarding.   
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 











27 I wish I were closer 
to my partner. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 







Code: Frustration Relationship 
Quality 
28 I feel frustrated with 
my relationship. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 




29 I feel lonely. Four-point dichotomous-ordinal, 
likert style response scale: 
Adapted from 
Nottingham 












30  I have a close and 
warm relationship 
with my partner. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 

















likert style response scale: 
Rarely/Never, Sometimes, 






32 I feel angry, irritated, 
or frustrated. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 






33 In general, I feel 
happy or in good 
spirits. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 







Code(s): Compensatory and Coping behaviours Coping  34 Please briefly 
describe any 
strategies you use to 
cope with reduced 
facial expression/ 
movement. State 
how helpful, or not 
helpful, you have 
found these 
strategies. 
Open answer  Reworded to 
simplify: Expert 
Opinion 
Theme 4. ‘It can affect you quite badly without you realising 





35 Take a moment to 
reflect on what living 
with reduced facial 
expression/movemen
t is like for you.  
Please briefly 











Theme 4. ‘It can affect you quite badly without you realising 







36 Please rate how the 
loss of facial 
expression/movemen
t has affected you 
and your 
relationships. 
5-point Likert style:  Not at all, A 
little, moderately, quite a lot, 
considerably 
 
Subtheme 4a. ‘They don’t get that information because it’s not 
there and because the harm that’s already done in a relationship 
isn’t understood at all’: Unmet Health Resource Need 
 
“No one’s talked to me about the masking thing, at all… if 
someone had been able to say… There’s the facial stuff and that 
may have been fucking up your relationships for some time… 
without you realizing it, and people may be not reading you as you 
think they are. Have a think about that, but here’s something to 
read about that …There should be a hand-out that people get you 




37 Would you like more 
information about 
the topics raised in 
this questionnaire? 
Dichotomous forced choice: 









Item provenance, content, and response format of the FMQ-SO (preliminary version) 
Qualitative Findings Quantitative Assessment Instrument  
Themes, Subthemes, Codes & Interview Quotes Domain/ 
Dimension 







Theme 1. Unmoving and Unmoved: Disturbances of Facial 
Movement and Social-emotional Expressivity 
 
“It’s interesting, he can be really upset and your face wouldn’t tell 
anything. You know it’s that real sort of, dead pan face. You 
know, he can be saying the words but the face doesn’t tell, it 
doesn’t tell anything” (P13 - Partner). 
 
“Well, a lot of the time he won’t do emotions on his face at all. 
But then sometimes he will really surprise me. He will 
spontaneously laugh or maybe look really sad or something” 




1 Please rate the 
overall expression or 
movement of the 
person with 
Parkinson’s face, on 
everyday basis. 
 
Closed-ended response (select 
the best descriptor from four 
options):  
3 =Facial movement and/or 
expressions are almost always 
absent.  
2=Facial movement and/or 
expression are noticeably less 
intense or less frequent than 
before Parkinson’s developed.  
1=Facial movement and/or 
expressions appear somewhat 
less intense or less frequent 
than before Parkinson’s 
developed.  
0= Facial movement and/or 
expressions are present and 
unchanged.  
MDS-UPDRS 
(item 3.2) & 
ICRP-PD (items 





Theme 4. ‘It can affect you quite badly without you realising 
exactly what it is’: Poor Symptom Recognition and 
Understanding 
 
“It’s quite … probably one of the most serious things about the 
FM 
Knowledge  
2 Had you heard about 
the symptom of 
facial masking (the 
loss of facial 
expression or 
Three-point response scale: I 
have heard of it and feel 
informed about it, I have heard 
of it but do not know much about 








Parkinson’s … with masking it’s a bit subtle, and when you live 
with someone all of the time, it happens sort of, gradually, and 
you’re not necessarily aware of it. So it can affect you quite 
badly without you realizing exactly what it is” (P14 – Partner). 
movement) before 
today? 
Theme 2. ‘If that information’s not there, you fill it in’: 
Misinterpretations of Negative Affect   
 
“if that information’s not there, you fill it in and everything you fill 
in no facial expression with is boredom, tiredness, anger. The 
really negative emotions” (P12- Partner).  
     
FM Impact 
 
3 My partner appears 
to be in bad mood a 
lot of the time 





likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Subtheme 3a.’ You haven’t got someone who’s excited when 
you’re excited, or sad when you’re sad’: Reduced Emotional 
Reciprocity. 
 
“I can’t just look at him and figure out what he thinks ‘cause I’m 
not getting that (laughs) now either. And sometimes I just think I 
could shake him you know, so…yeah um, I mean we have been 
married a long time so… used to each other without you know 
having those um interactions necessarily. But sometimes I just 
really would like to know (sighs) what he thought about things or 
you know, (spoken sadly) what he wanted to do or something” 
(P18 - Partner). 
 
FM Impact 4 It is hard for me 
when my partner’s 
face does not 
respond. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 






Subtheme 3a. ‘You haven’t got someone who’s excited when 
you’re excited, or sad when you’re sad’: Reduced Emotional 
Reciprocity. 
 
“It does impact on your enjoyment of life. Because you haven’t 
got someone who’s excited when you’re excited or sad when 
you’re sad….You haven’t got someone you can share that with, 
at any given time. (Spoken softly) Yeah it does make you sad. 




5 My partner shares in 
my life’s ups and 
downs. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Code(s): Reduced Displays of positive emotional 
responsivity  
 
“Cause now he has difficulty smiling so I’m not getting any kind 
FM Impact 
(reversed) 
6 I can easily tell when 
my partner is feeling 
positive emotions.    
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 







of reaction… Occasionally he will really surprise me and he will 
really laugh about something, but there is that intermediate 
thing, you know, with someone just smiling when you say 
something that they agree with and whatever, that we don’t, we 
don’t have that any longer” (P18 - Partner). 
Questionnaire 
(BEQ) 
Code(s): feeling missed out of expressions 
 
 “I love seeing him when he’s really animated. I love seeing that 
side of him again…but if he is with somebody that he doesn’t 
know as well or it’s a social occasion and he’s trying his best, I 
feel like they get the absolute best” (P12 - Partner). 
FM Impact 7 My partner is more 
expressive with other 
people, than with me.  
For e.g., they try to 
smile at a social event 
but not when we are at 
home alone. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Theme 2. ‘If that information’s not there, you fill it in’: 
Misinterpretations of Negative Affect   
Code(s): Backtracking, second guessing 
 
“I’ve had to kind of pick myself up because I’ve looked at [him] 
and thought, oh my God, he’s not interested at all! But then I 
remember he probably is, but…it doesn’t show…I said to him 
one day, he looks like he’s bored shitless! And, and he’s not, but 
that’s how the face can sometimes look. You know, and he’s not, 
not really” (P13 - Partner). 
FM Impact  8 I find myself second-
guessing what my 
partner is thinking 
and feeling.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Reworded to 
clarify:  Expert 
opinion 
Subtheme 2a. Misattribution of Negative Affect 
Code(s): Internally directed negative assumptions about FM 
 
“Sometimes he was looking disapproving … I was being a bit 
apologetic. And he said to me one day, ‘why do you keep 
apologising? I can’t understand why you keep apologising to me 
all of the time’. And I said, ‘because I think you’re upset with me 
in some way’. And he said, ‘but I’m not!’ “ (P14 -  Partner). 
FM Impact  9 I think my partner’s 
unhappiness must 
be my fault. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Subtheme 3a. (reversal) ‘You haven’t got someone who’s 
excited when you’re excited, or sad when you’re sad’: Reduced 
Emotional Reciprocity. 
Code(s): Perceived emotional (un)supportiveness 
 
“It’s the not getting the sort of feedback about something that 
might be quite important… when I try to talk to him…I don’t really 
get any sense of him being particularly worried or caring …but 
FM Impact 
(reversed) 
10 I can count on my 




likert style response scale: 
Rarely/Never, Sometimes, 










it’s those sort of things where maybe I feel like maybe I would 
like some emotional support over something and (pause, sighs) 
he doesn’t give any indication from his face. I suppose he does 
more from his actions …It’s been more the fact that his face 
doesn’t show emotion I guess”.  (P18 - Partner). 
Subtheme 2a. Misattribution of Negative Affect 
Code(s): Internally directed negative assumptions about FM 
 
“It can make me feel a bit insecure at times. Um make me feel 
um, certain rejection sometimes, um make me feel a wee bit 
upset. Um, a bit oversensitive…. he’s at times wondered why I 
was reacting the way I was…Because I’m trying harder to seek 
his approval and it was annoying him… I was assuming that he 
was being disapproving or critical in some way, of me. Mm, 
judging”. (P14 – Partner).  
FM Impact 11 
 
I feel rejected or 
criticised when my 
partner shows little 
expression. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Theme 3. (reversal)‘Your connections between people are 
being chipped away at’: Social-emotional Distancing and 
Disconnection 
Code(s): perception of indifference, feeling neglected 
 
“Oh it’s miserable, it’s miserable….Always with him, when you 
walk into a room and you get home from work and he doesn’t 






My partner is 
interested in 
interacting with me.   
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Subtheme 3a. ‘You haven’t got someone who’s excited when 
you’re excited, or sad when you’re sad’: Reduced Emotional 
Reciprocity. 
 
“ I would think did he not hear what I’ve said, does he not care 
that this is so exciting or…. I stopped telling him stuff…..not tell 
him things because I thought he was disapproving or I thought 
that he was disinterested.”  (P10 - Partner). 
FM Impact  13 My partner’s lack of 
expression creates a 
barrier between us  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
 
Code(s): behavioural avoidance, withdrawal 
 
“I don’t tend to spend as much time sitting with him like in the 
evening watching TV. I’m probably more likely to go and do 
things on the computer or do my um sewing um…I tend to stay 
at work. I sort of think ‘oh, oh nah, I might as well just stay at 
FM Impact  14 I avoid being near my 
partner or interacting 
with my partner. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 





work, I might as well just stay here and potter around and do 
things here’. I can fill my time in at work. So um, so that is partly 
because he doesn’t respond, I mean there’s no, yeah there is 
no, not so much response in that way”. (P16 -Partner). 
Theme 3. (reversal)‘Your connections between people are 
being chipped away at’: Social-emotional Distancing and 
Disconnection  
Subtheme 2a. (reversal) Misattribution of Negative Affect 
 
“I read into that, that in some way we weren’t as close as we 
were before. It was a perception of something subtle. It wasn’t 




15 I have a close and 
warm relationship 
with my partner.                                                   
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 




Index (CSI)      
Subtheme 1d. ‘I can see him, but I can’t’: Facelessness 
 
“I’ve lost…some aspects of that person…the face is definitely 
one of them. He’s still got a lovely face, but...I can’t read that 
face anymore… I can see him, but I can’t…It’s definitely still him, 
it’s still his lovely face…I just have to really look to see what that 
face is telling me, you know” (P13 - Partner).   
 
“It was really difficult because, lots of reasons. One, was I’d look 
at him and see a different face. I’d see the sternness of his older 
brother…It was quite disconcerting… And [my husband] is a 
very humorous and funny person. I don’t know this person, you 
know. I don’t know this face”. (P10 - Partner)   
FM Impact  16 It is upsetting my 
partner’s 
face/expression has 
changed so much 
from their former 
self. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 








clarify:  Expert 
opinion 
Subtheme 2a. Misattribution of Negative Affect 
Code(s):  backtracking, compensatory behaviours (challenge 
cognitions based on FM) 
 
“I have to remind myself all the time that what I think he’s feeling 
is probably not what he’s feeling…. I have to remind myself that 
actually um, he’s not, he’s not unhappy because of me and the 
kids...Check in with him a lot...Remind myself of all the good 
things … just constantly reminding myself ….I struggle with that 
personally” (P12 - Partner) 
FM Impact  17 I remind myself how 
my partner’s face 
looks on the outside 
probably isn’t how 
they feel inside. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Reworded to 




Subtheme 3a. ‘You haven’t got someone who’s excited when 
you’re excited, or sad when you’re sad’: Reduced Emotional 
FM Impact 
(reversed) 
18 My partner’s 
company is 
Four-point dichotomous-ordinal, 







Code(s): decreased shared enjoyment/engagement in 
companionship, sense of unease  
 
“I used to be able to easily tell when he’s happy and like with 
[our hobby] …You’d be enjoying it…and build off that, feed off 
that.… I don’t see that now anymore. You don’t get that 
automatic feedback, and therefore you can’t just go with the feel 
of the moment… We have had to bring in verbal 
checks…(spoken quietly, looking away & down) which 
sometimes takes away from the moment, you can’t just go with 
the feel of it” (P17 - Partner). 
enjoyable and 
comfortable.                          
Rarely/Never, Sometimes, 






8)      
 
 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection 
Code(s): Loneliness, isolation 
 
“His expression doesn’t change whether I’m in the room or not 
… that can be lonely. Just creates this barrier … this distance, 
it’s like this gulf between us or before we’ve even started any 
conversation” (P12– Partner)     
     
FM Impact 
 
19 I feel disconnected 
from my partner 
because their face 
does not respond to 
me. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 





Subtheme 2a. Misattribution of Negative Affect 
Code(s): loneliness, questioning commitment or relationship 
future 
 
“Incredible loneliness for me, like a real sense of um, I don’t like 
where this relationship is going…you know like whoa! This is not 
who we are, or what, how I communicate, or yeah. It was really 
quite painful. (P10 – Partner) 
 
FM Impact  20 My partner’s 
emotional signals 
make me concerned 
they might want to 
end our relationship. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 





Subtheme 2a. Misattribution of Negative Affect 
Code(s):  undermining trust, questioning fidelity 
 
“I mean we’ve been together nearly thirty years almo- thir- 
bloody hell! And I’d never questioned anything in our relationship 
ever, around loyalty, around fidelity, around trust, anything” (P10 
– Partner) 
FM Impact  21 My partner’s 
emotional signals 
make me concerned 
they are considering 
an affair or are 
having an affair.      
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 








Theme 3 (reversal). ‘Your connections between people are 
being chipped away at’: Social-emotional Distancing and 
Disconnection 
Code(s):  loss of emotional relatedness  
 
“I just have to really look to see what that face is telling me, you 
know...I mean as much as it is hard for me to interpret, it’s also 
hard for him sometimes to share that too… I sure he misses that 




22 I feel a strong 
emotional 
connection with my 
partner. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 










Subtheme 1b The Discomfort of Facial Difference: The Absence 
of Expression 
 
“I think it’s affected our sexual relationship...I’ll say “don’t stare at 
me like that!” I’m like, ahh, you know! …It’s a stare, not an 
intimate look into your lovers eyes (laughs)…So I find it quite off-
putting….I feel really exposed. Invaded almost, you know. Then, 
well, we laugh. Thank god we can laugh about it, but (pause) it’s 
like, yeah” (P10 - Partner). 
FM Impact 23 My partner’s staring 
or lack of expression 




likert style response scale: 
Rarely/Never, Sometimes, 





Subtheme 2a. Misattribution of Negative Affect 
Code(s): Internally directed negative assumptions about FM, 
self-blame 
 
“I wish I was a lot more oblivious to it because I feel a lot of the 
time I’m beating myself up… over something that actually um, is 
probably not even true…. maybe he’d be happier if we weren’t 
around…Maybe he would be happier if I wasn’t living at home”. 
(P12 – Partner) 
FM Impact  24 I think my partner 
might be better off 
without me.  
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 







Subtheme 2a. Misattribution of Negative Affect 
Theme 3. ‘Your connections between people are being chipped 
away at’: Social-emotional Distancing and Disconnection  
Code(s): Internally directed negative assumptions about FM 
 
“Without realising it… well, I have started to make assumptions 
that the romance is not what it was.” (P14 - Partner). 
       
   
FM Impact  25 I worry my partner 
cares less for me 
than before. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
















26 My romantic 
relationship with my 
partner is strong and 
rewarding.   
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 











27 I wish I was closer to 
my partner. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 







Code: Frustration Relationship 
Quality 
28 I feel frustrated with 
my relationship. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 






29 My partner makes me 
feel loved and 
wanted. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 
Often, Almost all the time 
Adapted from 
MOSS-SSS 




30 I feel lonely. Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 













likert style response scale: 
Rarely/Never, Sometimes, 






32 I feel angry, irritated, 
or frustrated. 
Four-point dichotomous-ordinal, 
likert style response scale: 
Rarely/Never, Sometimes, 





33 In general, I feel 
happy or in good 
spirits. 
Four-point dichotomous-ordinal, 
















Code(s): Compensatory and Coping behaviours Coping  34 Please briefly 
describe any 
strategies you use to 
cope with reduced 
facial expression/ 
movement. State 
how helpful, or not 
helpful, you have 
found these 
strategies. 




Theme 4. ‘It can affect you quite badly without you realising 





35 Take a moment to 
reflect on what living 
with reduced facial 
expression/movemen




Open answer Researcher 





Theme 4. ‘It can affect you quite badly without you realising 





36 Please rate how the 
loss of facial 
expression/movemen
t has affected you 
and your 
relationships.  
5-point Likert style:  
Not at all, A little, moderately, 
quite a lot, considerably 
 
Subtheme 4a. ‘They don’t get that information because it’s not 
there and because the harm that’s already done in a relationship 
isn’t understood at all’: Unmet Health Resource Need 
 
“It’s not talked about when they have the meetings…So I don’t 
know what there is really and what you can do to counteract it or 




37 Would you like more 
information about 




Dichotomous forced choice 






Study 2 Appendix II. Item-Level Analysis and Item Removal 
Summary (FMQ-PwP version)  
 Table 3 shows item completeness and response distributions for each item of the 
preliminary FMQ-PwP, by self-reported FM status. Table 4 provides item descriptive 
statistics for the FMQ-PwP items, also by self-reported FM status. Table 5 lists item 
exclusion criteria and decisions for the FMQ-PwP. Table 6 summarises item reduction of the 
FMQ-PwP and items which did not fit well psychometrically but were conceptually or 
clinically important and therefore retained outside the main subscales.  
 Prior to the main analyses, four items were excluded from the PwP version of the 
FMQ (#12, #17, #25 & #26). Two items (#25 &26) were excluded for high missing values 
(greater than or approximately equal to 15% missing data, Tables 3 & 5). Another two items 
were identified where low response variability was found among respondents reporting FM 
(#12 & #17, Tables 3 & 5). Item #17 refers to taking extra medication to make one’s face 
more expressive in social situations. Because only 1.9 % (n = 1) of respondents with FM 
said this occurred “sometimes”, the item was deemed to be minimally descriptive. Item #12 
refers to other people being unkind about one’s facial appearance. As only 11.3% of 
respondents with FM (n = 6) answered this occurred “sometimes”, this item was also 
considered unsuitable due to low respondent variability.  
 Nine items were eliminated during the exploratory factor analysis as they did not 
contribute to the factor structure (table 6). One item (#23) was removed for loading < .4, and 
one item (#28) for cross loading (an absolute difference in factor loadings of < .2). Seven 
items (#13, #10, #3, #16, #24, #29 & #27) were removed for low communalities (< .2). 
 During reliability analysis of the FMQ-PwP Relationship Difficulty subscale, two items 
(#19 and #30) showed relatively high corrected item total correlation coefficients and were 
removed (r = .789 and r = .756, respectively). One additional item (#6) was deleted to 





Table 3.   
Item completeness and response distribution for each FMQ-PwP item, compared by self-reported FM status 
     Observed Item Response Distribution 
Cases reporting FM  
(n = 53) 
Cases NOT reporting FM 
(n = 27) 
Item Never or 






















Q3(R) 1 (1.9) 10 (19.2) 13 (25) 28 (53.8) 1 (1.9) 1 (3.8) 3 (11.5) 1 (3.8) 21 (80.8) 1 (3.7) 
Q4 27 (50.9) 21 (39.6) 3 (5.7) 2 (3.8) 0 (0) 18 (66.7) 8 (29.6) 1 (3.7) 0 (0.0) 0 (0) 
Q5 17 (32.1) 16 (30.2) 12 (22.6) 8 (15.1) 0 (0) 23 (85.2) 4 (14.8) 0 (0.0) 0 (0.0) 0 (0) 
Q6 (R) 4 (7.5) 10 (18.9) 16 (30.2) 23 (43.4) 0 (0) 3 (11.5) 8 (30.8) 3 (11.5) 12 (46.2) 1 (3.7) 
Q7 18 (34) 25 (47.2) 8 (15.1) 2 (3.8) 0 (0) 23 (85.2) 4 (14.8) 0 (0.0) 0 (0.0) 0 (0) 
Q8 18 (34) 20 (37.7) 12 (22.6) 3 (5.7) 0 (0) 17 (63.0) 10 (37.0) 0 (0.0) 0 (0.0) 0 (0) 
Q9 (R) 0 (0) 9 (17.0) 5 (9.4) 39 (73.6) 0 (0) 0 (0.0) 3 (11.1) 3 (11.1) 21 (77.8) 0 (0) 
Q10 21 (39.6) 25 (17.0) 6 (11.3) 1 (1.9) 0 (0) 11 (42.3) 14 (53.8) 1 (3.8) 0 (0.0) 1 (3.7) 
Q11 36 (67.9) 13 (24.5) 3 (5.7) 1 (1.9) 0 (0) 26 (96.3) 1 (3.7) 0 (0.0) 0 (0.0) 0 (0) 
Q12 47 (88.7) 6 (11.3) 0 (0) 0 (0) 0 (0) 2 (96.3) 1 (3.7) 0 (0.0) 0 (0.0) 0 (0) 
Q13 (R) 3 (5.7) 15 (28.3) 19 (35.8) 16 (30.2) 0 (0) 2 (7.7) 6 (23.1) 4 (15.4) 14 (53.8) 1 (3.7) 
Q14 35 (66) 14 (26.4) 4 (7.5) 0 (0) 0 (0) 27 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0) 
Q15 (R) 1 (2.0) 8 (15.7) 8 (15.7) 34 (66.7) 2 (3.9) 1 (3.7) 3(11.1) 8 (29.6) 15 (55.6) 0 (0) 
Q16 37 (71.2) 12 (23.1) 2 (3.8) 1 (1.9) 1 (1.9) 25 (96.2) 1 (3.8) 0 (0.0) 0 (0.0) 1 (3.7) 
Q17 51 (98.1) 1 (1.9) 0 (0) 0 (0) 1 (1.9) 27 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0) 
Q18 48 (90.6) 4 (7.5) 1 (1.9) 0 (0) 0 (0) 26 (100) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.7) 
Q19 (R) 0 (0) 3 (5.7) 8 (15.1) 41 (77.4) 0 (0) 1 (3.8) 1 (3.8) 1 (3.8) 24 (92.3) 1 (3.7) 
Q20 37 (69.8) 14 (26.4) 2 (3.8) 0 (0) 0 (0) 21 (80.8) 4 (15.4) 1 (3.8) 0 (0.0) 1 (3.7) 
Q21 41 (77.4) 10 (18.9) 2 (3.8) 0 (0) 0 (0) 24 (92.3) 2 (7.7) 0 (0.0) 0 (0.0) 1 (3.7) 
Q22 (R) 0 (0) 2 (3.8) 5 (9.4) 43 (81.1) 0 (0) 1 (3.8) 2 (7.7) 1 (3.8) 22 (84.6) 1 (3.7) 
Q23 39 (78) 9 (17.0) 1 (1.9) 1 (1.9) 0 (0) 22 (88.0) 3 (12.0) 0 (0.0) 0 (0.0) 2 (7.4) 
Q24 34 (69.4) 9 (17.0) 5 (9.4) 1 (1.9) 0 (0) 18 (69.2) 8 (30.8) 0 (0.0) 0 (0.0) 1 (3.7) 
Q25 (R) 8 (20.5) 8 (15.1) 8 (15.1) 15 (28.3) 14 (26.4) 3 (37.5) 0 (0.0) 1 (12.5) 4 (50.0) 19 (70.4) 
Q26 (R) 2 (4.2) 8 (15.1) 12 (22.6) 26 (49.1) 5 (9.4) 1 (5.6) 2 (11.1) 5 (27.8) 10 (55.6) 9 (33.3) 
Q27 24 (49) 15 (28.3) 6 (11.3) 4 (7.5) 4 (7.5) 14 (66.7) 5 (23.8) 1 (4.8) 1 (4.8) 6 (22.2) 
Q28 31 (62) 15 (28.3) 4 (7.5) 0 (0) 3 (5.7) 16 (69.6) 7 (30.4) 0 (0.0) 0 (0.0) 4 (14) 
Q29 27 (50.9) 
0 (0) 
21 (39.6) 3 (5.7) 2 (3.8) 0 (0) 13 (50.0) 
1 (4.5) 
8 (30.8) 5 (19.2) 0 (0.0) 1 (3.7) 





















Descriptive statistics of the FMQ-PwP, compared by self-reported FM status 
 Descriptive Statistics  
Cases reporting FM   
(n = 53) 
Cases NOT reporting FM   
(n = 27) 
Item Mean Median Mode SD Min Max Skew Kurtosis   Mean Median Mode SD Min Max Skew Kurtosis 
Q3(R) 0.69 0.0 0.0 0.85 0 3 0.85 -0.51 0.38 0.0 0.0 0.85 0 3 2.07 3.15 
Q4 0.62 0.0 0.0 0.77 0 3 1.31 1.80 0.37 0.0 0.0 0.56 0 2 1.25 0.74 
Q5 1.21 1.0 0.0 1.06 0 3 0.37 -1.09 0.15 0.0 0.0 0.36 0 1 2.10 2.59 
Q6(R) 0.91 1.0 0.0 0.97 0 3 0.73 -0.54 1.08 1.0 0.0 1.13 0 3 0.38 -1.42 
Q7 0.89 1.0 1.0 0.80 0 3 0.68 0.15 0.15 0.0 0.0 0.36 0 1 2.10 2.59 
Q8 1.00 1.0 1.0 0.90 0 3 0.50 -0.60 0.37 0.0 0.0 0.49 0 1 0.57 -1.82 
Q9(R) 0.43 0.0 0.0 0.77 0 2 1.40 0.22 0.33 0.0 0.0 0.68 0 2 1.85 2.08 
Q10 0.75 1.0 1.0 0.73 0 3 0.73 0.35 0.65 1.0 1.0 0.69 0 3 1.38 3.92 
Q11 0.42 0.0 0.0 0.69 0 3 1.77 3.06 0.04 0.0 0.0 0.19 0 1 5.20 27.00 
Q12 0.11 0.0 0.0 0.32 0 1 2.51 4.48 0.04 0.0 0.0 0.19 0 1 5.20 27.00 
Q13(R) 1.09 1.0 1.0 0.90 0 3 0.30 -0.84 0.85 0.0 0.0 1.05 0 3 0.78 -0.82 
Q14 0.42 0.0 0.0 0.63 0 2 1.28 0.56 0.00 0.0 0.0 0.00 0 0 - - 
Q15(R) 0.53 0.0 0.0 0.83 0 3 1.31 0.45 0.63 0.0 0.0 0.84 0 3 1.25 0.99 
Q16 0.37 0.0 0.0 0.66 0 3 2.03 4.49 0.12 0.0 0.0 0.59 0 3 5.10 26.00 
Q17 0.02 0.0 0.0 0.14 0 1 7.21 52.00 0.00 0.0 0.0 0.00 0 0 - - 
Q18 0.11 0.0 0.0 0.38 0 2 3.57 13.32 0.00 0.0 0.0 0.00 0 0 - - 
Q19(R) 0.27 0.0 0.0 0.56 0 2 2.03 3.22 0.22 0.0 0.0 0.70 0 3 3.33 10.90 
Q20 0.34 0.0 0.0 0.55 0 2 1.39 1.06 0.27 0.0 0.0 0.67 0 3 3.14 11.23 
Q21 0.26 0.0 0.0 0.52 0 2 1.90 2.89 0.08 0.0 0.0 0.27 0 1 3.37 10.16 
Q22(R) 0.18 0.0 0.0 0.48 0 2 2.77 7.18 0.31 0.0 0.0 0.79 0 3 2.56 5.74 
Q23 0.28 0.0 0.0 0.61 0 3 2.63 8.01 0.12 0.0 0.0 0.33 0 1 2.49 4.56 
Q24 0.45 0.0 0.0 0.77 0 3 1.63 1.86 0.31 0.0 0.0 0.47 0 1 0.89 -1.32 
Q25(R) 1.23 1.0 0.0 1.18 0 3 0.34 -1.41 1.25 0.5 0.0 1.49 0 3 0.48 -2.25 
Q26(R) 0.71 0.0 0.0 0.90 0 3 0.99 -0.08 0.67 0.0 0.0 0.91 0 3 1.30 1.08 
Q27 0.80 1.0 0.0 0.96 0 3 1.02 0.09 0.48 0.0 0.0 0.81 0 3 1.93 3.75 
Q28 0.46 0.0 0.0 0.65 0 2 1.10 0.15 0.30 0.0 0.0 0.47 0 1 0.91 -1.29 
Q29 0.62 0.0 0.0 0.77 0 3 1.31 1.80 0.69 0.5 0.0 0.79 0 2 0.63 -1.07 
















Item Screening of the FMQ-PwP, by self-reported FM status 
Item Exclusion Criteria 
Cases Reporting FM (n = 53) All cases (N = 80) 
Item 
I.                    
Mean close 
to mid score 
(±1) 





III.                     
SD 
>0.75 

















III.                     
SD 
>0.75 
IV.                          
Response





Q3(R) Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q4 Yes Yes Yes Yes 0 RETAIN Yes Yes No Yes 1 RETAIN 
Q5 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q6(R) Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q7 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q8 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q9(R) No Yes Yes No 2 RETAIN No Yes No Yes 2 RETAIN 
Q10 Yes Yes No Yes 1 RETAIN Yes Yes No Yes 1 RETAIN 
Q11 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q12 No Yes No No 3 REMOVE No Yes No No 3 REMOVE 
Q13(R) Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q14 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q15(R) Yes No Yes Yes 1 RETAIN Yes No Yes Yes 1 RETAIN 
Q16 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q17 No Yes No No 3 REMOVE No Yes No No 3 REMOVE 
Q18 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q19(R) No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q20 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q21 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q22(R) No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q23 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q24 No Yes Yes Yes 1 RETAIN No Yes No Yes 1 RETAIN 
Q25(R) Yes Yes Yes Yes 0 REMOVE Yes Yes Yes Yes 0 REMOVE  
Q26(R) Yes Yes Yes Yes 0 RETAIN Yes No Yes Yes 1 REMOVE  
Q27 Yes Yes Yes Yes 0 RETAIN Yes No Yes Yes 1 RETAIN 
Q28 No Yes No Yes 1 RETAIN No Yes No Yes 2 RETAIN 
Q29 Yes No Yes Yes 1 RETAIN Yes No Yes Yes 1 RETAIN 
Q30(R) No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 







 Summary of item removal decisions, during development and testing of the FMQ-PwP 
Item Abbreviated Item 
Content 
Stage at Item 
Removal 













Yes Clinically useful to 
identify if medicating 
safely.  
Q12 Others have been 




Yes Rare but conceptually 
important to some 
individuals with FM.  
Q25 General relationship 
quality 
Suitability of 






Q26 Intimacy quality High proportion 
missing values 
(>15%) 
Yes Sensitive topic 
relevant to some 
individuals with FM. 





Cross loading No  
Q23 Worry partner cares 
less 
Low loading (<.4) No  




Yes Clinically relevant in 
assessing symptom 
awareness. 




Yes Clinically relevant in 
evaluating insight of 
FM impact. 
Q13 Partner can read 
mental state  
Low communality 
(<.2) 
Yes Clinically relevant in 
evaluating insight of 
FM impact. 
Q16 Feel isolated as 




Yes Rare yet conceptually 
important to some 
individuals with FM. 





Q29 Loneliness Low communality 
(<.2) 
No  





Q6 Partner shares in 








Q19 Enjoyment of 
companionship 
Item Redundancy  No - 
Q30 General relationship 
quality 
Item Redundancy  No - 
Note. * Items excluded from the main analyses but retained in the FMQ total scale. Such items reflected conceptually 






Study 2 Appendix III: Item-Level Analysis and Item Removal 
Summary (FMQ-SO version) 
 Table 7 shows item completeness and response distributions for each item of the 
preliminary FMQ-SO, by SO-reported FM status. Table 8 provides item descriptive statistics 
for the FMQ-SO items, also by SO-reported FM status. Table 9 lists item exclusion criteria 
and decisions for the FMQ-SO. Table 10 summarises item reduction of the FMQ-SO and 
items which did not fit well psychometrically but were conceptually or clinically important and 
therefore retained outside the main subscales.  
 Six items were excluded from SO version of the FMQ prior to the main analyses 
(#14, #20, #21, #23 & #26, tables 7 & 8).  Two items (#23 & #26) were excluded for high 
missing values (≥ 15% missing data). Three items were identified as having low response 
variability among FM-reporting respondents (# 14, #20 & #21).  Item #14 refers avoiding 
being near one’s partner, with 20.4% reporting this occurred “sometimes” (n = 10).  Item #21 
refers to concern one’s partner might be having an affair because of the emotional signals 
they appear to display.  Additionally, on item #20 respondents with FM used all response 
categories, but the three highest value options were endorsed by just one respondent each. 
Item #20 was conceptually similar to item #21, as it refers to concern one’s partner might 
want to end the relationship because of the emotional signals they appear to display.  
 During screening for suitability of data for factor analysis, one item (#7) was removed 
based on a lack of bivariate correlations > .2. No further items were eliminated from the 
FMQ-SO during the exploratory factor analysis. In the internal reliability analysis, three items 
(#13, #18, #19) were identified with patterns of comparatively high inter-item correlations (> 
.7) with at least four other items, and corrected item-totals relatively close to one (r = .828, r 
= .852, and r = .814, respectively). The largest inter-item correlation was observed between 
#13 and #19 (r = .782). On examination, the conceptual content of item #13 item was similar 
to item 19. In addition, a second cluster of inter-item correlations was observed between 




(r = .722, r = .712, and r = .719, respectively). Given this, it was decided to remove items 



















Table 7   
Item completeness and response distribution for each FMQ -SO item, compared by self-reported FM status 
 Observed Item Response Distribution 
Cases reporting FM   
(n = 50) 
 Cases NOT reporting FM    
(n = 8) 
























Q3 10 (20.83) 29 (60.4) 6 (12.0) 3 (6.0) 2 (4.0)  4 (50) 4 (50) 0 (0) 0 (0) 0 (0) 
Q4 11 (22.9) 28 (58.3) 7 (14.6) 2 (4.2) 2 (4.0)  7 (87.5) 1 (12.5) 0 (0) 0 (0) 0 (0) 
Q5 (R) 5 (10.2) 11 (22.4) 14 (28.6) 19 (38.8) 1 (2.0)  1 (12.5) 0 (0) 2 (25.0) 5 (62.5) 0 (0) 
Q6 (R) 3 (6.3) 13 (27.21) 14 (29.2) 18 (37.5) 2 (4.0)  0 (0) 1 (12.5) 1 (12.5) 5 (62.5) 0 (0) 
Q7 14 (28.6) 20 (40.8) 14 (28.6) 1 (2.0) 1 (2.0)  6 (75.0) 2 (25.0) 0 (0) 0 (0) 0 (0) 
Q8 6 (12.5) 29 (60.4) 9 (18.8) 4 (8.3) 2 (4.0)  3 (37.5) 5 (62.5) 0 (0) 0 (0) 0 (0) 
Q9  30 (61.2) 16 (32.7) 2 (4.1) 1 (2.0) 1 (2.0)  7 (87.5) 1 (12.5) 0 (0) 0 (0) 0 (0) 
Q10 (R) 1 (2.0) 14 (28.0) 7 (14.0) 28 (56.0) 0 (0)  0 (0) 0 (0) 1 (12.5) 7 (87.5) 0 (0) 
Q11 27 (54.0) 19 (38.0) 4(8.0) 0 (0) 0 (0)  7 (87.5) 1 (12.5) 0 (0) 0 (0) 0 (0) 
Q12 (R) 1 (2.0) 11 (22.0) 18 (36.0) 20 (40.0) 0 (0)  0 (0) 1 (12.5) 2 (25.0) 5 (62.5) 0 (0) 
Q13  21 (43.8) 21 (43.8) 5 (10.4) 1 (2.1) 2 (4.0)  6 (75.0) 1 (12.5) 0 (0) 0 (0) 0 (0) 
Q14 39 (79.6) 10 (20.4) 0 (0) 0 (0) 1 (2.0)  8 (100) 0 (0) 0 (0) 0 (0) 0 (0) 
Q15 (R) 3 (6.1) 3 (6.1) 4 (8.2) 39 (79.6) 1 (2.0)  0 (0) 0 (0) 0 (0) 8 (100) 0 (0) 
Q16 14 (29.2) 14 (29.2) 11 (22.9) 9 (18.8) 2 (4.0)  5 (62.5) 1 (12.5) 0 (0) 0 (0) 0 (0) 
Q17 14 (28.6) 19 (38.8) 11 (22.4) 5 (10.2) 1 (2.0)  6 (75.0) 1 (12.5) 0 (0) 0 (0) 1 (12.5) 
Q18 (R) 1 (2.0) 12 (24.5) 9 (18.4) 27 (55.1) 1 (2.0)  0 (0) 0 (0) 1 (12.5) 7 (87.5) 0 (0) 
Q19  25 (52.1) 16 (33.3) 6 (12.5) 1 (2.1) 2 (4.0)  7 (87.5) 0 (0) 0 (0) 0 (0) 1 (12.5) 
Q20 44 (93.6) 1 (2.1) 1 (2.1) 1 (2.1) 3 (6.0)  7 (87.5) 0 (0) 0 (0) 0 (0) 1 (12.5) 
Q21 46 (97.9) 1 (2.1) 0 (0) 0 (0) 0 (0)  8 (100) 0 (0) 0 (0) 0 (0) 0 (0) 
Q22 (R) 2 (4.1) 4 (8.2) 3 (6.1) 40 (81.6) 1 (2.0)  8 (100) 0 (0) 0 (0) 0 (0) 0 (0) 
Q23 29 (70.7) 5 (12.2) 4 (9.8) 3 (7.3) 9(18.0)  4 (50.0) 0 (0) 0 (0) 0 (0) 4 (50.0) 
Q24 44 (91.7) 3 (6.3) 0 (0) 1 (2.1) 2 (4.0)  6 (75.0) 0 (0) 0 (0) 0 (0) 2 (25.0) 
Q25  40 (83.3) 6 (12.5) 2 (4.2) 0 (0) 2 (4.0)  6 (75.0) 0 (0) 0 (0) 0 (0) 2 (25.0) 
Q26 (R) 4 (9.1) 11 (25.0) 10 (22.7) 19 (43.2) 6 (12)  0 (0) 0 (0) 0 (0) 6 (75.0) 2 (25.0) 
Q27 18 (38.3) 18 (38.3) 8 (17.0) 3 (6.4) 3 (6.0)  5 (62.5) 0 (0) 0 (0) 0 (0) 3 (37.5) 
Q28 24 (49.0) 20 (40.8) 4 (8.2) 1 (2.0) 1 (2.0)  4 (50) 1 (12.5) 0 (0) 0 (0) 3 (37.5) 
Q29 (R) 4 (8.2) 9 (18.4) 12 (24.5) 24 (49.0) 1 (2.0)  0 (0) 0 (0) 2 (25.0) 6 (75.0) 0 (0) 
















Descriptive statistics of the FMQ-SO, compared by self-reported FM status 
 Descriptive Statistics  
 Cases reporting FM   
(n = 50) 
Cases NOT reporting FM   
(n = 8) 
Item Mean Median Mode SD Min Max Skew Kurtosis  Mean Median Mode SD Min Max Skew Kurtosis 
Q3(R) 1.04 1.00 1 .771 0 3 .801 .976  .50 .50 0 .535 0 1 .000 -2.800 
Q4 1.00 1.00 1 .744 0 3 .648 .748  .13 .00 0 .354 0 1 2.828 8.000 
Q5 2.00 2.00 2 .744 0 3 -.648 .748  .63 .00 0 1.061 0 3 1.960 3.937 
Q6(R) 1.04 1.00 0 1.020 0 3 .530 -.899  .75 .00 0 1.165 0 3 1.355 .620 
Q7 1.02 1.00 0 .956 0 3 .414 -.960  .25 .00 0 .463 0 1 1.440 .000 
Q8 1.04 1.00 1 .815 0 3 .164 -.901  .63 1.00 1 .518 0 1 -.644 -2.240 
Q9(R) 1.23 1.00 1 .778 0 3 .699 .505  .13 .00 0 .354 0 1 2.828 8.000 
Q10 .47 .00 0 .680 0 3 1.565 2.839  .13 .00 0 .354 0 1 2.828 8.000 
Q11 .76 .00 0 .938 0 3 .663 -1.178  .13 .00 0 .354 0 1 2.828 8.000 
Q12 .54 .00 0 .646 0 2 .794 -.361  .63 .00 0 1.061 0 3 1.960 3.937 
Q13(R) .86 1.00 0 .833 0 3 .493 -.776  .14 .00 0 .378 0 1 2.646 7.000 
Q14 .71 1.00 0 .743 0 3 .860 .530  .00 .00 0 - 0 0 - - 
Q15 (R) .20 .00 0 .407 0 1 1.515 .307  .00 .00 0 - 0 0 - - 
Q16 .39 .00 0 .862 0 3 2.197 3.718  .17 .00 0 .408 0 1 2.449 6.000 
Q17 1.31 1.00 0 1.095 0 3 .250 -1.229  .14 .00 0 .378 0 1 2.646 7.000 
Q18 1.14 1.00 1 .957 0 3 .445 -.688  .13 .00 0 .354 0 1 2.828 8.000 
Q19(R) .73 .00 0 .908 0 3 .737 -.937  .00 .00 0 - 0 0 - - 
Q20 .65 .00 0 .785 0 3 1.005 .327  .00 .00 0 - 0 0 - - 
Q21 .13 .00 0 .536 0 3 4.537 21.018  .00 .00 0 - 0 0 - - 
Q22(R) .02 .00 0 .146 0 1 6.856 47.000  .00 .00 0 - 0 0 - - 
Q23 .35 .00 0 .805 0 3 2.273 4.118  .00 .00 0 - 0 0 - - 
Q24 .54 .00 0 .951 0 3 1.630 1.425  .00 .00 0 - 0 0 - - 
Q25(R) .13 .00 0 .489 0 3 4.870 26.373  .00 .00 0 - 0 0 - - 
Q26(R) .21 .00 0 .504 0 2 2.455 5.463  .00 .00 0 - 0 0 - - 
Q27 1.00 1.00 0 1.034 0 3 .528 -1.025  .00 .00 0 - 0 0 - - 
Q28 .91 1.00 0 .905 0 3 .725 -.234  .20 .00 0 .447 0 1 2.236 5.000 
Q29 .63 1.00 0 .727 0 3 1.039 .989  .25 .00 0 .463 0 1 1.440 .000 



















Item Screening of the FMQ-SO, by self-reported FM status 
Item Exclusion Criteria 
Cases Reporting FM (n = 50) All cases (N = 58) 










III.                     
SD 
>0.75 



















III.                     
SD 
>0.75 










Q4 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q5 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 1 RETAIN 
Q6(R) Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q7 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q8 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q9(R) Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q10 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q11 Yes No Yes Yes 1 RETAIN Yes No Yes Yes 1 RETAIN 
Q12 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q13(R) Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 3 REMOVE 
Q14 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 0 RETAIN 
Q15 (R) No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q16 No Yes Yes Yes 1 RETAIN No Yes Yes Yes 1 RETAIN 
Q17 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 2 RETAIN 
Q18 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 3 REMOVE 
Q19(R) Yes No Yes Yes 1 RETAIN Yes No Yes Yes 2 RETAIN 
Q20 Yes No Yes Yes 1 RETAIN Yes No Yes Yes 2 RETAIN 
Q21 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q22(R) No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q23 No Yes No Yes 2 RETAIN No Yes No Yes 2 RETAIN 
Q24 No Yes Yes Yes 1 REMOVE            No Yes Yes Yes 2 RETAIN 
Q25(R) No Yes No Yes 2 RETAIN No Yes No Yes 1 RETAIN 
Q26(R) No Yes No Yes 2 RETAIN No Yes No Yes 0 REMOVE  
Q27 Yes Yes Yes Yes 0 REMOVE             Yes Yes Yes Yes 1 REMOVE  
Q28 Yes Yes Yes Yes 0 RETAIN Yes Yes Yes Yes 1 RETAIN 
Q29 Yes No No Yes 2 RETAIN Yes No No Yes 2 RETAIN 
Q30(R) Yes No Yes Yes 1 RETAIN Yes No Yes Yes 1 RETAIN 
Q3(R) Yes No No Yes 2 RETAIN Yes No No Yes 2 RETAIN 




























Summary of item removal decisions, during development and testing of the FMQ-SO 
Item Abbreviated Item 
Content 
Stage at Item 
Removal 











Yes Rare but 
conceptually 
important  





Yes Rare but 
conceptually 
important  





Yes Rare but 
conceptually 
important  









Yes Sensitive topic 
relevant to some 
individuals.  





Yes Sensitive topic 
relevant to some 
individuals. 






Yes Rare but 
conceptually 
important  
Q13 Lack of expression 





Improve Reliability No  
Q18 Enjoyment of 
companionship 
Improve Reliability No  
Q28 Frustration with 
relationship 
Item Redundancy No  
Q30 Loneliness Item Redundancy No  
Note. *Items excluded from the main analyses but retained in the FMQ total scale. Such items reflected conceptually 






Study 2 Appendix IV: Principle Axis factoring of the FMQ 
FMQ-PwP 
A principle axis factor (PAF) analysis was conducted with orthogonal (varimax) rotation for 
the FMQ-PwP, as initial analyses revealed factors were not correlated. Table 11 shows a 
comparative summary of the factor structure of the FMQ-PwP, before and after removal of 
items as a result of the reliability analysis.  
 Initial Factor Matrix. KMO measure of sampling adequacy (KMO = 0.731) and 
Bartlett’s test of Sphericity (p < 0.001) were acceptable. Scree plot inspection and 
Eigenvalues of >1 identified a two-factor solution with eigenvalues of 4.56 and 3.24 (factor 1 
and 2, respectively), explaining 45.55% of the total variance. 
 Final Factor Matrix (following removal of items to reduce redundancy and improve 
reliability). KMO measure of sampling adequacy (KMO = 0.71) and Bartlett’s test of 
Sphericity (p < 0.001) met predetermined criteria. A two-factor solution was retained with 
eigenvalues of 3.70 and 2.61 (factor 1, factor 2 respectively), explaining 44.03% of the total 
variance.  The first and second factors switched after the removal of items to reduce 
redundancy and improve reliability.  
FMQ-SO 
A principle axis factor (PAF) analysis was conducted for the FMQ-SO. Table 12 shows a 
comparative summary of the factor structure of the FMQ-SO, before and after removal of 
items as a result of the reliability analysis.  
 Initial Factor Matrix. KMO measure of sampling adequacy (KMO = 0.852) and 
Bartlett’s test of Sphericity (p < 0.001) were adequate. Scree plot inspection and 
Eigenvalues of > 1 identified a single factor solution as the most clinically interpretable with 
an eigenvalue of 10.39, explaining 45.19% of the total variance.  
 Final Factor Matrix (following removal of items to reduce redundancy and improve 




Sphericity (p < 0.001) were acceptable.  A single factor solution was retained with an 






Table 11   
Comparative summary showing the factor matrix of the FMQ-PwP, before and after removal of items during 
reliability analysis 
Initial Final* 





















Q 8 .845 -.086 26.7% .840 
Q30 
(R)  
0.782 .119    Q7 .787 -.057   
Q15 
(R)  
0.727 .062    Q11 .726 .126   
Q9 
(R)  
0.710 -.072    Q14 .680 .147   
Q22 
(R)  




0.525 -.076   
 
Q4  .425 .189   







.036 .791 17.3% .770 
Q21 0.477 .196   Q9 
(R)  
-.070 .643   








Q8 -.093 0.846 18.56% .830 Q21 .177 .549   
Q7 -.035 0.776   Q18 .165 .540 
  
Q11 .095 0.727   Q20 .109 .443   
Q14 .149 0.683    
   
  
Q5 .070 0.660    
   
  
Q4 -.093 0.429    
   
  
Note. Two factor solution retained using Principle Axis Factoring and Varimax Rotation.   
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Table 12 
Comparative summary showing the factor matrix of the FMQ-SO, before and after items were 
removed due to results of the reliability analysis 
Initial  Final * 
Scale Item  Factor 
1 





Q18(R)  .807 45.2% .953 FM  
Difficulty 
Q19  .794 41.7 % .936 
Q19 .804   Q29(R) .742   
Q13 .791   Q3  .737   
Q4 .744   Q10(R)  .737   
Q8 .739   Q8  .733   
Q30 .735   Q4  .729   
Q28 .733   Q27 .683   
Q10(R) .729   Q16 .676   
Q29(R) .719   Q11 .671   
Q3 .717   Q15(R) .653   
Q27 .712   Q24 .624   
Q16 .690   Q5(R) .570   
Q11 .677   Q22(R)  .566   
Q15(R) .636   Q12(R) .546   
Q24 .633   Q6(R)  .540   
Q22(R) .561   Q9  .525   
Q6(R) .556   Q17 .495   
Q12 .534   Q25 .469   
Q5(R) .532       
Q9 .526       
Q17 .491       
Q25 .485       
Note. Single factor solution with Principle Axis Factoring.  





Study 2 Appendix V. Suggestions for future revisions  
 The final questionnaires and instructions for scoring and interpretation are presented 
in Appendix VI. Further development of the questionnaires could focus on the following 
recommendations. 
 Item Response Options. Only a small proportion of respondents endorsed the 
highest value on items of both versions of the FMQ. Typically, those respondents were 
individuals who described the highest severity of FM.  Based on this finding, the FMQ 
response options could be modified to aggregate the two highest response options (“often” 
and “almost all of the time”) into one “often” option, and the middle option expanded to 
“occasionally” and “somewhat often”.    
 To make it easier for answer for individuals who have FM but experience few 
associated problems, or who attribute the cause of a statement to other symptoms of PD 
(such as speech difficulties), we suggest adding a “not applicable” or “because of another 
aspect of PD” option to the response scale. 
 Scale redundancy / Capturing different aspects of FM-related difficulty. Internal 
consistency analyses indicated there may be some redundancy in the FMQ-PwP and FMQ-
SO. In general, future researchers may wish to reword some items to reduce ambiguity and 
better represent thematic content of the experiences of people with FM in PD. On the FMQ-
SO this might include the following: “My partner is interested in interacting with me” could be 
reworded as “It feels like my partner does not notice me”; and “My partner’s company is 
enjoyable and comfortable” could be reworded as “My partner’s lack of expression takes 
away from sharing in the feel of the moment”. Future investigations in this area might also 
explore stigma as one of the impacts of FM in public settings, and other contributors to FM 
problems in close relationships within the home. Suggested topics for future revisions of the 
FMQ might include fear about the progression of FM perceptions of how close family versus 
casual acquaintances react to FM, and feelings of stigma in public places or social 




facial appearance at gatherings with colleagues, friends or wider family”; “I am troubled by 
the way my partner reacts to the changes in my face”; “I am concerned what losing 
expression on my face will mean for the future”. New items for SO might include the 
following: “When out in public, I am bothered by the loss of expression on my partner’s face”; 
“I am concerned about my partner losing expression in their face in future”; “The blank 
response in my partner’s face is frustrating”; “I find it hurtful when my partner’s face does not 
respond”.  
 Some items that reflected conceptually important themes from the interviews did not 
behave as expected in the preliminary analysis and were subsequently removed from the 
factor structure. For instance, FMQ-SO #13, “My partner’s lack of expression is a barrier 
between us”. As the theme of distance and disconnection figured prominently for several 
interviewees and in respondent’s open answer responses on the FMQ, this topic is worthy of 
further exploration.  
 Ambiguity in Wording of Item Statements. During expert consultation, short 
statements were added to demarcate topics and remind respondents to answer keeping in 
mind their facial expressivity. However, items could be amended to ensure they explicitly 
refer to FM. For example, comprehensibility of item #8 on the FMQ-PWP could be improved 
by changing “It troubles me that way I feel inside is different from how I look on the outside”, 
to “It troubles me that way I feel inside is different from how my face looks on the outside”.  
 The questionnaire’s psychometric properties may have been impacted by the 
valence of item phrasing. As the FMQ measures a negative attribute, it included negatively 
phrased statements and positively phrased statements, with the positive statements being 
reverse scored. The practice of reversing the phrasing of items can sometimes be 
problematic for internal consistency and factor structures of a questionnaire (Barnette et al., 
2000). In addition, the absence of FM-difficulty does not mean an equivalent absence of 
psychological distress or relationship strain.  It is possible that some items of the FMQ could 
be capturing general relationship state impressions, rather those likely to related to FM.  




consistent item-phrasing valence. This may result in questionnaire that has greater 
psychometric properties and may also be more likely to lessen the burden of cognitive 
switching for respondents. 
 Fluctuations in FM Severity. General feedback provided by respondents indicated 
the FM severity item may not capture daily fluctuations of this symptom. For instance, some 
PwP reported FM varied due to factors such as fatigue and medication off-periods, stating 
their appearance could range from close to normal, to almost no expression. An 
understanding of state vs trait-like dimensions of FM might be captured by re-phrasing the 
FM severity item of the questionnaires to ask respondents to rate FM severity “when facial 
movement/expression is at its worst” and then “as facial movement/expression appears most 
typically”. As the remaining FMQ subscale questions include a response scale that captures 




Study 2 Appendix VI:  Final Questionnaire Versions and User 
Instructions 
























































FMQ USER INSTRUCTIONS 
 The FMQ can be administered in pen and paper form or verbally, ideally as part of an 
assessment interview once rapport has been established. The FMQ-SO was primarily 
developed for use with the spouse or partner of people who have PD, but it may also be 
used with adult family members or close friends. A significant other may also complete the 
questionnaire alone, with consideration given to how the person who has PD may be 
included in the assessment and/or discussion of findings. Assistance should be provided to 
patients who have difficulty writing their responses or would find writing unduly taxing. If 
administered verbally, the questionnaire should be undertaken in a private room or office 
because of the sensitive nature of some of the items.  
 Since people with PD and their families may not realise FM is a symptom and/or may 
be reluctant to raise the topic with their healthcare providers, it is recommended that items 1 
and 2 of the questionnaires are administered even when FM is not seen on clinical exam 
(these items may be abbreviated to be conducted verbally). If FM is perceived to be present 
by one or both respondents, it is recommended to proceed with the remainder of 
questionnaire to evaluate the impact of living with FM, at the administrator’s discretion.   
 
SCORING SUMMARY  
 The FMQ provides an FM severity rating, FM-related difficulty subscales (two 
subscales for PwP and a single scale for SO), and a total score.  Additional items provide 
clinically or conceptually important information to the administrator, including a mental health 
screen, open answer items assessing subjective experience and self-management of FM, 
perceived global FM Difficulty rating, and FM education preference.   
o FM Severity & Awareness Rating 
Item 1 requires the respondent to select the description which best describes 
their/their partners level of facial expressivity (or facial masking). No 




FM, with the next lowest option indicating Moderate FM, the following option 
Low FM, and the bottom description indicates normal expression.  
Item 2 requires the respondent selects the description which best describes 
their FM knowledge. No calculation is required.  
o FM-related Difficulty Subscales 
Respondents indicate the frequency each item is experienced. Items are 
scored as following: Rarely/Never = 0, Sometimes = 1, Often = 2, Almost all 
the time = 3. Simply write the numeric value corresponding to respondent 
answers for each item, in the box on the righthand side of the questionnaire. 
When each item score has been completed, add up the numeric scores for 
each of the vertical columns to calculate the raw scores. 
 FMQ-PwP Individual Difficulty (ID) subscale  
 Summed Items: 5, 6, 7, 10, 12 
 FMQ-PwP Relationship Difficulty (RD) subscale  
 Summed Items: 4, 15, 16, 17, 18, 20. 
 FMQ-SO FM Difficulty (FMD) scale  
 Summed Items: 3, 4, 5, 6, 8, 9, 10, 11, 12, 14, 15, 16, 17, 20, 22,  
 23, 25, 26. 
 Please note scoring is reversed for FMQ-PWP items 15, 16, 20 and 
 FMQ-SO items 5, 6, 10, 12, 14, 20, 26.  
o Other Clinical Indicators 
This is a set of items that represent clinically or conceptually important topics, 
but due to their psychometric properties are separate to the main subscale 
items. Other Clinical Indicator (OCI) items are scored on the same response 
scale as the FM Difficulty subscales (above). Please note scoring is reversed 
for FMQ-PWP items 3,9,21 and FMQ-SO item 24.  




 For the FMQ-PwP a total score is calculated by adding Individual Difficulty 
 (ID) subscale, the Relationship Difficulty (RD) subscale, and the set of items 
 forming Other Clinical Indictors (OCI). For the FMQ-SO, a total score is 
 calculated from adding the FM Difficulty scale (FMD) to the set of OCI items. 
 
Other items of note: 
o Mental Health Screen 
There are three separate items which provide a general screening of 
psychological distress (FMQ-PwP items 22-24, and FMQ-SO items 27-29). 
These are also scored on the same item response scale as FM Difficulty 
subscales (above). Any individual item score of 2 or higher signals the need 
for further investigation or psychological/specialist assessment. Please note 
scoring is reversed for FMQ-PWP item 24, and FMQ-SO item 29.  
o Open Answer & Single Index Items  
There are two open answer items which provide information on the 
experience of having FM and how well any socioemotional difficulties arising 
from having FM are self-managed. Responses to these items offer subjective 
information to gauge how impactful FM is as a symptom of PD and help to 
identify intervention targets. There are two further single items, one where 
global FM difficulty is rated on a 5-point scale, and another item indicating 
health education preference in a yes/no format. These single index items 
require no calculation and are included to assist with score interpretation and 





INTERPRETATION OF SCORES 
 The higher the score on the FMQ subscales and total score, the more subjective 
wellbeing is compromised. There are no cut-off scores to indicate clinical significance. 
o FMQ-PwP Total Score 
Theoretical range: 0 - 60, Observed range during initial validation: 0 - 27  
o FMQ-PwP Individual Difficulty (ID) subscale  
Theoretical range: 0- 18, Observed range during initial validation: 0-15 
o FMQ-PwP Relationship Difficulty (RD) subscale  
Theoretical range: 0- 18, Observed range during initial validation: 0-12 
o FMQ-SO Total Score 
Theoretical range: 0-72, Observed range during initial validation: 0-49 
o FMQ-SO FM Difficulty (FMD) scale  
Theoretical range: 0-54, Observed range during initial validation: 0-40 
 
Interpretation of the results can also be aided by subjective comparison of scores across 
respondent versions, and within the questionnaire. Administrators may consider the following 
elements when interpreting the FMQ:  
o Discrepant FM severity ratings between PwP and SO may indicate poor 
awareness of FM as symptom of PD, or poor insight of the degree of facial 
expressive impairment. 
o A large disparity in FM difficulty scores between PwP and SO may occur (one 
respondent scoring exceptionally low and the other high on FM difficulty 
subscales, or as subjectively judged for the open answer and single index 
items). This indicates a difference in the consequences of FM between 
respondents, or in how they may be coping with FM. It may be helpful to 





o If a respondent indicates low FM severity or normal expression, but has 
elevated scores on the FM difficulty subscales, this may also reflect low 
awareness or insight of FM. Objective assessment of FM can be confirmed by 
clinician-based observation or use of other clinical staging tools. On the other 
hand, if an administrator does not observe signs of FM (such as reduced 
expressivity, reduced blink rate, or a lack of active mouth closure) this may 
reflect problems associated with of another aspect of PD (such as speech 
difficulty). In the latter circumstance, it is recommended administrators 
enquire why a respondent positively to the items contributing to the elevated 
FM difficulty scale score.  
 
RECOMMENDATIONS FOR PATIENT EDUCATION/SUPPORT  
 Engaging in a dialogue to ascertain awareness of FM and discuss its potential 
consequences is generally encouraged regardless of the apparent clinical staging of FM 
pathology seen on exam. The higher the FMQ scores, the more strongly education and 
support are recommended. Practitioners should use their clinical judgement to decide the 
depth and content of information appropriate to each respondent. Decisions to provide 
information can also be guided by responses to the symptom knowledge and education 
preference items.  
 Responses to the open answer items will assist administrators in understanding of 
what living with FM has been like for that individual and help identify intervention targets. For 
instance, a respondent who reports minimal strategies to help them cope with FM may 
benefit from referral to physiotherapy or speech programmes – which may mitigate the 
reduction of facial mobility in the short term. Respondents who report relationship strain 
related to FM may benefit from tips to strengthen connection and support communication 
without facial expression. For example, verbalising what is felt for the person with PD, and 




face. A summary of compensatory behaviours used by people with FM and their partners 
can be found in Wootton, Starkey, and Barber (2018), but note that further investigation is 





6. Study 3 
Face Value: Perception of Facial Masking and 
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The findings of this paper form part of a wider doctoral research project, thus participant 
characteristics and method sections of the present report have similarities to work previously 






Background: Little is known about how people with Parkinson’s disease or their family 
members perceive facial masking, or the effects of this symptom on psychosocial outcomes. 
This study explored the psychosocial correlates of facial masking for people who have 
Parkinson’s and their family members. A secondary aim was to compare how different 
observers perceived facial masking. 
Methods: Self-report questionnaires measuring psychological health, social functioning, and 
quality of life were completed by 80 people who had Parkinson’s and 58 of their significant 
others. Self and significant other ratings of facial masking severity were made on the Facial 
Masking Questionnaire (FMQ). Clinical ratings of facial masking severity were made by two 
healthcare professionals using the MDS-UPDRS, based on videos of the participants, and 
the researcher (AW) coded facial expressive behaviours from the same video.  
Results: Greater perceptions of facial masking severity/lower retained expressivity were 
significantly associated with greater masking-related difficulty, which was in turn strongly 
associated to poorer psychosocial outcomes. Clinical ratings of facial masking were not 
significantly related to people with Parkinson’s or significant other reports of facial masking 
severity.  Few significant correlations were found between healthcare professional ratings of 
masking-related difficulty, or with psychosocial outcomes.  
Conclusion: Facial masking can have detrimental effects on psychosocial outcomes, but 
individuals with Parkinson’s and their family members may be affected differently. Relying 
solely on clinical ratings of facial masking may not accurately appraise the possible effects of 
this symptom in the everyday lives of people with Parkinson’s and their families.  
 




Facial masking (FM) is a characteristic and common symptom of PD [1, 2]. FM 
involves a decrease in facial emotional expressivity and an unusual stillness in the face, 
arising from disease-related impaired mobility and increased rigidity of the facial 
musculature. It has been long noted that FM leads people with PD to be perceived as losing 
feeling, interest, or intellect [3]. Research examining social perceptions of people with FM 
has shown perceivers form negatively biased judgements of mood, character, and mental 
state [4-8]. People are also less accurate at recognising the emotions of people with FM [9]. 
Even healthcare practitioners with knowledge of PD may find it difficult to override the 
negative impression that FM appears to produce. When shown silent videotapes of people 
with heart disease and people with PD, healthcare professionals made more negative 
judgements of intellect, affect and personality traits in the individuals with PD, despite there 
being no other measured difference between the groups [10]. As the degree of expressive 
loss increases, individuals with FM tend to be evaluated less favourably by healthcare 
professionals, especially in interpersonal and affective domains [4, 6]. Unsurprisingly, less 
experienced (student) practitioners were found to be more susceptible to forming inaccurate 
judgements of individuals with FM, compared to practitioners with greater experience in PD, 
although neither seem to be immune to the influence of FM [4]. Interestingly, the amount of 
expressivity displayed in PD may be, in part, be a function of the type of relationship or the 
social setting. Individuals with PD were observed to display greater expressivity when 
interacting with an attentive but unfamiliar person, such as a researcher, compared to when 
conversing with their spouse in the same environment [11]. Thus, the effects of expressive 
loss may be different when the perceiver is more familiar with the individual with PD. While 
several studies have explored how FM affects social perception in casual or healthcare 
interactions, little is known of how people with PD themselves and their partners perceive 
FM, or how their perceptions of this symptom might correspond to psychosocial outcomes in 




PD is now recognised to affect much more than physical mobility; it deeply affects an 
individual’s daily life [12]. Motor symptoms may cause difficulty with walking and carrying out 
tasks of everyday living, while problems in communication, cognition, behaviour, emotion, 
sleep, fatigue, and pain may also compromise quality of life (QOL) [13]. One factor thought 
to contribute to QOL in PD is social functioning [14-16]. Difficulties in speech and 
communicating [17], feelings of social isolation [18], stigma [19], and changes to the ability to 
read social cues and emotion [20] are thought to have strong implications for social 
functioning in PD.  
PD does not just happen to the individual; it also affects those who share in their life. 
Family and couple relationships are influenced from the earlier stages of the condition, as 
changes to the individual’s functional ability reshape roles and responsibilities in family 
systems [20]. Caregiving for a person with PD is also associated with decreases in 
psychological and physical health [21, 22]. Given that the visible displays of affection, care 
and understanding may become compromised in FM, deepening understanding of how FM 
may influence relationships with family and carers is important, to identify opportunities that 
promote satisfying and supportive relationships and to help people better cope with the 
challenges and changes that occur in PD.   
Few clinical evaluation tools include FM. The Movement Disorder Society’s Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS) provides clinical staging of PD symptoms, 
including FM [23], but it does not include questions to assess FM-related psychosocial 
dysfunction. The Parkinson’s Disease Questionnaire (PDQ-39) [24], a commonly used 
measure of QOL in PD, includes three questions about social functioning but none refer to 
FM [25]. Computer and video-based techniques have also been investigated as methods of 
identifying FM [26, 27]. 
Only a few studies have investigated how FM relates to psychosocial outcomes in 
PD. Qualitative research has shown FM is perceived as embarrassing [28] and may cause 




attachment [29]. Similarly, our earlier work suggested partners of people with FM have 
trouble attributing the symptom of FM to PD, seeing it as persistent bad mood or 
impassiveness, resulting in a loss of feelings of security and confidence in their relationship 
[30]. Two quantitative studies have investigated the effects of FM in PD. Gunnery and 
colleagues [31] found greater levels of FM corresponded with decreased relationship 
enjoyment for partners, but not people with PD. For the participants with PD, having FM 
predicted increased feelings of social rejection, although this association was reduced when 
controlling for depression [31]. In Ma and colleagues [32], greater feelings of stigma and 
female gender were found to mediate poorer quality of life in people who experience FM. It is 
not clear if the findings on stigma extend from general social functioning to primary social 
relationships. Psychosocial functioning is important to address clinically because PD is an 
incurable condition characterised by increasing disability, with most individuals experiencing 
a considerable reduction in functioning across all areas of quality of life [33, 34]. With day-to-
day support often relying on familial caregivers, it is important to document the psychosocial 
consequences of the condition for individuals with PD and their family members.  
Purpose of the Present Study 
This paper focuses on the effects of FM on psychosocial outcomes in people with PD 
and their significant others (spouse/partner or other close family member). The main aim 
was to assess the association between FM and psychosocial outcomes for both people who 
have PD and their family members. The secondary aim was to compare how different 






This research included 138 community-residing participants from the North Island of 
Aotearoa New Zealand, comprising people who have PD (PwP, n = 80) and their significant 
others (SO, n = 58). Demographic and clinical characteristics for the participants are 
displayed in Table 1. Advertisements seeking participants were placed in PD support group 
newsletters and emailed to support group members. Data collection took place from March 
to November 2019. After potential participants made contact, they were telephoned and 
screened for eligibility. Verbal/written information about the study was provided to potential 
participants, before being asked if they consented to taking part. Testing usually took place 
at the participant home or workplace.  
Individuals were required to have been diagnosed with idiopathic PD by a healthcare 
professional, usually a neurologist. Respondents who might have required extra support, 
such as those formally diagnosed with a memory impairment or who had difficulty 
conversing in English, were excluded from taking part. As we did not want to exclude people 
with PD who had no available significant other, individuals with PD could also take part by 
themselves. Selection was not made based on FM status, so that participants had a range of 
FM severity from none to severe.  
Design  
This cross-sectional multiple centre project forms part of a wider programme of 
research and a portion of the participant characteristics and method sections described here 
are similar to that published previously [35].   
Assessment and Procedure  
Four separate groups provided ratings of FM severity using various methods of 
measurement (PwP, SO, healthcare professional, and researcher). Self/SO-reported 
expressive disposition of the PwP was also measured. Psychosocial outcomes assessed in 




(marital satisfaction and affectionate/positive aspects of social support), and health-related 
quality of life. Psychosocial outcome measures completed by SO included psychological 
health (general psychological health and caregiver strain), and social functioning (general 
social relationships quality, marital satisfaction, and affectionate/positive aspects of social 
support). The assessment session included the PwP/SO completion of self-report 
questionnaires and a video recording of a discussion approximating natural interaction 
between the PwP and the researcher (AW).  
Ethical approval was received from the University of Waikato School of Psychology 
Human Research Ethics Committee (#2018:46). Respondents received verbal and written 
information about the study and gave written informed consent before participating. At the 
completion of questionnaires, consenting participants received a $20 supermarket voucher. 
The videoed discussion was a separate and optional consent, so individuals who were 
sensitive about having their facial movement recorded/analysed could opt out without 
impacting their overall participation. Five participants opted out of the video, and an 
additional two videos were unable to be analysed, as Parkinson’s related symptoms made 
viewing the face difficult. As the New Zealand Parkinson’s community is relatively small, 
participants were informed their video might be reviewed by an expert known to them and 
were given the option to nominate their own preferred healthcare professional to view the 
recording. One participant chose this option, but that video was one of the two unable to 
analysed.  
Self-report Measures 
Social functioning was measured using Medical Outcomes Study-Social Support 
Survey (MOS-SSS) [40]. For the sake of brevity and relevance, we selected the six items 
comprising affectionate support and positive interaction subscales [41]. Affectionate support 
items measure perceived expressions of love and affection, where positive social interaction 
items measure perceived availability of other persons to share in enjoyment or in fun 




time), with lower scores indicating a lower level of perceived social support. These two 
subscales have been previously modified to assess spousal relationship enjoyment in PD 
[31]. We used the original items, asking study participants to rate their most important 
(closest) social relationships, to avoid excluding those who took part without a romantic 
partner. Participants in marital/stable relationships also rated relationship satisfaction using 
the Kansas Marital Satisfaction Scale (KMSS) [42]. This brief three-item scale measures 
how satisfied an individual is in their relationship. Items are rated on a 7-point scale, ranging 
from extremely dissatisfied (1) to extremely satisfied (7). Higher scores indicate greater 
marital satisfaction/quality, with a marital distress/non-distress cut-off score of 17 [43]. 
To measure psychological health, PwP completed the Hospital Anxiety and 
Depression Scale (HADS), a 14-item screening tool which measures symptoms of anxiety 
and depression in hospital and community settings [44]. Each item is rated on a four-point 
scale. The HADS is shown to be a valid and responsive scale for PD populations [45], with a 
score of 11 or higher indicating clinical distress in PD [46]. 
Disease-specific quality life measures exist for PD but had a prohibitive cost for this 
project. Instead, PwP completed the Health-Related Quality of Life Instrument: Fifteen 
Dimensions (15D) [47]. This 15 item self-report questionnaire utilises population-based 
preference weights to produce a single index score on a 0 to 1 scale, where 0 = being dead 
and 1 = no problems on any dimension. The item response format is a 1-5 scale, with the 
respondent choosing the best descriptor of their present state of health. The 15D has been 
shown to be a valid instrument to assess Health-Related Quality of Life (HRQOL) in PD 
populations [48].  
SO psychological health was assessed using the World Health Organisation Quality 
of Life Assessment -Short Version (WHOQOL BREF) [49]. This 26-item measure four broad 
domains, each providing a score: physical health, psychological health, social relationships, 
and environment. Items are rated on a five-point Likert‐type scale, with scores calculated on 




used in patients and caregivers in various chronic illness and has been previously used in 
PD caregiver populations [50]. Psychological health in SO was also assessed with the 
Caregiver Strain Index (CSI) [51]. The CSI a 13-item self-report questionnaire that measures 
burden strain related to the caregiving role in long-term family caregivers. Strain is assessed 
across five domains: Financial, Physical, Psychological, Social, and Personal. The response 
format is yes/no, with higher scores indicating greater caregiver burden. Although there is a 
newer version which uses a 0-2 response scale, the original was used here to aid 
comparison with previous usage in Parkinson’s caregivers [52-54]. The range of mean CSI 
scores across those PD studies is reported as 3.0 – 8.7 (SD 2.7 – 3.5) [55]. 
 FM variables were assessed using the Facial Masking Questionnaire (FMQ), an 
instrument designed to assess the amount of psychosocial difficulty associated with facial 
masking in people who have PD and their significant others [35]. The FMQ-PwP (person with 
Parkinson’s version) is a self-report scale (n = 28 items) of FM-related difficulty that includes 
individual and relationship subscales. The FMQ-SO (significant other version) is a 
unidimensional self-report measure (n = 30 items). Items are rated by selecting how often 
each statement occurs on a four-point response scale where 0 = rarely/never and 3 = almost 
all the time. Several additional items of clinical relevance are included: perceived FM 
severity, knowledge of FM, indicators of psychological distress, open answer items to voice 
personal experiences of FM, a global FM difficulty rating item, and preference for further 
information about FM.  
 Individual expressive disposition was assessed using The Berkeley Expressivity 
Questionnaire (BEQ), a 16 item self-report questionnaire measuring perceived emotional 
expressive disposition across three facets: negative expressivity, positive expressivity, and 
impulse strength [41]. BEQ items are rated on a 7-point scale, from strongly disagree to 
strongly agree. Higher scores show greater perceived expressiveness. We administered the 





Videoed Discussion  
 An informal discussion between the first author and the participant was recorded. 
Usually, this was conducted after completing the self-report measures when participants had 
established a rapport with the researcher. During the videoed discussion, the researcher 
asked five questions which were chosen to increase the likelihood of range of emotional 
expressions being elicited and to provide balance to the emotional tone of the interaction. 
Question topics included: Q1) typical daily routine, Q2) enjoyed activities, Q3) a frustrating or 
challenging event in the past few weeks, Q4) an enjoyable event in the past few weeks, and 
Q5) a future event the interviewee is looking forward to. The questions were followed by 
informal prompts to increase elaboration, where necessary. Four of the five questions topics 
(Q1, Q2, Q3, & Q4) were adapted from existing interview procedure developed for the 
Interpersonal Communication Rating Protocol – Parkinson’s disease version [56]. 
 Raw video data was transformed by removing audio (to minimise the influence of 
verbal communication) and then edited into two sets of silent clips. The first set of silent clips 
was rated by the first author and a research assistant to provide assessment of facial 
expressive movement and key clinical features of FM. Response start and end times for the 
five interview questions were identified and standardised clips were extracted by taking the 
first 20-45s of each response. Extraction length was calculated separately for each question, 
by retaining the maximum duration while keeping the number of participants with insufficient 
footage to <15% for each question. Extracted clips for all five questions were then coded 
(around 170s total duration per participant). Raters used the Facial Expression Coding 
System (FACES) to measure the frequency and duration of facial expressive behaviours [57, 
58]. In addition to expressions of emotion, codes were added for ‘neutral’ (at rest with no 
observable expression and no observable features of FM) and ‘masked’ (one or more of: 
reduced blink frequency; unintentional lip/jaw separation or lips closed with jaw visibly 
dropped and unintentional downturned lip corners; eyebrows which may be raised or 




Neutral and masked codes were combined for a researcher-based rating of facial masking. 
The first author and a research assistant trained as raters on the modified version of the 
FACES, using the unextracted video data. Raters trained on 20% of the sample (n = 15) until 
an acceptable level of inter-rater agreement was reached on all observation pairs (kappa 
>.7). Remaining coding using the modified FACES was then completed by the first author. 
Training video data was selected to represent a range of expressive dispositions and roughly 
equal genders of participants. Following procedure for observational video data [59], Kappa 
statistic was used to assess inter-rater reliability of the codes for each observation pair. 
Average kappa, tallying instances of all main codes by duration, was .82 (range = .71 to .93) 
and by tallying the frequency of all main codes was .77 (range = .76 to .81). The adapted 
version of the FACES and rater training protocol is described in the supplementary data.   
 A second set of shortened clips was created for experts to rate, so that video footage 
could be viewed within approximately one hour. Standardised extracts (20s in total per 
participant) were comprised of interviewee responses to questions 2 and 3, which were 
selected to maximise the likely emotional range displayed by video participants. Clips for 
each participant were separated by a black screen listing the clip number and instructions for 
the viewer to make a rating. Experts, two registered nurses experienced in providing PD 
support, viewed the recordings of consenting participants in person and rated the level of FM 
using item 3.2 of the Movement Disorder Society Unified Parkinson’s disease Rating Scale 
(MDS-UPDRS) [60]. This clinical staging measure assesses FM severity by reduced eye-
blink frequency, loss of facial expression/spontaneous smiling, and frequency of parting of 
lips when the mouth is at rest. The response format is a five-point scale from 0 = none, to 4= 
severe FM.  
Data Analysis 
Qualtrics Survey Software was used for data entry of paper-based self-report 
measures. Statistics were calculated using IBM SPSS (version 26). Encoding of video 




software aided coding of facial expressive behaviours in the video data. As this is a clinical 
sample where much of the data had non-normal distributions, the analyses primarily use 
nonparametric statistics. 
Spearman’s rank order correlations were used examined the associations between 
different ratings of FM severity. Krippendorff’s Alpha (K alpha) was conducted to measure 
the magnitude of agreement between PwP-SO pairs and between healthcare professional 
(Parkinson’s nurse) raters [36, 37]. The versatility of K alpha was important for the present 
study, which involved unequal group sizes and some missing data [38]. K alpha ≥ .67 was 
taken as the lowest acceptable limit of agreement [36]. Upper and lower limits reported are 
95% confidence intervals. Spearman’s rank order correlations were calculated to explore the 
associations between FM variables and psychosocial outcomes. The magnitude of 
correlations was interpreted using Cohen’s criteria [39]. Comparison of differences in 
observed mean psychosocial outcome scores for the present sample with other population 





   
Table 1 
Sociodemographic and clinical characteristics of study participants  
PwP Participants (n = 80) 
Age in years mean (SD) range 69.64 (9.36) 44.00-86.00 
Male n (%) 57.00 (71.25%) 
Early Onset < 50 years n (%) 6.00 (7.50%) 
Time since diagnosis mean (SD) range 6.40 (4.99) 0.50-22.00 
Facial Masking duration mean (SD) range 2.63 (4.33) 0.10-23.00 
Dopamine Replacement therapy n (%) 74.00 (92.50%) 
No medication n (%) 4.00 (5.00%) 
Deep Brain Stimulation n (%) 3.00 (3.75%) 
New Zealand or Other European n (%) 73.00 (91.25%) 
Māori & Pasifika n (%) 5.00 (6.25%) 
Other ethnic background n (%) 3.00 (3.75%) 
Retired or unable to work n (%) 65.00 (81.25%) 
Married/Living together n (%) 68.00 (85.00%) 
Took apart alone n (%) 22.00 (27.50%) 
Lives in private home n (%) 73.00 (91.25%) 
 SO Participants (n = 58) 
Female n (%) 45.00 (77.59%) 
Relationship length mean (SD) range 41.97 (12.52) 11.00-62.00 
New Zealand or Other European n (%) 55.00 (94.83%) 
Other ethnic background n (%) 2.00 (3.45%) 
Māori n (%) 1.00 (1.18%) 
Retired n (%) 40.00 (68.97%) 
Has current illness n (%) 9.00 (15.52%) 
Tertiary Education n (%) 31.00 (53.45%) 
Took part with spouse or partner n (%) 55.00 (94.83%) 
Took part with parent n (%) 3.00 (5.17%) 





Ratings of Facial Masking  
There was a statistically significant, moderate positive correlation between PwP and 
SO ratings of FM severity. The more FM perceived by PwP, the more FM SO also perceived 
(r = .430, p = 0.01). While the correlation between PwP and SO ratings of FM severity was 
statistically significant, the agreement between PwP-SO pairs did not reach an acceptable 
level (α = .41, lower limit = .21, upper limit = .58, where α ≥ .67 indicates an acceptable level 
for agreement). A significant, strong positive correlation was found between the two 
healthcare professionals’ ratings of FM (r = .71, p < .01). Their ratings also showed an 
acceptable level of agreement (α = .70, lower limit = .58 upper limit = .81). Subsequent 
analyses in this paper use the mean healthcare professional rating.  
Correlations between healthcare professional ratings of FM severity and PwP reports 
of FM severity were not statistically significant (r = .17, p = 0.15), and SO reports of FM 
severity (r = .14, p = .30). Because different methods of measurement were used across the 
four rater groups, analysis of agreement was not suitable. The presence of FM yes/no 
responses across the four rater groups was compared, based on the subset of PwP 
participants who consented to take part in the video (n = 73 PwP video participants). The 
healthcare professionals separately rated 2.70 % (n = 2) and 8.2% (n = 6) of the video 
sample as having normal expression, whereas 33.30% (n = 25) of the PwP group rated 
themselves as having normal expression, and 14.30% (n = 8) of their SO’s reported normal 
expression.  
Table 2 reports the correlations of researcher-rated expressive facial behaviour with 
PwP/SO report and with healthcare professional assessment of FM severity. Correlations 
between PwP-reported FM severity and most aspects of researcher-rated facial behaviour 
were not statistically significant, except for high intensity expressions (table 2). SO ratings of 
FM severity had significant, small positive correlations with the “Masked” (clinical features of 




codes (table 2).  
Health professional evaluations of FM were significantly related to most researcher-rated 
facial behaviours, but the highest of these correlations was of only of moderate magnitude  
(maximum r = .53, “masked” code).  
Table 2 
Correlations of researcher-rated expressive facial behaviour with PwP/SO report and with 
healthcare professional assessment of FM severity. 
Facial Behaviour Codes 





(observable emotion or expressive 
movement) 
-.29* -.15 -.24 
NEUTRAL  
(at rest with no observable 
expression) 
-.37** -.21 -.17 
MASKED  
(other clinical signs of FM) 
.53** .18 .30* 
FM SEVERITY  
(Masked & Neutral combined) 
.28* .16 .28* 
Modifier codes for type of 
Expression 
 
Positive  -.22 -.09 -.23 
Negative  .19 .04 .15 
High-Very High Intensity  -.14 -.26* -.13 
Low-Medium Intensity  .11 .21 .06 
Note. Spearman rank correlation coefficients. Significant correlations in bold. Facial behaviours coded by researcher from video using 
the modified FACES. Codes represent the proportion of observation (duration). Other clinical signs of FM in addition to reduced 
expression, reduced blink rate, mouth dropping open, unusually fixed eyebrows. Healthcare Professional ratings, MDS-UPDRS; 
PwP/SO-report, FMQ-PwP/FMQ-SO.  
 *Correlation is significant at the 0.05 level (2-tailed) 




General Psychosocial Outcomes 
People with Parkinson’s  
Scores on the psychosocial outcomes and comparison with the general older 
population and other clinical samples, are provided in table 3. PwP in our study had poorer 
HRQOL when compared with other PD groups and similarly aged (non-clinical) older adults, 
with a significant difference in mean scores between the present sample and non-clinical 
older adults (see table 3).  
Good psychological health was generally reported by PwP. Overall, low levels of 
symptoms of depression and anxiety were reported (mean HADS depression score = 4.50, 
mean HADS anxiety score = 5.65, where score of ≥11 indicates clinical levels of distress in 
PD populations). Three respondents (~4%) had scores corresponding to a clinical level of 
depression symptoms, and 12 (15%) had scores corresponding to anxiety symptoms at a 
clinical level. Interestingly, psychological distress of the present sample was significantly 
lower than that reported in other studies of PD and in general samples of similarly aged New 
Zealanders (see table 3). 
PwP perceived a good overall availability of positive and affectionate support from 
the important people in their lives (MOS-SSS positive interaction mean score = 70.25, 
affectionate support mean score = 78.0, where maximum score is 100 and higher scores 
indicate greater support). PwP in the present study had a statistically significant difference in 
both perceived affectionate support and positive social support, when compared with general 
older populations. Perceived availability of positive social interactions, but not affectionate 
support, was significantly lower in the present sample relative to other clinical populations.  
The marital satisfaction of people with PD indicated they were not, on average, 
experiencing relationship distress (mean KMSS score = 19.36, where higher scores indicate 
greater marital satisfaction/quality with scores < 17 indicating marital distress). The present 
sample reported similar levels of marital satisfaction to other clinical and non-clinical 




relationship satisfaction, and availability of affectionate support when compared to other 
clinical samples. They perceived a lower availability of positive social interactions but had 
better psychological health than other clinical samples.  
Significant Others    
SO psychosocial outcomes, comparisons with the general older population, and 
comparisons with other clinical samples, are provided in table 4. SO in our sample had lower 
QOL domain scores for psychological health and physical health, relative to their social 
relationships and environment scores (WHOQOL BREF domain scores, see table 4). SO 
physical health and psychological health (domain scores) were similar to other carer 
populations, but significantly worse than in general older adult samples. SO in the present 
sample also experienced similar levels of caregiver strain to other PD carer samples.  
SO perceived a poor availability of affectionate support and positive social 
interaction, compared to caregivers in other clinical groups and community samples of older 
adults (see table 4). They were also significantly more dissatisfied with their relationships 
compared to general older adult populations but experienced a similar level of marital 
satisfaction to carers in other clinical populations (table 4). Overall, SO in the present sample 
reported similar levels of psychological health, caregiver strain and marital satisfaction to 
carers in other samples. They perceived a lower availability of affectionate support and 





Table 3  
Descriptive statistics comparing PwP scores on psychosocial outcomes, with scores of other PD populations and nonclinical populations. 
 Present Study Other PD populations a Non-Clinical Populations 
Psychosocial 
Outcomes 
n  Mean  
(SD)  
range 










Quality of Life  
 79 .73  
(0.92) 






routine care (n= 
256, mean age 
in years= 67) 
.77  
(0.13) 









0.13 2.21 .028* 
Anxiety 
 
79 5.65  
(3.96) 
0 to 17 
Martinez 




routine care  
(n =72 patients, 












sample (n = 
203, mean age 
in years= 68) 
11.9  
(3.6) 
6.25 12.73 .001** 
Depression 
 
79 4.51  
(2.71)  
0 to 12  
7.86  
(0.52) 
3.35 10.32 .001** 9.9  
(2.5) 




79 78.0  
(1.25)  
0 to 100 b 






disease (n =74, 










sample (n = 
355, mean age 
in years= 77). 
77.0  
(2.50) b 




79 70.25  
(3.0)   
25 to 100 b 
76.6 
 (25.1) 
6.35 2.23 .027* 74.75  
(4.25) b 






53 19.36  
(2.34)  







outpatients (n = 
52, mean age 
in years =66) 
18.6  
(3.5) 






n = 168, mean 




-0.82 -1.57 .118 
Note. a Other chronic illness groups used where PD data unavailable, b Scores transformed to 1-100 scale to allow for comparison.   
 Comparison of differences in observed mean scores for present sample with other population groups. Statistically significant differences in bold  
* Correlation is significant at the 0.05 level  





Descriptive statistics comparing SO scores on psychosocial outcomes, with scores of other PD carer and nonclinical populations. 
 Present Study (n = 58) Other Carer Populations a Non-Clinical Populations 
Psychosocial 
outcomes 
n Mean  
(SD)  
range 




















sample (n = 61) 
65.78  
(14.56) 








(n = 202, mean  
age in years = 73) 
75.40 
(13.26) 









-9.38 -2.56 .012* 72.96 
(17.02) 
1.9 0.72 .471 
Physical 
Health (QOL) 





1.93 0.5 .523 75.57  
(18.7) 
15.97 6.23 .001** 
Environment 
(QOL) 





-12.98 -5.10 .001** 80.18  
(14.7) 
-1.75 -0.82 .416 
Affectionate 
Support 









(n = 39, mean 










(n = 355, mean 
age in years= 77) 
77.0  
(2.50) b 
4.25 10.56 .001** 
Positive 
Interaction 
57 66.25  
(0.75) 
 0 -100 b 
68.75  
(3.0) b 
2.5 6.04 .001** 74.75  
(4.25) b 
8.5 15.05 .001** 
Marital 
Satisfaction 






American PD  
carers, routine 
care (n = 41, 
mean age in 
years= 67) 




sample (n = 168, 
mean age in 
years = 69 years) 
18.54  
(3.57) 
1.30 2.24 .026* 
Caregiver 
Strain 









study (n = 61) 
3.1  
(2.7) 
-0.45 -0.84 .405 - - - - - - 
Note. a Other carer populations used where PD carer data unavailable, b Scores transformed to 0-100 scale to allow for comparison, c SD not reported.  
Comparison of differences in observed mean scores for present sample with other population groups. Statistically significant differences in bold.  
* Correlation is significant at the 0.05 level  




Perceived FM Severity and Psychosocial Outcomes in PD 
People with Parkinson’s 
Table 5 reports the correlations of PwP perceptions of FM severity with psychosocial 
outcomes in PwP participants. Interestingly, perceived retention of expression (expressive 
disposition, as measured on the BEQ) had the strongest magnitude of significant correlations 
with psychosocial outcomes, rather than the perceived loss of expression (FM severity as 
measured on the FMQ). Statistically significant correlations were found between higher BEQ 
scores and the following: better marital satisfaction; a higher perceived availability of 
affectionate/ positive social support; and fewer symptoms of depression (see table 5).  
Correlations between PwP-reported FM severity and social functioning were not 
statistically significant. Significant, small to moderate negative correlations were found between 
PwP FM severity and HRQOL, and between FM severity with symptoms of depression. A 
significant, moderate negative correlation between FM duration and HRQOL was also found. 
One explanation for the latter correlation is that a longer duration of FM is related to disease 
progression. Consistent with this, PD stage had a significant, moderate negative correlation with 
HRQOL.   
Some demographic and clinical variables had significant correlations with psychosocial 
outcomes in PwP. Small significant correlations were found between the following: female PwP 
gender and greater positive social interactions; shorter relationship length and more symptoms 
of anxiety; more advanced PD and reduced HRQOL (see table 5). 
Significant Others 
Correlation between SO perceived FM severity with SO psychosocial outcomes are 
reported in table 6. As expected, SO-reported FM severity had significant moderate correlations 
with relationship-related outcomes. The more FM SO perceived, the lower marital satisfaction, 




A longer duration of FM had a significant, moderate negative correlation with perceived 
availability of positive interactions, but was not significantly correlated with all other psychosocial 
outcomes measured (psychological health, general social relationships, affectionate support, 
marital satisfaction, and caregiver strain). There was no significant relationship between SO 





Correlations between participant characteristics with wellbeing and FM-related outcomes, for PwP (n = 80). 






























Health related  
Quality of Life  
.03 .10 -.01 .04 -.31** -.10 -.35** -.36** -.04 -.19 .20 
Anxiety  -.21 .16 -.27* -.17 .06 .29** .15 .03 -.24* -.02 .05 
Depression  -.11 .03 -.14 -.11 .18 .08 .22 .28* -.04 .01 -.30** 
Affectionate 
Support  
-.10 .07 .09 -.02 -.11 .21 .12 -.04 -.15 .20 .34** 
Positive 
Interaction  
-.11 .24* .02 -.10 .09 .05 .06 .08 .05 .01 .31** 
Marital 
Satisfaction 
.14 .04 .15 .15 -.05 .01 -.08 -.14 .22 -.06 .35* 
Note. Spearman’s rank order correlation coefficient. Significant correlations in bold. H & Y (Hoehn & Yahr) stage is based on participant interview. Treated for Depression is self-
reported pharmacological and/or psychological treatment for low mood. FM severity is the amount of perceived FM, as measured by the FMQ (PwP), MDS-UPDRS (healthcare 
professional evaluation), and FACES (researcher rating).  Expressive disposition is PwP-reported perceived emotional expressive disposition, as measured on the BEQ.  
*Correlation is significant at the 0.05 level (2-tailed) 






Correlations between participant characteristics with wellbeing and FM-related outcomes, for SO (n = 58) 
 
Demographic and General PD 
Characteristics 
























Psychological Health  -.18 -.07 -.12 .15 -.01 -.17 -.10 .14 .19 
Social Relationships  -.09 .16 -.12 .04 -.19 -.28* -.08 .09 .07 
Affectionate Support  -.10 .12 .04 -.12 -.15 -.33* .01 .01 .24 
Positive Interaction  -.16 -.04 -.09 -.15 -.33* -.23 .01 -.09 .22 
Marital Satisfaction -.34* .21 -.12 -012 -.06 -.36** .10 -.04 .35** 
Caregiver Strain .15 -.23 .10 .11 .21 .43** .09 .10 -.21 
Note. Spearman’s rank order correlation coefficient. Significant correlations in bold. H & Y (Hoehn & Yahr) stage is based on participant interview. FM severity is the amount of FM 
perceived by rater, as measured by the FMQ (SO), MDS-UPDRS (healthcare professional evaluation), and FACES (researcher rating). Expressive disposition is SO-reported 
perceived emotional expressive disposition, as measured on the BEQ.  
*Correlation is significant at the 0.05 level (2-tailed),  






FM-Specific Difficulties and Psychosocial Outcomes in PD 
Table 7 presents the correlations between FM-specific difficulty, as measured on the 
FMQ, with psychosocial outcomes (rather than FM symptom severity, as in the previous 
section). In PwP, significant small correlations were found between greater FM-related 
relationship difficulties and worse psychological health, and moderate significant correlations 
with poorer social functioning. Most notably, the more FM-related relationship difficulties 
PwP reported on the FMQ, the lower levels of marital satisfaction, availability of affectionate 
support, and availability of positive social interactions they perceived (table 7). A significant 
moderate correlation was also found between greater FM-related individual difficulty and 
more symptoms of depression. Significant, small positive correlations were found between 
FM-related individual difficulties and psychological health outcomes. No other significant 
correlations were observed between FM-related individual difficulty and psychosocial 
outcomes.  
For SO, negative consequences of FM were most strongly correlated with outcomes 
related to relationship functioning. FM difficulty on the FMQ-SO had a significant moderate 
correlation with lower perceived affectionate support, and significant large correlations with 
lower marital satisfaction and greater caregiver strain (table 7). Significant, small positive 
correlations were also found between SO FM difficulty on the FMQ with poorer psychological 






Correlation between FM-related outcomes and other wellbeing outcomes in PD 
Psychosocial outcomes FM-Specific Difficulty  
 
PwP (n = 80) 
FM Relationship 
Difficulty Subscale 
FM Individual  
Difficulty Subscale 
 









Affectionate Support -.43** 
-.01 
 
Positive Interaction -.26* 
.08 
 
Marital Satisfaction -.39** 
-.02 
 
SO (n = 58) 
FM Difficulty  
Scale 
  
Psychological Health  -.26* 
Social Relationships  -.13  
Affectionate Support  -.30*  
Positive Interaction  -.27*  
Marital Satisfaction -.50**  
Caregiver Strain .53**  
Note. Spearman’s rank order correlation coefficient. Significant correlations in bold.  
FM-Specific Difficulty as measured on the FMQ 
*Correlation is significant at the 0.05 level (2-tailed). 






Other Characteristics Corresponding to FM-specific Difficulty in PD 
Scores on the FMQ were also correlated with the demographic and clinical variables 
and are reported in table 8. The most notable findings were that healthcare professional 
evaluations of FM severity were not significantly correlated with any scales of FM difficulty 
on the FMQ, for both PwP and SO. Additionally, researcher-rated FM severity only had one 
significant small correlation with a single FM difficulty subscale. It was also of note that PD 
stage was not related to any of the FM variables. 
For PwP, a younger age at PD onset had a significant moderate correlation with 
greater FM-related individual difficulty. Interestingly, PwP self-report of FM severity was not 
significantly correlated with their perception of FM-related relationship difficulties, but did 
have a significant, strong positive correlation with FM-related individual difficulty. For SO, 
female gender was the only other variable to have a statistically significant correlation with 
greater FM-related difficulty on the FMQ. SO-reported FM severity had a significant large 







Correlations between study variables and FM-specific outcomes, as measured on the FMQ. 
PwP (n =80)  
Demographic and Clinical Characteristics 
FM Relationship  
Difficulty Subscale 
FM Individual  
Difficulty Subscale 
Age in years .04 -.40** 
Gender .02 -.07 
Relationship length -.17 -.31* 
Age at PD Onset .08 -.42** 
H&Y Stage Estimate .09 .10 
Treated for Depression .01 .14 
FM-Related Characteristics  
FM Duration .03 .56** 
FM Severity Self-report .10 .63** 
FM Severity Healthcare Practitioner-rated .13 -.02 
FM Severity Researcher-rated .24* .11 
FM Self-reported Expressive Disposition -.31** .01 
SO (n = 58) 
FM Difficulty  
 Scale 
 
Demographic and Clinical Characteristics  
Gender .29*  
Relationship length -.17  
PD Duration -.04  
H&Y Stage Estimate .03  
FM-Related Characteristics   
FM Duration .14  
FM Severity SO-report .53**  
FM Severity Healthcare Practitioner-rated .04  
FM Severity Researcher-rated .20  
FM SO-reported Expressive Disposition -.58**  
Note. Spearman rank order correlation coefficient. Significant correlations in bold. H & Y (Hoehn & Yahr) stage is based on 
participant interview. FM severity is the amount of FM perceived by rater, as measured by the FMQ (PwP/SO), MDS-UPDRS 
(healthcare professional evaluation), and FACES (researcher rating). FM Knowledge is the level of symptom knowledge, as 
reported the FMQ. 
*Correlation is significant at the 0.05 level (2-tailed),  






This paper examined the association between FM and psychosocial outcomes in 
PwP (people who have PD) and their SO (spouse/partner or other close family member). 
The primary aim was to explore the psychosocial correlates of having FM. The secondary 
aim was to compare how different observers perceived FM.  
Overall, greater SO perceptions of FM severity and lower PwP perceptions of 
retained expressivity were the variables most strongly associated with greater FM-related 
difficulty, which in turn was the study variable most significantly related to poorer 
psychosocial outcomes. For PwP, the more negative consequences of FM that were 
reported, the more the anxiety and depression symptoms that they experienced. They also 
experienced lower levels of marital satisfaction, perceived a lower availability of affectionate 
support and a lower availability of positive social interactions. For SO, the more negative 
consequences of FM that were reported, the lower the level of marital satisfaction, more 
caregiver strain, the less available they perceived affectionate support or positive social 
interaction, and the worse psychological health they experienced. These findings share 
similarities with previous evidence exploring the associations between FM and reduced 
social functioning in PD caregivers [31] and compromised quality of life in PwP who have 
greater FM [32]. Given the limited number of current studies, further investigation is required 
to clarify our understanding of the psychosocial consequences this symptom.  
It was noteworthy that PwP did not report compromised social relationship 
functioning when compared to other PD populations and to normative samples of older 
adults, but SO did. This may occur because the person with PD’s perception of the 
relationship is protected, possibly by disease-related deficits in their own emotion recognition 
abilities, as suggested by Gunnery and colleagues [31]. It could also be that FM affects the 
social functioning of significant others differently to people who have PD, because significant 
others face the challenge of balancing caring for a person with PD and keeping up with 




overall social functioning reported by participants with PD may also be one factor to impact 
favourably on their psychological health, which represented normal (nonclinical) levels of 
psychological distress, and surprisingly, was found to be statistically better than that reported 
in other PD populations and similarly aged adults. An additional explanation for this may be 
that participants self-selected based on a relatively low levels of distress and other 
psychosocial stressors. Notwithstanding this limitation, we found greater FM-related difficulty 
was significantly correlated with more symptoms of depression and anxiety for PwP, and to 
poorer psychological health and decreased social functioning in SO.  
Only a few demographic and general clinical variables were found to correspond with 
greater FM-related difficulty. What stood out was the lack of significant correlations between 
PD stage and most psychosocial outcomes measured. This may suggest that the effects of 
FM are somewhat independent of PD progression. We also found the effects of FM were 
most marked for younger PwP. It is possible this reflects the impact of having a progressive 
condition at a life stage where there is greater expectation of health and higher 
responsibilities in work and family roles.  
Differences were found in raters perceptions of FM severity. We also found that 
associations between perceptions of FM and psychosocial outcomes/FM difficulty were not 
consistent across raters. The most striking finding was that healthcare professional 
evaluations of FM severity were largely unrelated to most psychosocial outcomes that were 
measured, and unrelated to reports of FM-specific difficulties, when compared to PwP/SO 
ratings of FM. These findings are congruent with the idea that observations of clinicians 
differ from the perspectives of people who live with FM every day [32] and are consistent 
with findings showing different social relationships influence the amount of expressivity 
displayed by people who have PD [11]. There is a need for investigation of how healthcare 
professional ratings of FM staging done in routine clinical settings relate to impressions of 




of FM. For example, how does the impression a PwP is grumpy all time relate to the 
presence and degree of clinical markers of FM typically evaluated in the MDS-UPDRS [23].  
It should be noted that these differences may be due in part to the different ways of 
assessing FM. The videoed discussion may not approximate the level of expressivity 
displayed in everyday family life or in usual interactions during routine PD care. Assessment 
by treating healthcare professionals, who are more familiar with the individual with PD, may 
agree better with PwP/SO FM ratings. That said, the present findings suggest that clinical 
ratings of FM do not provide sufficient information to evaluate the emotional and social 
consequences of FM, or to identify who experiences the most distress relating to this 
symptom. The findings further suggest it is important to ask PwP/SO about their experiences 
of FM, because their perceptions of FM difficulty were found to relate most strongly to wider 
psychosocial problems.  
The limitations of this exploratory study are the use of mainly correlational analyses 
and participant recruitment from a community sample where participants may have self-
selected based on relatively good psychological health and/or an earlier stage of PD. Further 
confirmatory research is needed to investigate how FM-specific difficulties may lead to 
poorer psychosocial outcomes in PD and to develop interventions to lessen the impact of 
FM. Future studies could be improved by using the same assessment methods or 
instruments across expert, family, and patient groups. Other variables that could be usefully 
explored which relate to the clinical evaluation and management of FM may include the 
following: adjustment to having FM including concepts such as psychological flexibility; 
fluctuations in FM (state-trait-like dimensions of FM severity); variations in FM experience 
based on sociocultural variables such as gender; a possible interaction between PD stage 
(and/or FM severity) and the ability to meet social role demands across the stages of life; the 
potential benefits of education in increasing understanding of FM; and the usefulness of 
various compensatory strategies. It is also noted that unequal gender distributions in PwP 




related changes imposed by PD may also have influenced the way respondents answered 
the FMQ items. Future investigations could usually include a larger sample of female 
participants with PD/FM and include clinical measurement of PD staging.  
Conclusion 
We identified that FM is related to poorer psychosocial outcomes in PD, however 
PwP and SO may be affected in different ways. The findings also highlight the importance of 
including patient and significant other perspectives of FM. Clinical evaluation of FM provides 
useful information about the staging of this symptom, but PwP/SO experiences of FM should 
be included in addressing the consequences of this symptom in the everyday lives of people 
who have PD and their families.  
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Supplementary Data  
Study 3 Appendix I. Rater Instruction Guide for Coding of Video 
Data   
 
 Three main rating variables are used in this research to measure facial expressivity 
are: expression; neutral; and masked neutral. The Facial Expression Coding System 
(FACES) was originally developed for measuring the frequency, duration, valence & intensity 
of facial expressions (Kring & Sloan, 2007). In this research, the FACES has been adapted 
for use with a Parkinson’s population who may experience bradykinesia (slowness of 
movement), akinesia (poverty of spontaneous movement) and hypokinesia (reduced 
amplitude of movement) in the musculature of the body and the face. The results in deficits 
in the expression of emotion, called hypomimia or facial masking.   
 Please follow the original FACES user guidelines to code the frequency, duration, 
valence, and intensity of emotional expressions (Kring & Sloan, 1991, The facial expression 
coding system: A users guide. Unpublished manuscript. pp. 2-8). To capture the nature of 
expressive dysfunction in Parkinson’s, this research introduces additional variables (or 
codes) to the FACES. This includes a ‘Neutral’ code which measures the frequency and 
duration of neutral facial displays. To measure the unique characteristics of hypomimia, an 
exploratory ‘Masked Neutral’ code was created. This represents the lack of expression plus 
other clinical features of common to people with hypomimia/facial masking. Additionally, the 
proportion of talking/not talking of each video clip will be measured. The following sections 






Detecting Neutral Displays – Additional to original FACES  
 This is the neutral configuration of the face when there is no observable use of facial 
muscles. There is no observable facial activity or repositioning of the facial muscles. Neutral 
looks slightly different on each individual- it may not always look the same in each instance it 
is observed.  Coding neutral will become easier as you develop a familiarity with the 
individual.  
 Take care to differentiate neutral from a low intensity expression. For example, when 
an individual is listening or thinking, they may appear neutral or may display an expression 
like concentration at a low level. If there is expressive muscle movement or clear affect can 
be observed, the coder should instead record an expression,. 
 
Detecting Masked Neutral – Additional to original FACES  
 This is a somewhat experimental code. It records characteristic features of 
Parkinson’s facial masking, in addition to a lack of expression. It may be useful to think of 
this code as Neutral plus features of facial masking. This is defined as an at-rest facial 
configuration plus one or more of the following:  
  i. Reduced blink frequency (staring). 
  ii. Unintentional lip separation (mouth open) or lips closed with jaw dropped 
  and unintentional downturned lip corners. 
  iii. Unusually fixed (static) eyebrows which may be raised or furrowed. 
  iv. A “stone-faced” rather than neutral or at rest appearance. 
 The general impression or demeanour is often negative, rather than at rest, while still 
not showing any active expressivity. For example, cold, uncaring, unfriendly, aloof, 
disinterested, inattentive, bored, grumpy, zoned out or cognitively impaired.  
 It can be difficult to determine this code from neutral at first. Make sure to attend to 
the overt (easily visible) presence of any masking features (mentioned above). If unsure, a 




or sigh, this is not counted as masked neutral.  
 It may also be possible to see features of this code combined with expression or 
gesture in other areas of the face. For example, a staring appearance and fixed upper face 
might be accompanied by a smile or grimace in the lower face. Since codes are mutually 
exclusive, meaning only one can be coded at a time, any observed expression takes 
precedence over other code types.  
 Masked Neutral looks slightly different on each individual. As you become more 
familiar with each person you will find it easier to identify and discriminate how masked 
neutral/neutral appears for that individual.  
 
Other Things to Note: 
Parkinson’s Symptoms  
 Participants may display facial or bodily movements related to their condition. These 
movements can be mistaken for expressions of emotion and/or make it challenging to view 
facial movement. Symptoms commonly observed in the participants of this study are listed 
below. If a distinct physical symptom is observed, carefully attend to other areas of 
movement in the face to discern if a facial behaviour can be coded or not. 
 
 
Symptom Definition Exemplar 




when at rest. 
From mild trembling of the jaw, a head 
‘bobble’, to intense shaking of 
extremities or the entire body.  This 
can appear to be distress, so examine 
other areas of facial movements to 
determine an expression.  
Dyskinesia Uncontrolled movement 
associated with use of 
anti-Parkinson’s 
medications. 
Writhing, twisting or twitching 
movements. May be one body part or 
the entire body. May occlude view of 
the face.  
Dystonia Cramping, spasm or 
twisting of muscles.  
Usually, one or two areas of the face 




symptom can be frustrating and 
painful.  Attend to other areas of facial 
movement and code an emotional 




positioning of the head or 
trunk 
Hunching over, stooping, dropped 
shoulders or head, leaning forward.  A 
few participants seem to do the 
opposite by angling their head 
upwards and away, in a manner that 
can appear aloof.  May occlude view 
of the face. 
Reduced Blink 
Frequency 
Because there is less 
lubrication eyes become 
teary or watery.  
Can appear to be weeping. Easily 
mistaken for sadness when combined 
with a jaw tremor. Examine other 
areas of facial movement to determine 
whether an expression can be coded. 
Hypomimia The reduction of 
spontaneous and 
voluntary movement of 
muscles of the face.  
A fixed or stone-like appearance, 
reduced blink frequency (staring), 
unintentional lip separation (mouth 
open) or unintentional downturned lip 
corners, fixed eyebrows which may be 
raised or furrowed. Gestalt impression 
is often negative rather than simply at 





Please respect the privacy of study participants by not discussing the individuals you 




Study 3 Appendix II. FM Compensatory Behaviours and Coping 
Strategies  
 Tables 1 and 2 summarise the types of compensatory behaviours and coping 
strategies used by PwP and SO, as reported on open answer items of the FMQ.   
Table 1 




Quotes from open answer item of the FMQ  
Exercising the 
face 
“When my face feels fixed I do exercises that stretch and move my face. It helps to a 
degree. It eases the contracted, fixed feeling of the muscles. 
“Sometimes I pull faces in the mirror when cleaning my teeth or having a shower”. 




“I attend [group] singers where facial expression exercises are given with the vocal 
exercises”. 






“Try to smile when I think it's appropriate. For example, if I'm feeling happy or 
someone has said something amusing, or when I've done something well. I wouldn't 
smile unless I've thought about it. This is helpful”.  
“When meeting friends or acquaintances, if stopping to talk to them, I try to force a 
smile. As if taking a photo and you try to smile. Being conscious of it makes it look 
better. But the impression you get from people is that you're still not all there sort of 
thing”.  
Humour  “I use whatever I can to keep engagement with others. Other tactics for example, like 
humour when public speaking or interacting with others”. 
Educating Others “I give people a poster that I made about FM, and I tell them about it (when in NZ). 
People at church here, when they see me, have a query. Now they don't worry about 
it as much. In Asia, I didn't say anything about FM. But when I question them, they 
say I look okay. But I don't think what they told is 100%. I do think it's helpful to 
mention it to people that you know. For example, say, I may look this way, but I don't 




“I accept it and keep going out with people. Don't worry about how you look and feel I 
tell myself sometimes. But I do limit myself sometimes”. 




“I extra take Parkinson medication when socializing or going out. Shaking seems to 
reduce but I'm not sure about the masking, but I think it is also reduced”.  





“I try to listen to people and understand their situation. This helps”.  
“With new people I try to be the best I can be”  





  Table 2 




Quotes from open answer item of the FMQ 
Asking questions 
and agreeing to 
check in  
“I used to ask him if he was alright and he got angry with me asking all the time. 
So now I just don't say anything on the agreement if something is wrong he will tell 
me”. 
“Although I have felt before my dad was diagnosed that his expressions can be 
hard to interpret, there has seemed to be a slight change since his diagnosis. 
Sometimes I am unsure how exactly to reconcile his expression with his words, so 
often I will ask further questions to help determine his mood”. 
“I sometimes ask directly how he is feeling, does he want to do 'whatever', is he 
happy with what we are doing, what we have planned - so he can tell me even if 
he can’t show me by expression. This works well assuming he is honest!” 
 
Creating 
awareness of FM 
“I tell him when he looks grumpy” 
“Reminding him to smile sometimes helps” 
“I tell him what he is displaying that I find difficult. He makes an attempt to change 
this expression” 
 
Relying on other 
cues  
“Focus on body language instead” 
“I try to sit directly in front of him so I can see his eyes/eye movements, and to 




“I remind myself that [her] masking is not a reflection of her emotional state, it is 
neither intentional or a reflection of her mood.” 
“Just keep trying to remember how he looks (in himself or what he is seeing) is not 
related to how he is feeling, (in himself, about himself, or about me or life in 
general)” 
Humour “We sometimes poke fun at each other and crack each other up” 
Avoidance “In some cases I simply look elsewhere to avoid being dismayed by a slack jaw 
look or staring eyes (especially when watching tv)” 
Educating others “I have used and distributed a Parkinson's fact sheet on facial masking to family 
and friends, so they have more understanding of [my husband's] responsiveness. 
This was very helpful”. * 
“Have to tell people about his Parkinson's so they understand his behaviour” 
Positive and 
accepting outlook 
“I understand that is part of the condition and accept that it is involuntary”. 
“I tell myself that it is not how it he wants to be but how the disease is affecting 
him.”  
“Not dwelling on it” 
“Each of the changes i.e., facial masking etc is a challenge to be understood and 
worked through” 




“After seeing a psychotherapist, I learnt ways to disengage from my 
concerns/worries”. 





“We try to smile and laugh a lot together” 
“We are working on creating other areas and ways to express our closeness just 
being together.”  
“Engaging him in conversation will usually enliven his face” 





7. Integrated Findings Summary  
 To evaluate the consistency between findings of the qualitative investigation and the 
quantitative investigation, the mixed-method inferences of this research project are 
described in a series of joint displays and brief summaries. Qualitative findings came from all 
PwP and their SO’s who were interviewed in Study 1. Quantitative findings comprise the 
results of Study 2 and Study 3. FMQ item response distributions reported here refer to the 
subsample of PwP/SO who self-reported FM, unless otherwise stated.  
 A joint display summarising the findings of how different observers perceived FM is 
provided in Figure 3 (see page 176). The lack of statistically significant correlations between 
PwP/SO ratings of FM severity with healthcare professional ratings was a striking finding. 
Further comparisons, for example of the concordance of ratings of the degree of FM 
severity, were limited because different methods and measurement tools were used across 
the rater groups. Comparisons of the frequency of FM/no FM ratings across the four rater 
groups, however, suggested the self-reports of the PwP may underestimate FM severity 
when it is a lower level.  
 When comparing attributes of FM emphasised in personal accounts with researcher-
rated facial expressive behaviours based on the videoed conversation, there was a mix of 
convergence and divergence of findings. Less frequent smiling was commonly mentioned as 
characteristic of FM in the interview findings, but a relationship was not found between the 
proportion of positive smiles in the videotaped samples and PwP/SO perceptions of FM 
severity. A lower amount of overall expressivity was also emphasised in the interviews, with 
decreased instances of expression in the videos found to be significantly related to 
perceptions of FM severity for PwP and SO. Another clinical feature of FM that was 
prominent in the interview findings was an appearance of blankly staring. A reduced blink 
frequency (which gives the appearance of staring) as part of the “masked” facial behaviour 




healthcare professionals and SOs, but not to PwP ratings of FM severity. Lastly, people who 
took part in the interviews also reported their or their partner's expressions to be “watered 
down” or reduced in amplitude. However, a lower intensity of observed expressions in the 
researcher-rated video data was not related with ratings of FM severity for PwP, SOs, or 
healthcare professionals. Changes to the speed or onset of expressions, as reported in the 
qualitative data, was unable to be quantitatively assessed. Respondent feedback collected 
about the FMQ extended the interview findings, as it revealed reports that fluctuations in the 
level of FM occurred.  Some participants stated that instances of relatively normal 





QUALITATIVE FINDINGS  
(n = 9 PwP, n = 9 SO) 
QUANTITATIVE FINDINGS 
   (n = 74 PwP, n = 54 SO, consenting to video sample) 
SUMMARY OF  











reduced in size, 
frequency, & 
delayed onset.  
 
Loss of or distorted 
smiling  
 
Blank & staring 
appearance 
  
           
Overall, a dissimilar 
presence of FM was 
reported across rater 
groups. Changes in FM 
severity ratings were not 
strongly correlated 
between rater groups. As 
expected, PwP and SO 
pairs had moderate 
positive association.  
Attributes of FM 
emphasized in personal 
accounts, converged with 
some findings from 
researcher-rated facial 
expressive behaviours 
observed in the 
videotaped conversations, 







































































































































































































































































































































































Expert A FM 
SEVERITY
Expert B FM 
SEVERITY














PwP  FM SEVERITY
SO  FM SEVERITY 0.430
**
Expert A  FM 
SEVERITY
0.175 0.089
Expert B  FM 
SEVERITY
0.127 0.225 0.714**
Expert (Ave) FM 
SEVERITY
0.168 0.143 0.886** 0.903**
EXPRESSION CODE -0.153 -0.237 -0.323** -0.273* -0.289*
NEUTRAL CODE -0.206 -0.168 -0.245* -0.457** -0.366** -0.101
MASKED CODE 0.176 0.299* 0.415** 0.603** 0.527** -0.561** -0.640**















MED Intensity CODE 
0.206 0.062 0.119 0.098 0.11 -0.136 -0.067 0.1 0.126
Expression HIGH -
VERY HIGH CODE
-0.258* -0.134 -0.162 -0.13 -0.141 0.208 0.123 -0.174 -0.198 -0.943**
 Expression 
POSITIVE CODE
-0.092 -0.228 -0.152 -0.281
* -0.22 0.041 0.254
*
-0.264









































































































































































         KEY                    
*Correlation is 
significant at  
the 0.05 level 
**Correlation is 
significant at  
the 0.01 level  







































































































































































































































































































































































Expert A FM 
SEVERITY
Expert B FM 
SEVERITY



















 Findings about the social discomfort associated with having a facial difference 
were not strongly consistent (see Figure 4, pg. 178).  PwP interviewees described 
having unpleasant experiences during social interactions due to FM. This included 
with close friends or family members, as well as in more casual interactions. FMQ 
items response were not strongly consistent with this finding. A minority of PwP 
endorsed items relating to feelings of awkwardness and avoidance in their close 
relationships, and very few endorsed the item that others had been unkind about 
their facial appearance, those that did reported it was an infrequent experience. 
Responses to open answer FMQ items extended the findings relating to facial 
difference further, for example:   
 I'm more self-conscious about facial masking than other symptoms. You can 
 hide your shakes... But the facial masking thing, people say, 'what's wrong 
 with him?'…If I had to choose between a reduction in physical mobility and 
 facial masking and speech, I would rather end up in a wheelchair and still be 
 able to communicate. It's a higher priority for me as a person than  my 
 mobility… Communicating using my face is also important so that I can 
 continue doing my job and contributing to the world. 
Fear of being evaluated negatively due to FM, or intense anxiety about the future 
consequences of FM, were not such strong thematic elements in the original 
interviews and therefore were not included in FMQ items.  
 SO interviewees described a sense of unease due to the lack of expressive 
response, which could negatively affect their sexual relationship. They also described 
a general reluctance or avoidance of interacting with the PwP. About one third of SO 
reported FM was an obstacle to physical intimacy, with around half of those 
responding it was a frequent experience. FMQ responses indicated around 20% of 
SO reported avoidance of interacting with the PwP, although most SO endorsed this 






QUALITATIVE FINDINGS  
(n = 9 PwP, n = 9 SO) 
QUANTITATIVE FINDINGS  
 (n = 53 PwP, n = 50 SO, subsample self-reporting FM) 












reluctance to  
interact.  
  
Sense of unease 








Interview findings showed that 
having FM could be an unpleasant 
experience for PwP during social 
interactions with close friends or 
family, as well as with casual 
acquaintances or strangers. On the 
FMQ, around one quarter of PwP 
respondents endorsed items 
relating to these themes, although 
most rated these as relatively 
infrequent experiences.  
 
For SO, it was partially confirmed 
that a sense of unease and 
avoidance could result from FM. 
FMQ item responses showed 
around one third of SO felt FM was 
an obstacle to physical intimacy. 
Findings were less consistent about 
SO avoidance of the PwP, with 
around one fifth of SO endorsing 
this item an infrequent experience.  
b) FMQ-SO Item-Level Responses    





a) FMQ-PwP Item-Level Responses   





Figure 4   




 Most PwP found posing socially appropriate voluntary expressions unfavourable as a 
strategy to compensate for the loss of spontaneous emotional expression (see Figure 5).  
Interviewees commented it was possible to form posed expressions, but when they did it felt 
inauthentic and/or required a great deal of mental and physical effort. Over half of the FMQ 
respondents self-reporting FM had a similar experience when making a posed expression. 
When PwP were asked to list what they found helpful to cope with reduced expression, 
around 15% of those self-reporting FM (n = 8) said they attempted to make appropriate 
expressions on occasion, such as a smile. It was unable to be assessed whether smiles 
were genuine or not in the video data.  
QUALITATIVE 
FINDINGS 
(n = 9 PwP) 
 QUANTITATIVE  
FINDINGS 













   
It was confirmed 
that PwP found 
posing voluntary 
expressions (to 




































Response Options (Item #5: When I try to make an expression, like a smile, it 
takes a lot of effort, feels false, or “put on”). 
FMQ-PwP Item-Level Responses   
Figure 5 





 PwP Interviewees felt a sense of “facelessness” where they were losing their identity 
and bodily autonomy, which was linked to FM. This was consistent with results on the FMQ, 
where just over half of PwP endorsed FMQ items relating to an experience of distress at 
their decreased ability to outwardly display they felt they were person inside (see figure 6, 
pg. 181). Additionally, in Study 3 a significant positive correlation was found between FM 
and psychological distress, with the greater degree of FM-related difficulty PwP described, 
the more symptoms of depression and anxiety they reported (see Chapter 6). 
 Findings that SO experienced distress at not being able to see their loved one in the 
masked face were consistent in the quantitative and qualitative findings also converged. A 
large proportion of SO endorsed FMQ items relating to emotional distress and strain caused 
by disease-related changes in facial appearance. For SO in Study 3, FM-related difficulty 






QUALITATIVE FINDINGS  
(n = 9 PwP, n = 9 SO) 
 
QUANTITATIVE FINDINGS 
  (n = 53 PwP, n = 50 SO, subsample self-reporting FM) 







SUBTHEME &  
CODE(S) 
 
Mismatch of  
internal experience  
and outward  
expression 
 
Unable to fully  
embody (express)  
internal experience 
 






Shared identity  
challenged 
  
The findings converged 
regarding the experience 
of "facelessness"- the 
feeling that oneself or 
one’s partner was being 
lost.  
 
It was also confirmed that 
SO experienced distress 
at not being able see the 
person beneath the 
masked face, with most 
SO endorsing FMQ items 
relating to experiences of 
distress resulting from 
changes to the facial 







Item Response Distribution (percent) 



























 b) FMQ-SO Item-Level Responses    
Figure 6 




 Findings about the misidentification of FM as a negative affect converged. A joint 
display summarising the findings is provided in Figure 7 (see pg. 183). SO interviewees 
described that FM could lead to misconceptions the PwP was persistently in a negative 
affective state, such as sad, angry, bored, or disinterested. FMQ item response distributions 
to relevant questions were consistent with this finding. The majority of SO responded they 
misinterpreted FM as a bad mood, and many experienced this frequently.  PwP responses to 
items relating to misreading FM converged, with most respondents indicating they perceived 
others read their emotion, attitude, or communication inaccurately. 
 Some SO interviewees described a state of uncertainty associated with the lack of 
clear cues of emotion or intention, with other SO reporting they automatically misread FM 
and had to remind themselves they could not rely on facial expressions (or lack thereof) 
despite having knowledge of FM in PD. SO responses to FMQ related items confirmed these 
findings.  The vast majority of SO endorsed having to backtrack and remind themselves of 
this cognitive bias and second-guessing what the PwP was thinking or feeling. These 








QUALITATIVE FINDINGS  
(n = 9 PwP, n = 9 SO) 
QUANTITATIVE FINDINGS 
  (n = 53 PwP, n = 50 SO, subsample self-reporting FM) 






of FM as 
negative affect 
 









The finding that SO 
commonly perceived FM 
as negative affect was 
confirmed.  
It was also confirmed that 
most PwP experienced 
their facial behaviour to 
be misread, even in 
perceivers who were 
close to them. 





a) FMQ-SO Item-Level Responses    





b) FMQ-PwP Item-Level Responses    
Figure 7 




 Findings that SO often attributed incorrect reasons for the lack of expression 
converged. A joint display summarising the findings is provided in Figure 8 (pg. 185). SO 
interviewees reported that they misread PwP emotion, attitude, or intention, and based on 
these judgements could make assumptions that were negative and self-blaming. FMQ item 
response distributions were consistent with these findings. Around half of SO endorsed FMQ 
items that they blamed themselves for the apparent bad mood of the PwP, and just under 
half of SO reported feeling hurt and rejected at FM.  
 A small number of SO interviewees described how FM could lead to a loss of 
confidence in the relationship or concerns about fidelity. SO found these experiences 
distressing and confusing because they did not reflect the nature of their relationship history 
with the person who had PD. FMQ item response distributions partly converged with this 
finding, indicating a handful of SO’s experienced concerns about the relationships, and for 
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SO interviewees described 
misattributing the reason for 
the lack of expression, and 
that their assumptions about 
the reasons for the PwP 
appearance tended to be 
negative and self-blaming. 
Overall, SO responses to 
items on the FMQ were 
consistent with these findings.   
A small number of SO 
interviewees described how 
FM could lead to doubts about 
commitment or trust in their 
relationship. FMQ item 
responses were consistent 
with this finding, indicating 
these concerns were mostly 
infrequent experiences 
reported by a small handful of 
SO.  
 





FMQ-SO Item-Level Responses    
Figure 8 




 A sense of growing disconnection, which was found in the interview themes, was 
partially consistent with the overall quantitative findings. In the interviews, some PwP 
described FM as a “emotional stonewall” between them and their family members, and that it 
can “put a couple apart”. FMQ items relevant to this theme were not endorsed as frequently 
or highly as expected by the subset of PwP reporting FM, given the importance and 
relevance of these themes for some interviewees (see figure 9, pg. 187). However, in Study 
3 (n = 80 PwP), greater levels of overall FM-related difficulty were found to have small 
significant associations to some aspects of social relationship functioning measured, such as 
marital satisfaction and perceived availability of affectionate support (see Chapter 6). 
 On the other hand, findings of a sense of emotional disconnection converged for SO.  
Some SO interview participants described FM as an interpersonal “gulf” between them and 
the PwP. FMQ Item response distributions of the subset of SO reporting FM indicated 
around half felt a sense of disconnection or alienation in response to the lack of expression. 
This was also consistent with the findings of Study 3 (n = 58 SO), where increased FM-
related difficulties had moderate sigficant correlations with poorer social relationship 
outcomes, such as reduced marital satisfaction and a lower perceived availability of 
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There was divergence of 
findings that FM alienates 
people with Parkinson’s 
and their partners and 
family members. Items 
relevant to emotional 
distance on the FMQ 
were not as commonly or 
highly endorsed as highly 
as expected, given the 
interview findings.  
For SO, findings that FM 
may cause a sense of 
emotional distance 
converged.  





a) FMQ-PwP Item-Level Responses    





b) FMQ-SO Item-Level Responses    
Figure 9   




 Findings that SO perceived a decrease in emotional reciprocity partly converged (see 
figure 10, pg. 189). This consisted of two related findings, the loss of the ability to share in 
the moment, and a reduction in perceived emotional supportiveness of PwP. Interview 
findings suggested SO may perceive the inability of PwP to visibly display social and 
emotional understanding as signalling increasing emotional distance the within the 
relationship. Overall, FMQ item response distributions were consistent with these findings. 
Around half of SO endorsed item relating to experiences of feeling unsupported and reduced 
enjoyment or engagement in the relationship. Interestingly, SO’s general perceptions of 
relationship quality and affection seemed to be relatively unaffected, with most SO 
respondents reporting they frequently experienced their relationship to be close and warm.  
 Qualitative findings revealed FM could result in a loss of perceived emotional 
reciprocity and was reported to cause distress and sadness for SO. Overall, the quantitative 
results converged with this finding. A substantial proportion of SO endorsed items referring 
to difficulty and alienation resulting from FM, which occurred at low to moderate frequency. 
Additionally, in Study 3, the greater degree of relationship difficulty related to FM (based on 
the whole group), the less marital satisfaction they reported and lower perceived availability 
of affectionate support (see Chapter 6). For all SO, an increase in FM-related difficulty also 
had significant links to decreased marital satisfaction and a lower perceived availability of 
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Sadness at loss 
of (perceived) 
companionship 
   
Findings that SOs perceived a 
decrease in emotional 
reciprocity partly converged.  
The finding that SOs 
experience distress or sadness 
at the lack of facial emotional 
responsiveness was 
confirmed. Over 70% of SOs 
reporting they struggled with 
the lack of response at least 









FMQ-SO Item-Level Responses    
Figure 10 




 Findings that FM was a difficult symptom to recognise, and FM health education/ 
support were unmet needs converged (see figure 11, pg. 191). In the interviews, both PwP 
and SO reported FM was less conspicuous than some other aspects of PD, which made it 
difficult to recognise as a symptom of the condition. Interviewees also noted a lack of FM 
knowledge meant they less readily ascribed FM-related consequences in their relationships 
to PD. The finding that SO and PwP reported a generally low level of FM knowledge was 
confirmed, with a substantial majority of respondents endorsing that they knew either nothing 
or little about FM on the FMQ item pertaining to this topic.  
 Interview findings also indicated New Zealand PwP and SO desired greater access 
to FM-related information, with some individuals also wishing for greater dialogue with their 
healthcare providers about this topic. Responses on the FMQ item related to FM 
education/support needs were generally consistent with these findings. Most PwP 
respondents indicated a desire for more information about this topic on FM education items 
of the FMQ. A sizeable minority of SO also indicated they would like more FM health 
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contextualising FM  
 
 
   
Findings that there was 
poor recognition of FM in 
PD, and that FM education 
was an unmet need 
converged.  
 
Findings that PwP and SO 
were found to desired 
greater access to FM-
related information partly 
converged. 
 
a) FMQ Item-Level Responses: Knowledge of FM at testing, by participant group   
b) FMQ Item-Level Responses: Preference for further FM Education, by participant group 
Figure 11 




8. General Discussion  
 This thesis set out to study FM in the everyday lives of people with PD and their SO. 
The overarching aims of the research was to build a deeper understanding of FM from the 
viewpoint of those people who live with this symptom, and to investigate the potential 
association of FM with psychosocial wellbeing in PD. Thus, the research had two central 
aims: 
 1. To explore the lived experiences of people who have FM and their partners. 
 2. To assess the link between FM and psychosocial outcomes in PwP and SO. 
The first aim was important to respond to gaps in existing literature by learning more about 
individual’s and partner experiences of FM and their needs and preferences, so that FM 
could be better understood from the perspective of living with FM. Exploring personal 
experiences of FM also allowed for the identification of relevant concepts that could be 
developed into a clinical tool to support the management of the FM in PD. The second aim 
was important to build upon knowledge of the psychosocial consequences of FM as a 
general contribution to improving knowledge of PD.  
 The present section includes a general discussion of the main research insights and 
their application to clinical practice. This is followed by a broad statement on the strengths 
and limitations of the current programme of research and suggestions for future research 








What are the lived experiences of people who have FM and their 
partners? 
 There was great individual variation in the experience of FM for people who have PD 
and their family members. Common experiences that were described included the following: 
a lessened ability to read the person with PD; perceptions that the person with PD is in a 
persistent bad mood; jumping to conclusions about the lack of expression displayed; feelings 
of hurt or rejection; a loss of confidence in or concerns about the relationship; a sense of 
increasing disconnection or withdrawal within the relationship; distress at being unable to 
express/see the person inside; fears about future loss of facial expressivity; self-
consciousness that FM will be negatively evaluated by others; and unkind reactions from 
others in casual interactions. Overall, the findings from the present programme of research 
and from existing studies (Gunnery et al., 2016; Ma et al., 2019) offer evidence that FM can 
have a detrimental impact on psychosocial wellbeing in PD. As scientific literature has 
scarcely begun to explore the psychosocial problems associated with FM or examined 
interventions to lessen their impact on quality of life, these findings speak to the need for 
greater research.  
 Psychosocial problems associated with FM also warrant greater clinical attention. FM 
is an aspect of PD that clinicians, their patients, and their families encounter nearly as 
regularly as speech deficits or tremor. Yet, most participants who self-reported FM in the 
present research described a difficulty identifying it, and poor knowledge of this symptom or 
how to cope to with it.  Other PD populations may exhibit different characteristics. 
American’s who had PD, for example, were found to have awareness of the level of 
expressive deficit (Mikos et al., 2009) and global self-ratings of the level of expressive 
difficulty have been shown to be significantly correlated with clinical evaluation of FM 
severity using the MDS-UPDRS, also in America (Ma et al., 2019). Nonetheless, it seems 
one key clinical undertaking for NZ PD populations may be improving awareness of FM and 




 This programme of research revealed novel insights of the ways FM is perceived, 
interpreted, and responded to, within the context of primary social relationships. Results 
suggested the impression bias commonly seen with unfamiliar observers also occurs in the 
context of primary social relationships. In familiar perceivers, the content, automaticity, and 
persistence of thoughts relating to (mis)perceptions of FM were revealed. FM was commonly 
perceived as a persistent bad mood or a lack of interest. SO frequently assumed they must 
be the cause of the perceived bad mood. A lack of perceived expressive response was also 
interpreted to signal discord in the relationship. Much like the evidence from healthcare 
professionals, some SO had a hard time overriding the negative impression bias FM creates, 
despite knowing FM was a symptom of PD.  
 One explanation for this negative impression bias is that the initial processing of 
emotion can occur automatically, often without intention or awareness of having done so 
(Lakin, 2006). In perceivers observing someone with PD, this could mean the lack of 
expression is automatically read as negative affect, even when perceivers know otherwise. 
In a second scenario, SO described a state of uncertainty because they were continually 
scrutinising the internal state of person with FM. This may be due to reduced, unclear, or 
conflicting emotional cues. Further description and investigation of these two scenarios is 
needed to better understand the ways FM is perceived in close social relationships and the 
various mechanisms which may underlie its misinterpretation. It may be that individuals who 
have greater FM, and therefore an absence of most or all expressive cues, are swiftly and 
globally judged by perceivers with a negative bias. It is possible when some degree of 
expression is retained an attenuation effect occurs, resulting in confusion for perceivers who 
attempt to make sense of weak, distorted, or conflicting expressive cues. 
 There is scare evidence of the way perceivers form impressions of individuals in 
other clinical conditions where facial movement and expression are impaired. It is also 
difficult to compare FM in PD to other clinical populations because the nature of expressive 
loss is different in each condition. In congenital facial paralysis (FP), individuals have greater 




others channels of communication (Bogart et al., 2014; Bogart et al., 2012), which often 
become impaired in PD, such as vocal and bodily expression. Individuals who acquire FP 
later in life are found to use fewer compensatory strategies than those with congenital FP 
(Bogart et al., 2014), but still have more options for adapting the communication of their 
thoughts and feelings than people with PD often do. Individuals with congenital FP are 
reported to describe experiences of social stigma and of being misunderstood by others, 
although the latter appear to be mainly associated with verbal communication being 
mistaken by others. (Bogart et al., 2012). Unlike in facial disfigurement or FP where 
irregularities in facial appearance are visible, the physical features of the face in FM appear 
largely unaltered, albeit abnormally still. The relative insidiousness of FM may be one 
explanation for the pervasiveness of the impression bias in FM, even in those perceivers 
who know the facial behaviours of an individual with FM are not valid cues.  
 Descriptions of how FM is misinterpreted are important because they can help us to 
better understand the effects of FM reported to occur within primary social relationships. As 
identified in this research and other qualitative studies (Chiong-Rivero et al., 2011; Schwartz 
et al., 2018), one such consequence was a growing emotional and interpersonal “gulf” within 
the relationships of people who have FM and their family members. Figure 12 depicts a 
proposed model for the dyadic processes that may be at work in FM, resulting in a pattern of 
increasing emotional alienation within close relationships. An adapted cognitive behavioural 
(CBT) framework can be used to understand this process (Beck, 1979; Padesky & Mooney, 
1990; Teichman & Teichman, 1990; Teichman, 1992; Greenberger & Padesky, 1995; 
Grimmer, 2013). The process begins with the lack of expression being misinterpreted as a 
negative signal of internal state by sigficant others, such as emotional detachment or 
dissatisfaction. SO may also jump to inaccurate conclusions about the cause of what they 
perceive in the face of the individual with FM, often experiencing doubts about their 







Naturally, such interpretations may cause emotional distress for SO, who commonly 
described feeling hurt, rejected, frustrated and apprehensive in response. SO could then 
become discouraged from interacting as frequently, warmly, or positively with the person 
who had FM.   
 At this point, the person with FM enters the cycle. The emotional and behavioural 
response of the SO is observed by the PwP, who also perceives these changes negatively. 
Feelings of sadness, confusion, resignation, and frustration were common in response. This 
could lead to increased social isolation and other changes in mood or behaviour for the PwP, 
which in turn, lessened opportunities for the social facilitation of expressive displays of 
emotion. The reciprocal misinterpretation and pattern of alienation results in fewer instances 
Figure 12  
Proposed dyadic CBT process model depicting the pattern of misinterpretation and alienation that can 
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of positive exchanges between the PwP and their SO, which would usually contribute to 
maintaining the emotional bond between them. In this way, both the PwP and SO become 
stuck in a cycle where they are both receiving inaccurate signals. These signals increasingly 
undermine the state of companionship, promoting feelings of doubt or self-blame, and 
increasing the sense of distance within the relationship. Initially this process may be 
triggered because sigficant others and PwP do not realise FM is a symptom of PD. While 
some participants from the qualitative investigation felt that gaining an understanding of FM 
broke this cycle, others had ongoing difficulty overriding misinterpretations of FM meaning 
the experience of a growing divide persisted. Further investigation and elaboration of this 
cycle is important because it could lead to the identification of areas for intervention (a topic 
further discussed below).   
 Similar models are proposed in facial difference/disfigurement literature. These 
theories incorporate the responses of other people to facial difference as well as the 
individual’s own reactions, to explain psychosocial problems. In one model a negative 
feedback loop is described, where the unfavourable responses of others to the individual 
with facial disfigurement negatively influences the emotions and behaviour of that individual, 
in turn influencing or reinforcing the perceptions of others (Partridge, 1998; Clarke, 
1999).The emergence of similar models that explain the consequence of facial expressive 
loss as an interaction between the individual and observers suggest it may be clinically 
important to incorporate partner or family members, to comprehensively and effectively 
address FM’s psychosocial problems.  
 Evidence indicates healthcare practitioners understand some of the consequences of 
FM and recognise the importance of greater clinical communication about the psychosocial 
problems it can create (Schwartz et al., 2018). Taken together with findings from the present 
research, this suggests more could be done clinically about FM. While FM cannot currently 
be cured, there are potentially modifiable factors that could be targeted to lessen its impact, 
including greater awareness, early detection, and proactive health education. A key desire of 




their healthcare providers about his symptom. Unfortunately, some participants described a 
delay in recognising FM, which they felt detrimental to their wellbeing because the 
psychosocial consequences went unchecked. During recruitment for Studies 2 and 3, a 
sizeable proportion of PwP participants reported they suspected they had FM but were not 
sure, often stating this had not been addressed by their healthcare providers or discussed 
within their family. It is therefore advisable that healthcare practitioners routinely enquire 
about this symptom and offer education, regardless of the apparent clinical staging of FM 
seen on exam. Dialogues which assist individuals and their families to recognise the issues 
potentially explained by FM and identify possible coping strategies could help people 
mitigate the cycle of increasing interpersonal disconnection that can occur (see Figure 13). 
The FMQ (developed in Study 2) is one clinical tool that could increase awareness in all 
parties in ways they may not be thinking of, and form part of the patient education process in 
understanding FM.  
 In summary, the negativity bias associated with stranger and healthcare professional 
perceptions also occurs in the context of relationships partners or close family members in 
PD. The influence of FM in close relationships extends beyond the inaccurate social 
judgements seen in less familiar receivers. In close relationships, FM leads to false 
perceptions that may promote emotional detachment and a loss of confidence or security 
within the relationship. The reciprocal cycle of misinterpretations and alienation that may 
occur within close relationships in FM, could be particularly damaging when FM remains 
unattributed to disease-related changes.  Increasing awareness, education, and early 
detection are clinically important in managing FM.  Greater clinical attention and proactive 
healthcare communication about FM could help mitigate the emotional and interpersonal gulf 




What is the link between FM and psychosocial outcomes in PD?  
 Overall, the more negative consequences of FM that SO reported, the lower the level 
of marital satisfaction, more caregiver strain, the less available they perceived affectionate 
support or positive social interaction, and the worse psychological health they experienced. 
In PwP, the more negative consequences of FM that participants reported, the more the 
anxiety and depression symptoms that they experienced. They also experienced lower 
levels of marital satisfaction, perceived a lower availability of affectionate support and a 
lower availability of positive social interactions. The link between the latter social relationship 
variables with FM in PwP, however, remains unclear. Not all relationship difficulty items on 
the FMQ explicitly attributed problems to FM, so may be measuring aspects of general 
relationship functioning. Answers to those FMQ items with ambiguous wording might reflect 
general relationship impressions predating FM, rather than the impact of facial expressive 
loss.  
 Also, PwP self-report of FM severity was not found to be linked PwP perceptions of 
FM impact or other social relationship outcomes measured. A possible explanation for this is 
a differential impact of FM for PwP and SO. Part of this explanation may be that PwP do not 
recognise the impact of FM in their relationships, even if FM is having an effect on their 
partner and (potentially) ultimately on PwP marital satisfaction or relationship functioning.  
This is consistent with the idea proposed by Gunnery and colleagues (2016), that the 
relationship perceptions of people who have PD may be sheltered from the influence of FM. 
The clinical implications of this are that partners’ experiences of FM should be included 
where possible, to help enhance understanding of FM in both individuals and their clinicians. 
Evidence evaluating successful outcomes in psychological interventions for people with PD 
is also supportive of the involvement of SO. Caregiver participation in CBT for PwP 
depression has been found to be a significant predictor of a positive treatment response 
(Dobkin et al., 2012).  




and the amount of FM-related difficulty they experienced. Interestingly, no significant 
correlations were found between healthcare professionals’ clinical ratings of FM and 
participants ratings of FM severity. Moreover, there was no correlation between healthcare 
professional ratings of FM and nearly all health and wellbeing outcomes measured (except 
for symptoms of anxiety, which had a small negative correlation with healthcare professional 
ratings).   This is in line with previous studies that found the expressivity of people with PD 
varied when in recorded in conversation with their spouse, compared to conversations with a 
researcher (Simons et al., 2004). It is also possible this could also be due to methodological 
reasons, such as the inclusion of only two healthcare professionals who were unfamiliar with 
most of the PwP in the present research. The usual/treating healthcare practitioner of 
participants with PD might provide different ratings of FM severity. It also possible that the 
level of FM is perceived differently by healthcare professionals, who assess for specific 
clinical features of FM. The implication of this finding for practice is that relying solely on 
clinical evaluations of FM may not provide sufficient assessment of the possible effects of 
this symptom for patients and their families.  
 The present research also provided an initial description of the ways PwP and SO 
adjusted to FM. Compensatory behaviours and coping strategies described by participants 
could be categorised into two broad approaches: practical and psychological. Practical 
strategies included enhancing communication and rehearsing expressions to promote 
greater facial mobility. One notable finding was that posing expressions (making a socially 
appropriate smile) was regarded as too effortful and contrived for many of the participants 
with PD. Healthcare professionals should be aware of this preference when providing 
information or support to individuals with FM. While people with FM may have the ability to 
use this strategy, it might not a practical or realistic approach to managing FM for some 
individuals. Psychologically based approaches included challenging false interpretations of 
FM (for SO), having an accepting and positive mental outlook, and various relationship 
strengthening behaviours. Methods for SO to manage unhelpful misinterpretations of FM 




and seem to be difficult to override. There is some indication in the broader literature on 
facial expressive impairment that training programmes for the perceiver may reduce the 
impression bias. Training perceivers to focus on the voice and body of people with facial 
paralysis was found to improve bias in impressions of extraversion but did not improve the 
accuracy of perceivers’ impressions (Bogart & Tickle-Degnen, 2015). Also, if models 
integrating the interpersonal and psychological in FM are accurate, then SO perceptions and 
experiences of FM play a significant role in the impact of this symptom for both persons in a 
relationship.  
 Although the link between FM and psychosocial wellbeing in PD seems to have 
received greater attention recently, current literature is characterised by a lack publications 
on psychosocial intervention and clinical management for FM in PD. FM interventions in 
published literature are impairment-oriented and focused on retaining or improving physical 
function of facial musculature (Katsikitis & Pilowsky, 1991; Dumer et al., 2014; Ricciardi et 
al., 2016). While physical mobility clearly plays an important role in facial functions, this 
neglects other issues and concerns encountered by individuals who have FM, including the 
emotional and interpersonal. Much of published research on psychological therapies in PD 
has focused on CBT for the treatment of depression (Spencer & Haub, 2018; Zarotti et al., 
2020). No published studies could be located that take a psychosocial approach to treating 
FM in PD. One UK-based community organisation, Changing Faces, uses a CBT- based 
self-model to help people cope with facial disfigurement (FD), with an overall aim of 
improving self-esteem and body-image (Partridge, 1998; Clarke, 1999).  In Clarke (1999), 
the key components are reported as exploring negative feelings about losing looks, 
challenging unrealistic beliefs about possible treatment or unhelpful beliefs about the future 
with FD, and learning problem-focused coping skills. A different CBT outpatient programme 
for facial and bodily disfigurement evaluated post treatment outcomes, finding social anxiety, 
depression, and distress related to appearance were significantly improved (Kleve et al., 
2002). CBT could be adapted to focus on key problems of FM and tested in PD. Future 




treat psychological and social issues in people with PD, such as family systems therapy 
(Spencer & Haub, 2018). Topics which could be usefully explored in psychological 
interventions for FM could include: intense anxiety about the future personal consequences 
of developing FM; recognising and challenging negative cognitions that stem from the 
misinterpretation of FM (the impression bias); problem-solving for FM-related difficulties that 
cause relationship discord. 
 In summary, FM does have a detrimental effect on social and psychological 
wellbeing in PD but may have a differential impact for PwP and their SO. It was participants 
perceptions of the impact of FM-related difficulties, rather than symptom severity per se, 
which was most strongly linked to poorer psychosocial outcomes. People who experienced 
FM used a range of strategies to help them cope but still desired greater education and 
support around this symptom. FM targeted psychosocial interventions are yet to be 
published in the literature, however existing psychological therapies in PD could be adapted 










Strengths, Limitations & Directions for Future Research 
 There are limitations with respect to the participant cohorts of this research. One 
limitation was the sample size, the level of FM severity, and range of PD stages represented. 
While a handful of people with a higher degree of FM took part, future research would 
benefit from including a greater proportion of people with severe FM. Another limitation was 
the recruitment of research participants who mostly came from Parkinson’s support group 
organisations, due to the lack of a central PD register within the New Zealand public health 
system. There may be differences in the characteristics of people who choose to engage in 
support services compared to those who do not. Self-selection of individuals who are 
relatively free of psychosocial stressors and/or at an earlier stage of PD might explain the 
generally positive findings on mental health and wellbeing measure for PwP in the present 
research. These limitations are in part a reflection of the relatively small NZ population and 
therefore small number of people PD (and FM) in NZ. They also reflect the lack of regular 
PD clinic times within the NZ public system. Replication of this research with a large multi-
site or international recruitment strategy would help to clarify the findings, in particular further 
validation of the FMQ (Study 2) is recommended. 
 From a methodological perspective, the interpretations of the findings of Study 3 
were limited because of the use of different methods of assessment and measurement 
instruments. Assessment of self-reported FM relied on a new questionnaire (the FMQ) in 
PwP and their SO, as no other patient or partner report measures could be located. The 
FMQ has good reliability and initial evidence of validity but may not accurately capture FM 
and its impact. Other FM studies have used a global rating item asking participants to rate 
the amount of expressivity difficulty they perceive on a 5-point scale, where 1 = no difficulty 
and 5 = severe difficulty (Gunnery et al., 2016; Ma et al., 2019). There may be differences in 
the characteristics of FM captured or emphasised by various methods of FM measurement.  
Due to practical restrictions, healthcare professionals used established clinical staging tools 




usual clinicians, which may have provided different ratings of FM severity. Further to this 
point, only two healthcare professionals provided assessment of FM severity, and those who 
took part were familiar with but not greatly experienced in using MDS-UPDRS rating scale.  
 Findings from the present programme of research suggest a number of additional 
directions for future investigations (other than those outlined above). Besides the main issue 
that outcomes of FM for patients and their families have been generally neglected in PD 
literature, there is a need for more comprehensive investigation of the differential impact of 
FM for PwP compared to SO. It could also be beneficial to examine the factors that could 
belie good adjustment to FM, such as psychological flexibility or the possible interaction 
between PD onset type and/or FM severity with the ability to meet social role demands 
across different life stages. This research began to describe the compensatory methods 
used by people with FM and their partners but did not investigate what strategies work best 
or for whom, which would be an interesting topic for future research. The focus of the 
present project and existing FM research has been the consequences for primary social 
relationships, the influence on interactions with healthcare professionals, and the influence 
on interactions with strangers. Future research could describe the influence of FM in 
relationships with other key members of support networks for people with PD, including 
support/rehabilitation programme associates, cultural or community groups, work 
colleagues, and wider family or friends. Different factors may influence psychosocial 
wellbeing across various types of social relationships, and this could be further investigated. 
Lastly, it was beyond the scope of this thesis to investigate the link between FM and 
changes to speech, and with other types of affective dysregulation that co-occur in PD.  
Current research has generally focused on individual variables such as FM, emotion 
recognition, or speech difficulties. It might be beneficial to take a holistic approach to 







 This thesis set out to understand the lived experiences and psychosocial 
consequences of FM for PwP and their SO. Findings from the initial qualitative investigation 
concluded FM does interfere with the ability of SO to decode the internal state of the person 
who has PD and can have a negative effect on subjective wellbeing for individuals and 
couples. Study 2 presented the development and validation of two targeted questionnaires 
which could help to improve clinical assessment of FM impact. The results of study 3 adds to 
what is known about the implications of FM, indicating that greater perceived FM severity 
and/or higher levels of difficulty related to FM are associated with poorer outcomes in some 
aspects of social and psychological wellbeing.  
 Overall, the findings from the present programme of research and existing evidence 
suggest FM can have a detrimental impact on psychosocial wellbeing in PD. However, FM 
may influence people who have PD and their partners/family members differently. More 
comprehensive exploration is required to better understand the psychosocial outcomes of 
FM in primary social relationships with close friends and family. As FM does have a negative 
impact for some people with PD and their family members, it warrants greater clinical 
attention. Therefore, two key directions for future research may include the adaptation and 
evaluation of psychological therapies for FM-related difficulty and investigation of the factors 
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